
<html lang="en"     class="pb-page"  data-request-id="63c79b0c-acfe-496e-aae7-40050c6b1ebd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00508;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-9"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine" /></meta><meta name="dc.Creator" content="Yudao  Shen" /></meta><meta name="dc.Creator" content="John D.  McCorvy" /></meta><meta name="dc.Creator" content="Michael L.  Martini" /></meta><meta name="dc.Creator" content="Ramona M.  Rodriguiz" /></meta><meta name="dc.Creator" content="Vladimir M.  Pogorelov" /></meta><meta name="dc.Creator" content="Karen M.  Ward" /></meta><meta name="dc.Creator" content="William C.  Wetsel" /></meta><meta name="dc.Creator" content="Jing  Liu" /></meta><meta name="dc.Creator" content="Bryan L.  Roth" /></meta><meta name="dc.Creator" content="Jian  Jin" /></meta><meta name="dc.Description" content="Functionally selective G protein-coupled receptor ligands are valuable tools for deciphering the roles of downstream signaling pathways that potentially contribute to therapeutic effects versus sid..." /></meta><meta name="Description" content="Functionally selective G protein-coupled receptor ligands are valuable tools for deciphering the roles of downstream signaling pathways that potentially contribute to therapeutic effects versus sid..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 9, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00508" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00508" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00508" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00508" /></link>
        
    
    

<title>D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00508" /></meta><meta property="og:title" content="D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0017.jpeg" /></meta><meta property="og:description" content="Functionally selective G protein-coupled receptor ligands are valuable tools for deciphering the roles of downstream signaling pathways that potentially contribute to therapeutic effects versus side effects. Recently, we discovered both Gi/o-biased and β-arrestin2-biased D2 receptor agonists based on the Food and Drug Administration (FDA)-approved drug aripiprazole. In this work, based on another FDA-approved drug, cariprazine, we conducted a structure–functional selectivity relationship study and discovered compound 38 (MS1768) as a potent partial agonist that selectively activates the Gi/o pathway over β-arrestin2. Unlike the dual D2R/D3R partial agonist cariprazine, compound 38 showed selective agonist activity for D2R over D3R. In fact, compound 38 exhibited potent antagonism of dopamine-stimulated β-arrestin2 recruitment. In our docking studies, compound 38 directly interacts with S1935.42 on TM5 but has no interactions with extracellular loop 2, which appears to be in contrast to the binding poses of D2R β-arrestin2-biased ligands. In in vivo studies, compound 38 showed high D2R receptor occupancy in mice and effectively inhibited phencyclidine-induced hyperlocomotion." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00508"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00508">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00508&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00508&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00508&amp;href=/doi/10.1021/acs.jmedchem.9b00508" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4755-4771</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00338" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00350" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">D<sub>2</sub> Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yudao Shen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yudao Shen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yudao++Shen">Yudao Shen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John D. McCorvy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John D. McCorvy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div><div class="loa-info-affiliations-info">Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++McCorvy">John D. McCorvy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael L. Martini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael L. Martini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+L.++Martini">Michael L. Martini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ramona M. Rodriguiz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ramona M. Rodriguiz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ramona+M.++Rodriguiz">Ramona M. Rodriguiz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vladimir M. Pogorelov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vladimir M. Pogorelov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vladimir+M.++Pogorelov">Vladimir M. Pogorelov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karen M. Ward</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen M. Ward</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Worldwide Research and Development, Internal Medicine Research Unit, Pfizer, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen+M.++Ward">Karen M. Ward</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">William C. Wetsel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">William C. Wetsel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=William+C.++Wetsel">William C. Wetsel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jing Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jing Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#72181b131c5c181b1c321f01011f5c171607"><span class="__cf_email__" data-cfemail="244e4d454a0a4e4d4a64495757490a414051">[email protected]</span></a> (J.J.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Liu">Jing Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bryan L. Roth</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bryan L. Roth</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3c5e4e455d52634e5348547c5159581249525f12595849"><span class="__cf_email__" data-cfemail="98faeae1f9f6c7eaf7ecf0d8f5fdfcb6edf6fbb6fdfced">[email protected]</span></a> (B.L.R.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+L.++Roth">Bryan L. Roth</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0561-6520" title="Orcid link">http://orcid.org/0000-0002-0561-6520</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jian Jin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3d5754535a135154487d504e4e5013585948"><span class="__cf_email__" data-cfemail="84eeedeae3aae8edf1c4e9f7f7e9aae1e0f1">[email protected]</span></a> (J.L.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Jin">Jian Jin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2387-3862" title="Orcid link">http://orcid.org/0000-0002-2387-3862</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00508&amp;href=/doi/10.1021%2Facs.jmedchem.9b00508" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4755–4771</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 9, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 March 2019</li><li><span class="item_label"><b>Published</b> online</span>9 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00508" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00508</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4755%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYudao%2BShen%252C%2BJohn%2BD.%2BMcCorvy%252C%2BMichael%2BL.%2BMartini%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D9%26contentID%3Dacs.jmedchem.9b00508%26title%3DD2%2BDopamine%2BReceptor%2BG%2BProtein-Biased%2BPartial%2BAgonists%2BBased%2Bon%2BCariprazine%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4771%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00508"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1746</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00508" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yudao&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. McCorvy&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;L. Martini&quot;},{&quot;first_name&quot;:&quot;Ramona&quot;,&quot;last_name&quot;:&quot;M. Rodriguiz&quot;},{&quot;first_name&quot;:&quot;Vladimir&quot;,&quot;last_name&quot;:&quot;M. Pogorelov&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;M. Ward&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;C. Wetsel&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;L. Roth&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Jin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4755-4771&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00508&quot;},&quot;abstract&quot;:&quot;Functionally selective G protein-coupled receptor ligands are valuable tools for deciphering the roles of downstream signaling pathways that potentially contribute to therapeutic effects versus side effects. Recently, we discovered both Gi/o-biased and β-arrestin2-biased D2 receptor agonists based on the Food and Drug Administration (FDA)-approved drug aripiprazole. In this work, based on another FDA-approved drug, cariprazine, we conducted a structure–functional selectivity relationship study and discovered compound 38 (MS1768) as a potent partial agonist that selectively activates the Gi/o pathway over β-arrestin2. Unlike the dual D2R/D3R partial agonist cariprazine, compound 38 showed selective agonist activity for D2R over D3R. In fact, compound 38 exhibited potent antagonism of dopamine-stimulated β-arrestin2 recruitment. In our docking studies, compound 38 directly interacts with S1935.42 on TM5 but has no interactions with extracellular loop 2, which appears to be in contrast to the binding poses of D2&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00508&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00508" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00508&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00508" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00508&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00508" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00508&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00508&amp;href=/doi/10.1021/acs.jmedchem.9b00508" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00508" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00508" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00508%26sid%3Dliteratum%253Aachs%26pmid%3D30964661%26genre%3Darticle%26aulast%3DShen%26date%3D2019%26atitle%3DD2%2BDopamine%2BReceptor%2BG%2BProtein-Biased%2BPartial%2BAgonists%2BBased%2Bon%2BCariprazine%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D9%26spage%3D4755%26epage%3D4771%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/jmcmar.2019.62.issue-9/20190509/jmcmar.2019.62.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Functionally selective G protein-coupled receptor ligands are valuable tools for deciphering the roles of downstream signaling pathways that potentially contribute to therapeutic effects versus side effects. Recently, we discovered both G<sub>i/o</sub>-biased and β-arrestin2-biased D<sub>2</sub> receptor agonists based on the Food and Drug Administration (FDA)-approved drug aripiprazole. In this work, based on another FDA-approved drug, cariprazine, we conducted a structure–functional selectivity relationship study and discovered compound <b>38</b> (MS1768) as a potent partial agonist that selectively activates the G<sub>i/o</sub> pathway over β-arrestin2. Unlike the dual D<sub>2</sub>R/D<sub>3</sub>R partial agonist cariprazine, compound <b>38</b> showed selective agonist activity for D<sub>2</sub>R over D<sub>3</sub>R. In fact, compound <b>38</b> exhibited potent antagonism of dopamine-stimulated β-arrestin2 recruitment. In our docking studies, compound <b>38</b> directly interacts with S193<sup>5.42</sup> on TM5 but has no interactions with extracellular loop 2, which appears to be in contrast to the binding poses of D<sub>2</sub>R β-arrestin2-biased ligands. In in vivo studies, compound <b>38</b> showed high D<sub>2</sub>R receptor occupancy in mice and effectively inhibited phencyclidine-induced hyperlocomotion.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">G protein-coupled receptors (GPCRs) are seven-transmembrane domain receptors<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> that have been implicated in the pathophysiology of numerous human diseases including schizophrenia,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Parkinson’s disease,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> attention-deficit disorders,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and obesity.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> More than 30% of current Food and Drug Administration (FDA) approved drugs target GPCRs.<a onclick="showRef(event, 'ref1 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref6 ref7">(1,6,7)</a> Historically, GPCR drug discovery has postulated that ligand engagement with a receptor could only lead to a single unique outcome.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Under this simplified paradigm, partial and full agonists were classified as ligands that stimulated the recognized downstream signaling pathway, whereas antagonists were ligands that simply blocked the actions of agonists.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Current research, however, suggests that GPCR ligands can induce conformational changes that result in selective activation of distinct downstream signaling pathways.<a onclick="showRef(event, 'ref1 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref7">(1,7)</a> This concept has been widely accepted by the academic and pharmaceutical communities and is termed biased signaling or functional selectivity.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14">(9−14)</a></div><div class="NLM_p">Functional selectivity in GPCR ligands has important potential clinical implications as it has been suggested that different signaling pathways contribute to various drug pharmacological profiles including both therapeutic actions and adverse effects.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> For example, carvedilol and metoprolol tartrate are both inverse agonists of cyclic adenosine monophosphate (cAMP) production at β<sub>2</sub>AR, but carvedilol has also been shown to possess phospho-ERK1/2 activity, likely leading to the reduction in mortality observed in a clinical trial on patients with chronic heart failure.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Another example includes PZM21, a potent Gi-biased agonist of the μ-opioud-receptor (μOR) that was shown to efficiently reduce pain without causing lethal side effects, such as fatal respiratory depression and morphine-like reinforcing activity. In contrast, both of these side effects are observed alongside therapeutic analgesia when the unbiased μOR agonist morphine is administered.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These findings have fueled great interest in the discovery of new functionally selective ligands for various GPCRs.<a onclick="showRef(event, 'ref13 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref13 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36">(13,21−36)</a></div><div class="NLM_p">Dopaminergic receptors are a subfamily of aminergic GPCRs that are highly expressed in the brain. Dopaminergic receptors are generally classified into subtypes as D<sub>1</sub>-like (D<sub>1</sub> and D<sub>5</sub>) and D<sub>2</sub>-like (D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub>). D<sub>2</sub>R is the most highly studied dopaminergic receptor due to its implication in neuropsychiatric diseases.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Previously, we discovered both β-arrestin2-biased and G protein-biased D<sub>2</sub>R agonists through investigation of the structure–functional selectivity relationship (SFSR) of the FDA-approved drug aripirazole.<a onclick="showRef(event, 'ref35 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref35 ref39 ref40 ref41">(35,39−41)</a> Other groups have also reported multiple functionally selective D<sub>2</sub> receptor agonists.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref42 ref43 ref44 ref45">(27−30,42−45)</a> Among them, cariprazine and its 1,2,3,4-tetrahydroisoquinoline (THIQ) isosteres were reported to selectively activate the D<sub>2</sub>R G<sub>i/o</sub>-mediated cAMP inhibition pathway over the phospho-ERK1/2 pathway.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> However, for these cariprazine analogues, there are no reports on ligand bias with regard to β-arrestin recruitment.</div><div class="NLM_p last">Cariprazine is an FDA-approved drug for the treatment of schizophrenia and bipolar mania in adults and is currently also under clinical investigation for the treatment of bipolar depression and major depressive disorder.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Cariprazine, however, is also known to carry several side effects including extrapyramidal symptoms, indigestion, nausea, headache, and weight gain.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> A functionally selective cariprazine-biased D<sub>2</sub>R agonist has the potential to serve as a tool for dissecting the therapeutic and adverse effects of different downstream pathways, which may ultimately lead to improved therapeutics. In the present study, we conducted an SFSR study starting from the cariprazine scaffold and report the discovery of compound <b>38</b>, a THIQ isostere of cariprazine, as a G protein-biased D<sub>2</sub>R partial agonist. Here, we present the design, synthesis, and biological characterization of compound <b>38</b> and its analogues.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Discovery of Compound <b>16</b> as a G Protein-Biased Agonist</h3><div class="NLM_p">We conducted an SFSR study on three regions of the cariprazine scaffold: (1) the left-hand side (LHS) 2,3-dichlorophenylpiperazinyl moiety, (2) the middle linker cyclohexylene ring moiety, and (3) the right-hand side (RHS) urea moiety, including a few known compounds in ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>. The syntheses of <b>9</b> (cariprazine) and the designed analogues, <b>10</b>–<b>12</b>, <b>15</b> and <b>16</b> are outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The Boc-protected ethyl 2-(<i>trans</i>-4-aminocyclohexyl)acetate <b>1</b> was prepared by esterification of commercially available 2-(<i>trans</i>-4-aminocyclohexyl)acetic acid, followed by protection of the amino group with di-<i>tert</i>-butyl dicarbonate. Lithium borohydride-mediated reduction of the methyl ester provided the alcohol <b>2</b>. After activation of the hydroxyl group, the resulting reactive methanesulfonate ester intermediate was converted into the cyano compound <b>3</b>. Diisobutylaluminium hydride (DIBAL-H)-mediated reduction of the cyano group afforded the <i>trans</i>-aldehyde <b>4</b>. The <i>cis</i>-aldehyde <b>8</b> was synthesized from 2-(<i>cis</i>-4-aminocyclohexyl)acetic acid using the same procedures described above for the preparation of compound <b>4</b>. Compound <b>10</b> was obtained via reductive amination of <b>4</b> and 1-(2,3-dichlorophenyl)piperazine in the presence of sodium triacetoxyborohydride. Boc-group deprotection under acidic conditions afforded compound <b>11</b>, which was subsequently converted to <b>9</b> by dimethylurea formation with dimethylcarbamoyl chloride. Compound <b>12</b> was prepared from the <i>cis</i>-aldehyde <b>8</b> using the same procedures as compound <b>9</b>. Compound <b>15</b> was synthesized using a 5-carbon linker moiety. Boc protection of commercially available 5-aminopentanol gave <b>13</b>. Activation of the free hydroxyl group followed by substitution with 2,3-dichlorophenylpiperazine yielded <b>14</b>. Boc deprotection followed by dimethylurea formation afforded compound <b>15</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Compound <b>16</b> was prepared from the <i>cis</i>-aldehyde <b>4</b> and 1,2,3,4-tetrahydroisoquinoline using the same procedures as compound <b>9</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Cariprazine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, reflux; (b) Boc<sub>2</sub>O, triethylamine (TEA), dichloromethane (DCM), 85–95% over two steps; (c) LiBH<sub>4</sub>, Et<sub>2</sub>O, MeOH, 94–95%; (d) MsCl, TEA, DCM; (e) NaCN, dimethyl sulfoxide (DMSO), 90 °C, 90–96% over two steps; (f) DIBAL-H, DCM, −78 °C, 76–80%; (g) NaBH(OAc)<sub>3</sub>, DCM, 75%; (h) trifluoroacetic acid (TFA), DCM, 58%; (i) dimethylcarbamoyl chloride, TEA, DCM, 33–47%; (j) 1-(2,3-dichlorophenyl)piperazine, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 12%.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>6</b> and Its Analogues <b>16</b>–<b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) NaBH(OAc)<sub>3</sub>, DCM, 73%; (b) TFA, DCM; (c) TEA, DCM, 41–74% over two steps.</p></p></figure><div class="NLM_p">All of these synthesized compounds were then evaluated for their effects on D<sub>2</sub>R G<sub>i/o</sub>-mediated cAMP inhibition and β-arrestin2 recruitment. The D<sub>2</sub>R G<sub>i/o</sub>-mediated cAMP inhibition assay measures inhibition of isoproterenol-stimulated cAMP production via the G<sub>i/o</sub>-coupled signaling pathway, whereas the D<sub>2</sub>R-mediated β-arrestin2 translocation Tango assay measured the recruitment of β-arrestin2 to D<sub>2</sub>R.<a onclick="showRef(event, 'ref41 ref48'); return false;" href="javascript:void(0);" class="ref ref41 ref48">(41,48)</a> Quinpirole, a full D<sub>2</sub>R agonist, was used as a balanced positive control in both assays (G<sub>i/o</sub>: EC<sub>50</sub> = 1.8 nM, pEC<sub>50</sub> = 8.74 ± 0.08; β-arrestin2: EC<sub>50</sub> = 2.7 nM, pEC<sub>50</sub> = 8.57 ± 0.10). The potency (EC<sub>50</sub>) and efficacy (<i>E</i><sub>max</sub>) in both pathways for each compound in this series are displayed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SFSR Study on Cariprazine<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub>, pEC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least three independent experiments performed in triplicate with standard error of the mean (SEM). Bias factors were calculated as described in the methods, with respect to quinpirole as a positive control (G<sub>i/o</sub>: EC<sub>50</sub> = 1.8 nM, pEC<sub>50</sub> = 8.74 ± 0.08; β-arrestin2: EC<sub>50</sub> = 2.7 nM, pEC<sub>50</sub> = 8.57 ± 0.10).</p></div></div><div></div></div><div class="NLM_p">Although compound <b>9</b> was reported to be functionally selective for the cAMP (G<sub>i/o</sub>-protein) pathway over the ERK1/2 phosphorylation pathway,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> this compound did not show significant bias for the G<sub>i/o</sub> pathway (EC<sub>50</sub> = 0.4 nM; <i>E</i><sub>max</sub> = 70%) over the β-arrestin2 pathway (EC<sub>50</sub> = 0.6 nM; <i>E</i><sub>max</sub> = 66%). Modification of the dimethylurea group to a <i>tert</i>-butyl carbamate (<b>10</b>) drastically reduced the potencies for both the G<sub>i/o</sub> (35-fold) and β-arrestin2 (15-fold) pathways, while slightly increasing the efficacies to approximately 75% of the maximal responsiveness in both pathways. Truncation of the dimethylurea group to the primary amino group (<b>11</b>) did not obviously change either potency or efficacy for the G<sub>i/o</sub> pathway. Compared to <b>9</b>, compound <b>11</b> displayed decreased potency (3-fold) and retained almost equal efficacy in the β-arrestin2 recruitment assay, suggesting that a positively charged amino group in this region is detrimental to potency in β-arrestin2 recruitment. Switching the <i>trans-</i>1,4-cyclohexylene of <b>9</b> to a <i>cis-</i>1,4<i>-</i>cyclohexylene moiety (<b>12</b>) resulted in a significant decrease in the potency and efficacy in both the G<sub>i/o</sub> and β-arrestin2 pathways (G<sub>i/o</sub>: EC<sub>50</sub> = 3 nM; <i>E</i><sub>max</sub> = 48%; β-arrestin2: EC<sub>50</sub> = 12 nM; <i>E</i><sub>max</sub> = 37%). Replacement of the <i>trans-</i>1,4<i>-</i>cyclohexylene group-containing linker to a more flexible 5-carbon chain led to a significant decrease in potency (17-fold) and efficacy (<i>E</i><sub>max</sub> = 24%) for β-arrestin2 recruitment and also an obvious decrease in potency (18-fold) and efficacy (<i>E</i><sub>max</sub> = 29%) for the G<sub>i/o</sub> pathway. Replacement of the 2,3-dichlorophenylpiperazine to its isostere 1,2,3,4-tetrahydroisoquinoline (THIQ) has been explored in D<sub>2</sub>R and D<sub>3</sub>R studies.<a onclick="showRef(event, 'ref27 ref49'); return false;" href="javascript:void(0);" class="ref ref27 ref49">(27,49)</a> The THIQ compound <b>16</b> displayed significantly reduced potency and efficacy in both pathways (G<sub>i/o</sub>: EC<sub>50</sub> = 12 nM; <i>E</i><sub>max</sub> = 60%; β-arrestin2: EC<sub>50</sub> = 69 nM; <i>E</i><sub>max</sub> = 22%). However, <b>16</b> also displayed bias toward G<sub>i/o</sub> signaling over β-arrestin2 recruitment with a bias factor of 11 relative to quinpirole.</div><div class="NLM_p last">Given the promising functional selectivity of <b>16</b>, we opted to focus our SFSR campaign on the THIQ series by exploring three regions of this scaffold: the LHS 1,2,3,4-tetrahydroisoquinoline moiety, the middle linker cyclohexylene ring moiety, and the RHS urea moiety.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> SFSR of the RHS of the THIQ Scaffold</h3><div class="NLM_p">We explored a series of compounds (<b>17</b>–<b>25</b>) with different sized urea, carbamate, and amide moieties at the RHS. These compounds were synthesized according to the procedures for the preparation of <b>16</b>, as outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The results from both cAMP and β-arrestin2 assays are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SFSR Study on the Right-Hand Side Moiety of Compound <b>16</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub>, pEC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least three independent experiments performed in triplicate with standard error of the mean (SEM). Bias factors were calculated as described in the methods, with respect to quinpirole as a positive control (G<sub>i/o</sub>: EC<sub>50</sub> = 1.8 nM, pEC<sub>50</sub> = 8.74 ± 0.08; β-arrestin2: EC<sub>50</sub> = 2.7 nM, pEC<sub>50</sub> = 8.57 ± 0.10). N.C., not calculated.</p></div></div><div></div></div><div class="NLM_p">Increasing the bulkiness of the dimethylurea moiety (<b>16</b>) to diethylurea (<b>17</b>) or diisopropyl urea (<b>18</b>) significantly reduced the potencies by 3–5-fold, while maintaining the maximal responsiveness for both the G<sub>i/o</sub> and β-arrestin2 recruitment pathways. Compared to <b>16</b>, a pyrrolidine carboxamide group (<b>19</b>) retained similar potency and increased the efficacy (G<sub>i/o</sub>: EC<sub>50</sub> = 14 nM; <i>E</i><sub>max</sub> = 66%; β-arrestin2: EC<sub>50</sub> = 88 nM; <i>E</i><sub>max</sub> = 42%) in both pathways. This modification, however, did not improve the bias profile toward G<sub>i/o</sub> protein activity. For the carbamate analogues, the <i>tert</i>-butyl group (<b>20</b>) showed better G<sub>i/o</sub> pathway activation (EC<sub>50</sub> = 33 nM; <i>E</i><sub>max</sub> = 59%) than isopropyl (<b>21</b>) (EC<sub>50</sub> = 74 nM; <i>E</i><sub>max</sub> = 49%) and ethyl groups (EC<sub>50</sub> = 144 nM; <i>E</i><sub>max</sub> = 53%). Similarly, the <i>tert</i>-butyl group (<b>20</b>) also demonstrated better activity in the β-arrestin2 recruitment assay (EC<sub>50</sub> = 195 nM; <i>E</i><sub>max</sub> = 52%) than isopropyl (<b>21</b>) (EC<sub>50</sub> = 238 nM; <i>E</i><sub>max</sub> = 26%) and ethyl (<b>22</b>) groups (EC<sub>50</sub> = 636 nM; <i>E</i><sub>max</sub> = 22%). For the amide RHS, benzamide (<b>23</b>) was more potent in inducing both G<sub>i/o</sub>-mediated cAMP inhibition (EC<sub>50</sub> = 8 nM; <i>E</i><sub>max</sub> = 62%) and β-arrestin2 recruitment (EC<sub>50</sub> = 65 nM; <i>E</i><sub>max</sub> = 50%) than propionamide (<b>24</b>) and acetamide (<b>25</b>). Albeit rather weak agonists for the G<sub>i/o</sub> pathway (for <b>24</b>: EC<sub>50</sub> = 132 nM; <i>E</i><sub>max</sub> = 33%; for <b>25</b>: EC<sub>50</sub> = 54 nM; <i>E</i><sub>max</sub> = 22%), both propionamide (<b>24</b>) and acetamide (<b>25</b>) showed diminished efficacy in β-arrestin2 recruitment (EC<sub>50</sub> not calculated; <i>E</i><sub>max</sub> < 10%). Consequently, these smaller amide moieties (<b>24</b> and <b>25</b>) confer apparent functional selectivity toward the G<sub>i/o</sub> pathway.</div><div class="NLM_p last">Overall, this SFSR study with the urea, carbamate, and amide moieties of the THIQ scaffold did not provide a significantly superior functionally selective D<sub>2</sub>R agonist compared to compound <b>16</b>. Modifications that lead to improved activities in the G<sub>i/o</sub> pathway were always accompanied with improved β-arrestin2 recruitment. To improve the functional selectivity and efficacy of this series in the G<sub>i/o</sub> pathway, we retained the dimethylurea moiety of compound <b>16</b> for the following studies on the middle linkers and LHS moieties.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> SFSR of the Middle Linker of the THIQ Scaffold</h3><div class="NLM_p">To determine effects of the middle linker on D<sub>2</sub>R functional selectivity, we explored compounds <b>26</b>, <b>28</b>, <b>30</b>, and <b>32</b>. The synthetic routes are summarized in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Their biological results are outlined in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds for Exploring the Middle Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) NaBH(OAc)<sub>3</sub>, DCM; (b) TFA, DCM; (c) dimethylcarbamoyl chloride, TEA, DCM, 64% over three steps; (d) MsCl, TEA, DCM; (e) 1,2,3,4-tetrahydroisoquinoline, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 95 °C, 15–43%; (f) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, tetrahydrofuran (THF), 80%; (g) dimethylcarbamoyl chloride, K<sub>2</sub>CO<sub>3</sub>, THF, 23% over four steps.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SFSR Study of the Middle Linker of Compound <b>16</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0015.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub>, pEC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least three independent experiments performed in triplicate with standard error of the mean (SEM). Bias factors were calculated as described in the methods, with respect to quinpirole as a positive control (G<sub>i/o</sub>: EC<sub>50</sub> = 1.8 nM, pEC<sub>50</sub> = 8.74 ± 0.08; β-arrestin2: EC<sub>50</sub> = 2.7 nM, pEC<sub>50</sub> = 8.57 ± 0.10). N.C., not calculated. N.A., no activity.</p></div></div><div></div></div><div class="NLM_p">Compound <b>26</b> was synthesized according to the same procedures for the preparation of <b>16</b> from the <i>cis</i>- aldehyde <b>8</b>. The preparation of compound <b>28</b> started from compound <b>2</b>. The activation of the hydroxyl group of <b>2</b> with methanesulfonyl chloride, followed by substitution with 1,2,3,4-tetrahydroisoquinoline, provided the Boc-protected intermediate <b>27</b>. Boc deprotection and subsequent urea formation yielded <b>28</b>. Compound <b>30</b> was synthesized following the protocols for the preparation of <b>28</b> from the alcohol intermediate <b>29</b>, which was prepared by selective Boc protection of the commercially available 2-(4-aminophenyl)ethan-1-ol. Similarly, compound <b>32</b> was synthesized using the same route as the preparation of <b>28</b> from the alcohol <b>13</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><div class="NLM_p last">Replacement of the <i>trans</i>-1,4-cyclohexylene ring of <b>16</b> with a <i>cis</i>-1,4-cyclohexylene group (<b>26</b>) significantly decreased potency (22-fold), while maintaining efficacy (<i>E</i><sub>max</sub> = 58%) for the G<sub>i/o</sub> pathway. Interestingly, compound <b>26</b> showed very low activity for β-arrestin2 recruitment (EC<sub>50</sub> > 1000 nM), resulting in our inability to calculate a bias factor for this compound. However, <b>26</b> still showed low potency for the G<sub>i/o</sub> pathway (EC<sub>50</sub> = 259 nM), indicating weak G protein-bias. Incorporation of a short linker (<b>28</b>), a rigid aromatic linker (<b>30</b>), or a flexible 5-C chain linker (<b>32</b>) resulted in compounds that were all inactive in both the cAMP inhibition and β-arrestin2 recruitment assays. Taken together, these findings suggest that the central linker plays an important role in the functional potency and efficacy of this scaffold in both the G<sub>i/o</sub> and β-arrestin2 signaling pathways.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> SFSR of the LHS of the THIQ Scaffold</h3><div class="NLM_p">We next explored compounds <b>33</b>–<b>43</b> to study the effects of phenyl substituents on D<sub>2</sub>R functional selectivity. Compounds <b>33</b>–<b>43</b> were prepared using the same synthetic routes for <b>16</b>, starting from the appropriately substituted 1,2,3,4-tetrahydroisoquinoline precursor (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The biological assay data are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds with Various Substituents on the LHS Phenyl Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) NaBH(OAc)<sub>3</sub>, DCM; (b) TFA, DCM; (c) dimethylcarbamoyl chloride, TEA, DCM, 29–53% over three steps.</p></p></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SFSR Study of Left-Hand Side Moiety of Compound <b>16</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0016.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0018.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub>, pEC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least three independent experiments performed in triplicate with standard error of the mean (SEM). Bias factors were calculated as described in the methods, with respect to quinpirole as a positive control (G<sub>i/o</sub>: EC<sub>50</sub> = 1.8 nM, pEC<sub>50</sub> = 8.74 ± 0.08; β-arrestin2: EC<sub>50</sub> = 2.7 nM, pEC<sub>50</sub> = 8.57 ± 0.10). N.C., not calculated.</p></div></div><div></div></div><div class="NLM_p last">Given that cariprazine featured a dichloro substitution pattern on its LHS, we designed and synthesized compound <b>33</b> bearing a 5,6-dicholoro-substituted THIQ. Similar to cariprazine, compound <b>33</b> was not functionally selective in the two signaling pathways. Notably, however, this compound exhibited higher efficacy than cariprazine for both the G<sub>i/o</sub> (<i>E</i><sub>max</sub> = 116%) and β-arrestin2 (<i>E</i><sub>max</sub> = 90%) pathways. In fact, its G<sub>i/o</sub> signaling efficacy was even higher than that of the control compound quinpirole (<i>E</i><sub>max</sub> = 100%), indicating superagonism. A 6,7-dioxole on the THIQ (<b>34</b>) did not show significant G<sub>i/o</sub> pathway selectivity. Because of the enhanced maximal responsiveness of both signaling pathways to the 5,6-dichloro substituent (<b>33</b>), we explored the effects of monochloro substituents at the 5-, 6-, 7-, and 8-positions on the THIQ. Similar to <b>33</b>, the 5-chloro compound <b>35</b> was a balanced near-full agonist for both the G<sub>i/o</sub> signaling pathway (<i>E</i><sub>max</sub> = 95%) and β-arrestin2 recruitment (<i>E</i><sub>max</sub> = 92%). A monochloro substituent at the 7-position (<b>37</b>) also resulted in a balanced effect in both pathways, however, a 6- or 8-chloro substituent on the THIQ moiety led to biased partial agonists for activating G<sub>i/o</sub> signaling. Although the functional selectivity of <b>36</b> (6-chloro) was moderate, compound <b>38</b> (8-chloro) displayed enhanced bias toward activating the G<sub>i/o</sub> signaling pathway (EC<sub>50</sub> = 11 nM; <i>E</i><sub>max</sub> = 62%) over β-arrestin2 recruitment (EC<sub>50</sub> = 40 nM; <i>E</i><sub>max</sub> = 11%) with a bias factor of 14. We next explored the methyl (<b>39</b>), bromo (<b>40</b>), fluoro (<b>41</b>), trifluoromethyl (<b>42</b>), and methoxy (<b>43</b>) substituents at the 8-position. Albeit with lower functional potencies (27–86 nM) for the G<sub>i/o</sub> signaling pathway than <b>38</b>, all of these compounds appeared to be partial agonists for stimulating G<sub>i/o</sub> signaling. Taken together, our results suggest that the substituents of the LHS 1,2,3,4-tetrahydroisoquinoline moiety play a critical role in modulating functional selectivity of D<sub>2</sub>R. The 8-chloro substituent on the THIQ moiety provided a potent and G<sub>i/o</sub>-biased compound, <b>38</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Evaluation of G<sub>i/o</sub> Protein-Biased D<sub>2</sub>R Agonist <b>38</b> in Orthogonal Assays</h3><div class="NLM_p">To further confirm the observed signaling bias, which has been shown to depend on cell background and readout.<a onclick="showRef(event, 'ref14 ref50'); return false;" href="javascript:void(0);" class="ref ref14 ref50">(14,50)</a> we tested <b>38</b> in a bioluminescence resonance energy transfer (BRET)-based assay<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> using quinpirole as the control. As demonstrated in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, in HEK 293T cells co-expressing D<sub>2</sub>R C-terminal tagged renilla luciferase (Rluc), a Venus-tagged β-arrestin2, and G protein-coupled receptor kinase 2 (GRK2), compound <b>38</b> displayed no activity for D<sub>2</sub>R-mediated β-arrestin2 recruitment compared to quinpirole (EC<sub>50</sub> = 115 nM; <i>E</i><sub>max</sub> = 100%). Next, to confirm compound <b>38</b> is an agonist in the D<sub>2</sub>R G protein pathway, we tested compound <b>38</b> in a Gαi1–Gγ2 dissociation BRET-based assay<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> using quinpirole as a control. In this assay, compound <b>38</b> showed potent partial agonist activity (EC<sub>50</sub> = 0.40 nM; <i>E</i><sub>max</sub> = 47%) compared to quinpirole (EC<sub>50</sub> = 2.4 nM; <i>E</i><sub>max</sub> = 100%) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). Taken together, BRET-based orthologous assay platforms for either G protein activation or β-arrestin2 recruitment confirmed that compound <b>38</b> is a G protein-biased D<sub>2</sub>R partial agonist.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Further confirmation that compound <b>38</b> is a G protein-biased D<sub>2</sub>R partial agonist. (A) D<sub>2</sub>R-mediated BRET β-arrestin recruitment activity of compounds <b>38</b> and quinpirole (EC<sub>50</sub> = 115 nM). (B) D<sub>2</sub>R-mediated Gi1 BRET activity of compounds <b>38</b> (EC<sub>50</sub> = 0.37 nM, <i>E</i><sub>max</sub> = 47%) and quinpirole (EC<sub>50</sub> = 2.4 nM). Data are the average of at least three independent experiments performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Evaluation of G<sub>i/o</sub> Protein-Biased D<sub>2</sub>R Agonist <b>38</b> in D<sub>2</sub>R β-Arrestin Antagonist Mode and in D<sub>3</sub>R Functional Assays</h3><div class="NLM_p">Considering that compound <b>38</b> is a G<sub>i/o</sub> protein-biased partial agonist showing no activity for D<sub>2</sub>R β-arrestin2 activity, we examined the antagonist activity of <b>38</b> for dopamine (DA)-induced D<sub>2</sub>R β-arrestin2 recruitment. Different from dopamine, compound <b>38</b> did not show agonist activity toward β-arrestin2 recruitment (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). However, similar to clozapine, <b>38</b> exhibited potent antagonism in blocking dopamine-stimulated β-arrestin2 recruitment (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Antagonist activity of compound <b>38</b> (IC<sub>50</sub> = 71 nM) on dopamine (DA)-stimulated D<sub>2</sub>R β-arrestin recruitment is similar to clozapine (IC<sub>50</sub> = 140 nM) as measured by Tango. Lack of D<sub>3</sub>R agonist activity of compound <b>38</b> compared to positive control quinpirole in the G<sub>i/o</sub>-mediated cAMP inhibition GloSensor assay (B) and β-arrestin recruitment Tango assay (C). Data are the average of three independent experiments performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Because cariprazine is a D<sub>2</sub>R/D<sub>3</sub>R dual partial agonist, we also tested whether the functionally selective D<sub>2</sub>R partial agonist, compound <b>38</b>, is also a D<sub>3</sub>R agonist. As demonstrated in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B,C, compound <b>38</b> acts as a selective agonist at D<sub>2</sub>R over D<sub>3</sub>R, showing no agonist activity in D<sub>3</sub>R G<sub>i/o</sub>-mediated cAMP inhibition assay (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) or β-arrestin2 recruitment assay (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Silico Studies</h3><div class="NLM_p">We next sought to explore how these findings from our SFSR campaign fit into the existing paradigms for biased signaling at D<sub>2</sub>R. To do this, we docked cariprazine, <b>16</b>, and <b>38</b> to a model based on the co-crystal structure of D<sub>2</sub>R in the complex with risperidone (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4">6CM4</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Because antagonists, such as risperidone, may stabilize different receptor conformations compared to agonists, we first compared this model to that of a previous D<sub>2</sub>R model from the literature that successfully modeled functional selectivity in D<sub>2</sub>R agonists.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The all-atom binding site root-mean-square deviation (RMSD) between our present model and this previously reported D<sub>2</sub>R model was 0.74 Å,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> indicating a high degree of similarity between the atom arrangements lining the binding pockets of both structures (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In silico structure-based SFSR studies of D<sub>2</sub>R agonists. (A) When the D<sub>2</sub>R crystal structure utilized for this study (gold) is overlayed with a D<sub>2</sub>R homology model from a previous study that examined the structural determinants of D<sub>2</sub>R agonist functional selectivity (blue), a high degree of similarity was noted between the two structures (all-atom binding site RMSD = 0.74 Å).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (B) The docked pose of cariprazine suggests that together with I184<sup>EL2</sup>, F189<sup>5.38</sup> may function as a “lid” over the binding pocket leading to increase ligand residence times and β-arrestin recruitment. (C) Compound <b>16</b> engages D<sub>2</sub>R from deeper within the orthosteric site, and the steric constraints it imposes on TM5 may partially underlie its G<sub>i/o</sub> bias. (D) Compound <b>38</b>’s chloro substituent forms a hydrogen bond with conserved TM5 serines and angles with the rest of the scaffold away from extracellular loop 2 (EL2), which would be predicted to enhance its G<sub>i</sub> bias compared to <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cariprazine docked to D<sub>2</sub>R revealed key binding pocket interactions including a salt bridge interaction between cariprazine’s protonated piperazinyl nitrogen and the conserved D114<sup>3.32</sup> residue (2.52 Å) and a close edge-to-face π interaction between cariprazine’s LHS dichlorophenyl entity and F390<sup>6.52</sup> (2.89 Å, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Notably in our pose, the LHS dichlorophenyl entity is oriented upward and toward TM5, such that the 3-chloro group can form a hydrogen bond with S193<sup>5.42</sup> (2.52 Å), which is a residue found to be important for D<sub>2</sub>R G<sub>i/o</sub>-dependent signaling.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Furthermore, the 3-chloro appears to form an n−π interaction with F189<sup>5.38</sup>, and the 2-chloro group is pointed toward I184<sup>EL2</sup> (4.70 Å), which is a residue previously implicated in D<sub>2</sub>R β-arrestin2 recruitment efficacy.<a onclick="showRef(event, 'ref41 ref45 ref53'); return false;" href="javascript:void(0);" class="ref ref41 ref45 ref53">(41,45,53)</a> Taken together, cariprazine’s binding pose appears to be consistent with its balanced agonist activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).</div><div class="NLM_p last">By contrast, D<sub>2</sub>R G protein-biased compounds <b>16</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C) and <b>38</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D) appear to dock deeper in the orthosteric binding site, lacking clear interactions with I184<sup>EL2</sup> and engaging TM5 further via strict steric constraints, which has previously been shown to play an important role in receptor activation and G protein signaling.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Specifically, the chloro substitution of <b>38</b> is able to directly interact with S193<sup>5.42</sup> on TM5 (2.07 Å). Given previous findings that ligand engagement with TM5 serines is critical for G protein signaling at D<sub>2</sub>R,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> this binding pose suggests that the TM5–LHS chloro interaction may contribute to <b>38</b>’s dramatic increase in G<sub>i/o</sub> bias compared to <b>16</b>, which by comparison has a weaker interaction with TM5. These docking poses suggest that the selective engagement with TM5 over EL2 may be important for the D<sub>2</sub>R G<sub>i/o</sub>-bias of compounds <b>16</b> and <b>38</b>, which is consistent with mechanisms previously proposed in the literature.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Receptor Occupancy and Behavioral Studies in Mice</h3><div class="NLM_p">To evaluate the in vivo D<sub>2</sub>R target engagement of compound <b>38</b>, we implemented a radioactive competitive assay to assess the displacement of [<sup>3</sup>H]-raclopride in mouse striatum and cerebellum.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Compound <b>38</b> dose-dependently bound to the D<sub>2</sub>R in mouse striatum and cerebellum, with full receptor occupancy observed at 32 mg/kg intravenous dose (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The high D<sub>2</sub>R target engagement of <b>38</b> encouraged us to examine the in vivo pharmacological effects of this ligand on supressing the NMDA receptor antagonist phencyclidine (PCP) in a PCP-stimulated hyperlocomotion open field test. Compound <b>38</b> significantly reduced PCP-induced hyperlocomotion at 1 mg/kg. At an elevated dose of 3.5 mg/kg, <b>38</b> almost completely suppressed the induced hyperlocomotion (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). It remains unclear whether the suppression of hyperlocomotor activity is due to compound <b>38</b>’s G protein-biased agonism or antagonism in this model of high dopamine efflux. Taken together, compound <b>38</b> was efficacious in vivo and may serve as a potential in vivo tool compound for elucidating the role of G protein-mediated D<sub>2</sub>R signaling.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>38</b> exhibits dose dependence to binding to D<sub>2</sub> receptor in male c57 mice. [<sup>3</sup>H]Raclopride in vivo binding assay was used.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>38</b> displays a potent antipsychotic-like activity in a hyperlocomotion study. C57Bl/6 mice were given the vehicle (Veh), 1, or 3.5 mg/kg <b>38</b> (intraperitoneally (i.p.)), followed 30 min later with the Veh or 6 mg/kg phencyclidine (PCP, i.p.). (A) Locomotor activities are shown as 5 min binned intervals. The repeated measures analysis of variance (RMANOVA) are provided for baseline [time: <i>F</i>(5, 145) = 12.731, <i>p</i> < 0.001; treatment: <i>F</i>(3, 29) = 2.722, <i>p</i> = 0.063; time by treatment: <i>F</i>(15, 145) = 1.878, <i>p</i> = 0.099] and for PCP-stimulated activity [time: <i>F</i>(17, 493) = 22.056, <i>P</i> < 0.001; treatment: <i>F</i>(3, 29) = 16.992, <i>p</i> < 0.001; time by treatment: <i>F</i>(51, 493) = 6.159, <i>p</i> = < 0.001]. (B) Locomotor activities presented as cumulative activity (0–30 min) and PCP-stimulated activity (31–90 min). A RMANOVA found the following: [pre–post: <i>F</i>(1, 29) = 55.625, <i>p</i> < 0.001; treatment: <i>F</i>(3, 29) = 20.004, <i>p</i> < 0.001; pre–post by treatment: <i>F</i>(3, 29) = 17.651, <i>p</i> < 0.001]. <i>N</i> = 8–9 mice/group; Bonferroni-corrected pair-wise comparisons—*<i>p</i> < 0.05, vs baseline within treatment; +<i>p</i> < 0.05, vs the Veh-PCP group within the post-stimulation interval; <sup>#</sup><i>p</i> < 0.05, 1 mg/kg compound vs 3.5 mg/kg compound <b>38</b> within the post-stimulation interval.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we designed and synthesized a series of cariprazine analogues and evaluated them in cAMP accumulation and β-arrestin2 recruitment assays. Our initial SFSR study revealed compound <b>16</b>, bearing a THIQ moiety, which exhibited bias for activating G<sub>i/o</sub> signaling over β-arrestin2 pathway with a bias factor of 11. Further optimization of <b>16</b> led to the discovery of compound <b>38</b>, which displayed an enhanced functional selectivity for the G<sub>i/o</sub> signaling pathway β-arrestin2 recruitment with a bias factor of 14. Orthologous BRET assays were used to confirm that <b>38</b> was a G protein-biased partial agonist. Unlike cariprazine, which was a dual partial agonist of D<sub>2</sub>R/D<sub>3</sub>R, compound <b>38</b> showed no agonist activity at D<sub>3</sub>R but demonstrated partial G<sub>i/o</sub> protein agonist activity at D<sub>2</sub>R. Compound <b>38</b> also exhibited potent D<sub>2</sub>R antagonism of dopamine-stimulated β-arrestin2 recruitment. Docking studies suggested that both a TM5–LHS chloro interaction and the resulting scaffold separation from EL2 could contribute to <b>38</b>’s high functional selectivity in the G<sub>i/o</sub> pathway. Finally, compound <b>38</b> was assessed in an in vivo receptor occupancy assay and a psychotomimetic-induced hyperlocomotion assay in rodents. Compound <b>38</b> showed high in vivo D<sub>2</sub>R target engagement as well as dose-dependent inhibition of PCP-induced hyperlocomotion in mice. Taken together, compound <b>38</b> is a highly G<sub>i/o</sub>-biased D<sub>2</sub>R partial agonist with the potential to serve as a tool compound for elucidating the role of G protein-mediated D<sub>2</sub>R signaling in pathophysiological systems.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry General Procedures</h3><div class="NLM_p last">High-performance liquid chromatography (HPLC) spectra for all compounds were acquired using an Agilent 1200 series system with a diode array detector. Chromatography was performed on a 2.1 × 150 mm<sup>2</sup> Zorbax 300SB-C18 5 μm column with water containing 0.1% formic acid as solvent A and acetonitrile containing 0.1% formic acid as solvent B at a flow rate of 0.4 mL/min. The gradient program was as follows: 1% B (0–1 min), 1–99% B (1–4 min), and 99% B (4–8 min). High-resolution mass spectra (HRMS) data were acquired in a positive ion mode using an Agilent G1969A API-TOF with an electrospray ionization (ESI) source. Nuclear magnetic resonance (NMR) spectra were acquired on either a Bruker DRX-600 spectrometer (600 MHz <sup>1</sup>H) or a Bruker Avance-III 800 MHz spectrometer (201 MHz <sup>13</sup>C). Chemical shifts are reported in ppm (δ). Preparative HPLC was performed on Agilent Prep 1200 series with UV detector set to 254 nm. Samples were injected into a Phenomenex Luna 250 × 30 mm<sup>2</sup>, 5 μM C<sub>18</sub> column at room temperature (rt). The flow rate was 40 mL/min. A linear gradient was used with 10% (or 50%) of MeOH (A) in H<sub>2</sub>O (with 0.1% TFA) (B) to 100% of MeOH (A). HPLC was used to establish the purity of target compounds. All final compounds had >95% purity using the HPLC methods described above. All final compounds are characterized as trifluoroacetic acid salt form, except compound <b>38</b>, of which form is free base.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Methyl <i>trans</i>-4-((<i>tert</i>-Butoxycarbonyl)amino)cyclohexane-1-carboxylate (<b>1</b>)</h3><div class="NLM_p">To a solution of 4-aminocyclohexane-1-carboxylic acid HCl salt (5 g, 27.9 mmol) in methanol (100 mL) was added thionyl chloride (7.5 mL, 103.5 mmol) at 0 °C. The resulting solution was warmed to rt and stirred for 18 h. Solvent removal under reduced pressure yielded the crude product as an off-white solid, which was used in the next step without further purification.</div><div class="NLM_p last">To a solution of the crude intermediate in dichloromethane (100 mL) was added triethylamine (6 mL, 43 mmol) at 0 °C, followed by di-<i>tert</i>-butyl dicarbonate (8.6 g, 39.5 mmol). The reaction was stirred overnight before being quenched with saturated aqueous sodium bicarbonate. The mixture was extracted with dichloromethane (3 × 50 mL). Combined organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was purified by silica gel flash chromatography (elution with hexane/EtOAc = 1:1) to give compound <b>1</b> as white powder (6.84 g, 95%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 3.67 (s, 3H), 3.33–3.25 (m, 1H), 2.36–2.16 (m, 1H), 2.03–1.88 (m, 4H), 1.45–1.47 (m, 11H), 1.31–1.16 (m, 2H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>tert</i>-Butyl (<i>trans</i>-4-(Hydroxymethyl)cyclohexyl)carbamate (<b>2</b>)</h3><div class="NLM_p last">To a solution of methyl <i>trans</i>-4-((<i>tert</i>-butoxycarbonyl)amino)cyclohexane-1-carboxylate (6.84, 26.5 mmol) in diethyl ether (120 mL) and methanol (0.6 mL) was added lithium borohydride (1.83 g, 84 mmol) in portions, followed by dropwise addition of methanol (3 mL). The resulting mixture was stirred for 45 min before being quenched with methanol and concentrated under reduced pressure. The resulting residue was treated with 1% aqueous sodium hydroxide and extracted with ethyl acetate (3 × 60 mL). The combined organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was purified with silica gel flash chromatography (elution with MeOH/DCM = 0–10%) to give the title compound as white solid (5.8 g, 95%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 3.37 (dd, <i>J</i> = 6.4, 1.3 Hz, 2H), 3.31–3.20 (m, 1H), 1.98–1.90 (m, 2H), 1.89–1.81 (m, 2H), 1.52–1.36 (m, 10H), 1.23–1.16 (m, 2H), 1.09–0.97 (m, 2H).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>tert</i>-Butyl (<i>trans</i>-4-(Cyanomethyl)cyclohexyl)carbamate (<b>3</b>)</h3><div class="NLM_p">To the solution of <i>tert</i>-butyl (<i>trans</i>-4-(hydroxymethyl)cyclohexyl)carbamate (4.34 g, 18.9 mmol) and triethylamine (5.3 mL, 37.8 mmol) in dichloromethane (150 mL) was added methanesulfonyl chloride (2.2 mL, 28.3 mmol) dropwise at 0 °C. The resulting mixture was stirred for 2 h before being quenched with water. The mixture was extracted with dichloromethane (3 × 60 mL). Combined organic phase was dried over sodium sulfate. After filtration, the solvent was removed under reduced pressure to provide the crude intermediate, which was used in next step without purification.</div><div class="NLM_p last">The crude material and potassium cyanide (3.6 g, 55.2 mmol) were mixed in dimethyl sulfoxide (60 mL). The mixture was stirred for 5 h at 100 °C, before being cooled to room temperature. After being cooled to rt, the reaction was diluted with water and extracted with ethyl acetate (3 × 100 mL). Combined organic phase was dried over sodium sulfate. The concentrated residue was purified by silica gel column (elution with hexane/EtOAc = 1:1) to yield the title compound as gray solid (4.3 g, 96%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 3.32–3.25 (m, 1H), 2.40 (d, <i>J</i> = 6.5, 1.4 Hz, 2H), 1.96 (d, <i>J</i> = 10.4 Hz, 2H), 1.89 (d, <i>J</i> = 11.1 Hz, 2H), 1.69–1.58 (m, 1H), 1.45 (s, 9H), 1.28–1.09 (m, 4H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>tert</i>-Butyl (<i>trans</i>-4-(2-Oxoethyl)cyclohexyl)carbamate (<b>4</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl (<i>trans</i>-4-(hydroxymethyl)cyclohexyl)carbamate (1.2 g, 5 mmol) in dichloromethane (20 mL), was added diisobutylaluminium hydride (1 M in hexane, 15 mL) at −78 °C. The resulting solution was stirred for 2 h before being quenched with saturated aqueous solution of Rochelle’s salt. The mixture was warmed to rt slowly and stirred vigorously until two phases were visualized. The organic phase was concentrated under reduced pressure. The resulting residue was purified by silica gel column to give the title compound as pale yellow solid (960 mg, 76%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 9.75 (d, <i>J</i> = 2.3 Hz, 1H), 4.38 (s, 1H), 3.47–3.30 (m, 1H), 2.32 (dd, <i>J</i> = 6.8, 2.2 Hz, 2H), 2.00 (d, <i>J</i> = 10.7 Hz, 2H), 1.90–1.74 (m, 3H), 1.43 (s, 9H), 1.15–1.08 (m, 4H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>tert</i>-Butyl (<i>cis-</i>4-(Hydroxymethyl)cyclohexyl)carbamate (<b>6</b>)</h3><div class="NLM_p last">Compound <b>6</b> was prepared according to the same procedures as preparing compound <b>2</b> (yield 95%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 3.63–3.56 (m, 1H), 3.43 (d, <i>J</i> = 6.4 Hz, 2H), 1.65–1.53 (m, 8H), 1.43 (s, 9H), 1.41–1.34 (m, 1H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>tert</i>-Butyl (<i>cis</i>-4-(Cyanomethyl)cyclohexyl)carbamate (<b>7</b>)</h3><div class="NLM_p last">Compound <b>7</b> was prepared according to the same procedures as preparing compound <b>3</b> (yield 96%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 3.68–3.54 (m, 1H), 2.41 (dd, <i>J</i> = 7.2, 3.6 Hz, 2H), 1.83–1.55 (m, 9H), 1.44 (s, 9H).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>tert</i>-Butyl ((1<i>s</i>,4<i>s</i>)-4-(2-Oxoethyl)cyclohexyl)carbamate (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was prepared according to the same procedures as preparing compound <b>4</b> (yield 80%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 9.75 (d, <i>J</i> = 2.2 Hz, 1H), 4.61 (s, 1H), 3.77–3.65 (m, 1H), 2.37 (dd, <i>J</i> = 6.9, 2.1 Hz, 2H), 2.12–1.97 (m, 1H), 1.66–1.56 (m, 6H), 1.44 (s, 9H), 1.29–1.18 (m, 2H).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(<i>trans</i>-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>9</b>)</h3><div class="NLM_p last">To the solution of Compound <b>11</b> (20 mg, 0.03 mmol) and triethylamine (12 mg, 0.12 mmol) in dichloromethane (2 mL) was added dimethylcarbamoyl chloride (7 mg, 0.06 mmol). The mixture was stirred for few minutes before being condensed. The resulting residue was purified by preparative HPLC (10–100% methanol/0.1% TFA in H<sub>2</sub>O) to give the title compound as white powder (8 mg, 43%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.37–7.29 (m, 2H), 7.24–7.18 (m, 1H), 3.73–3.67 (m, 2H), 3.60–3.46 (m, 3H), 3.36–3.24 (m, 4H), 3.18–3.04 (m, 2H), 2.90 (s, 6H), 1.97–1.91 (m, 2H), 1.92–1.84 (m, 2H), 1.77–1.66 (m, 2H), 1.43–1.25 (m, 3H), 1.17 (dd, <i>J</i> = 12.4, 3.5 Hz, 2H). MS (ESI) <i>m</i>/<i>z</i> 427.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl (<i>trans</i>-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)carbamate (<b>10</b>)</h3><div class="NLM_p last">To a solution of 1-(2,3-dichlorophenyl)piperzine (46.2 mg, 0.2 mmol) and aldehyde <b>4</b> (48.2 mg, 0.2 mmol) in chloromethane (4 mL) was added sodium triacetoxyborohydride (84.8 mg, 0.4 mmol) in portions. The resulting mixture was stirred overnight before being quenched with saturated aqueous sodium bicarbonate. The resulting mixture was extracted with dichloromethane (3 × 10 mL). The combined organic phase was dried over sodium sulfate and concentrated under reduced pressure. The resulting residue was purified by preparative HPLC (10–100% methanol/0.1% TFA in H<sub>2</sub>O) and lyophilized to give the title compounds as white powder (85.5 mg, yield 75%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.36–7.30 (m, 2H), 7.20–7.16 (m, 1H), 3.73–3.68 (m, 2H), 3.59–3.52 (m, 2H), 3.36–3.25 (m, 5H), 3.21–3.09 (m, 2H), 1.99–1.91 (m, 2H), 1.89–1.82 (m, 2H), 1.77–1.67 (m, 2H), 1.46 (s, 9H), 1.39–1.32 (m, 1H), 1.27–1.09 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 456.7 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>trans</i>-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexan-1-amine (<b>11</b>)</h3><div class="NLM_p last">Compound <b>10</b> (60 mg, 0.1 mmol) was treated with dichloromethane (1 mL) and trifluoroacetic acid (1 mL) for 1 h. After removal of the solvents, the resulting residue was purified by preparative HPLC (10–100% methanol/0.1% TFA in H<sub>2</sub>O) to give the title compound as white powder (35.5 mg, 58%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.37–7.29 (m, 2H), 7.18 (dd, <i>J</i> = 7.5, 2.1 Hz, 1H), 3.71 (d, <i>J</i> = 12.1 Hz, 2H), 3.56 (d, <i>J</i> = 13.2 Hz, 2H), 3.38–3.23 (m, 5H), 3.17–3.04 (m, 2H), 2.12–2.04 (m, 2H), 2.00–1.92 (m, 2H), 1.81–1.70 (m, 2H), 1.44 (qd, <i>J</i> = 12.5, 3.5 Hz, 3H), 1.25–1.18 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 356.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(<i>cis</i>-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>12</b>)</h3><div class="NLM_p last">To a solution of 1-(2,3-dichlorophenyl)piperzine (23.1 mg, 0.1 mmol) and compound <b>8</b> (24.1 mg, 0.1 mmol) in dichloromethane (2 mL) was added sodium triacetoxyborohydride (42.4 mg, 0.2 mmol) in portions. The resulting mixture was stirred overnight before being quenched with saturated aqueous sodium bicarbonate. The mixture was extracted with dichloromethane (3 × 5 mL). The combined organic phase was dried over sodium sulfate and concentrated under reduced pressure. The residue was treated with dichloromethane (1 mL) and trifluoroacetic acid (1 mL) for 1 h. After the solvent was removed under reduced pressure, the resulting residue was used in the next step without further purification. The crude material was dissolved in dichloromethane (2 mL). To the resulting solution was added triethylamine (50 mg, 0.5 mmol). After the solution was stirred for a few minutes, dimethylcarbamoyl chloride (22 mg, 0.2 mmol) in dichloromethane (1 mL) was added dropwise. After the resulting solution was stirred for 1 h, the mixture was concentrated under reduced pressure. The resulting residue was purified by preparative HPLC (10–100% methanol/0.1% TFA in H<sub>2</sub>O) to give the title compound as white powder (25.3 mg, yield 47%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.39–7.26 (m, 2H), 7.22–7.16 (m, 1H), 3.77–3.65 (m, 2H), 3.61–3.51 (m, 2H), 3.39–3.24 (m, 5H), 3.20–3.10 (m, 2H), 2.93 (s, 6H), 1.89–1.80 (m, 2H), 1.73–1.60 (m, 7H), 1.58–1.46 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 427.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-(5-(4-(2,3-Dichlorophenyl)piperazin-1-yl)pentyl)-1,1-dimethylurea (<b>15</b>)</h3><div class="NLM_p last">To a solution of <b>13</b> (203 mg, 1 mmol) and triethylamine (200 mg, 2 mmol) in dichloromethane (10 mL) was added methanesulfonyl chloride (137.4 mg, 1.2 mmol) dropwise at 0 °C. The resulting solution was stirred for 2 h at rt before being quenched with 1 mL of saturated aqueous sodium bicarbonate. The mixture was extracted with dichloromethane and washed with water. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The resulting residue was dissolved in acetonitrile (10 mL) before potassium carbonate (414.6 mg, 3 mmol) and 1-(2,3-dichlorophenyl)piperzine (231 mg, 1 mmol) were added successively. The mixture was refluxed overnight before being diluted with 10 mL of water. After being cooled to rt, the mixture was extracted with ethyl acetate (3 × 10 mL). The combined organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was purified by silica gel column (CH<sub>3</sub>OH/DCM, 0–10%) to give compound <b>14</b> (50 mg, yield 12%). Compound <b>14</b> was treated with trifluoroacetic acid (1 mL) and dichloromethane (2 mL) for 3 h at rt. The reaction was condensed under reduced pressure. The resulting residue was used for next step without further purification. To a solution of the residue above and triethylamine (40 mg, 0.4 mmol) in dichloromethane (2 mL), was added dimethylcarbamoyl chloride (16.1 mg, 0.15 mmol). The mixture was stirred for 1 h before being concentrated under reduced pressure. The resulting residue was purified by preparative HPLC (10–100% methanol/0.1% TFA in H<sub>2</sub>O) to give the title compound as a white powder (20 mg, yield 33%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.40–7.25 (m, 2H), 7.24–7.17 (m, 1H), 3.71 (d, <i>J</i> = 12.1 Hz, 2H), 3.55 (d, <i>J</i> = 13.1 Hz, 2H), 3.36–3.28 (m, 2H), 3.27–3.23 (m, 2H), 3.22–3.13 (m, 4H), 2.91 (s, 6H), 1.89–1.80 (m, 2H), 1.65–1.53 (m, 2H), 1.45 (t, <i>J</i> = 7.3 Hz, 2H). MS (ESI) <i>m</i>/<i>z</i> 387.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure for Preparing <b>16</b>–<b>19</b>, <b>21</b>–<b>25</b></h3><div class="NLM_p last">Compound <b>20</b> (212 mg, 0.45 mmol) was treated with trifluoroacetic acid (10 mL) and dichloromethane (10 mL) for 3 h at rt. The solution was concentrated under reduced pressure. The resulting residue was dissolved in dichloromethane (9 mL). To the solution was added triethylamine (404 mg, 4.0 mmol). The mixture was equally divided into nine portions. To each portion was added the corresponding acyl chloride or anhydride (0.1 mmol, 2 equiv). The resulting mixture was stirred overnight, followed by concentration under reduced pressure. The resulting residue was purified by preparative HPLC (10–100% methanol/0.1% TFA in H<sub>2</sub>O) to give the title compound as a white powder.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-(<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>16</b>)</h3><div class="NLM_p last">Dimethylcarbamoyl chloride was used to afford a powder (15 mg, yield 68%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.38–7.26 (m, 3H), 7.23 (d, <i>J</i> = 7.5 Hz, 1H), 4.62 (d, <i>J</i> = 15.3 Hz, 1H), 4.34 (d, <i>J</i> = 15.3 Hz, 1H), 3.89–3.79 (m, 1H), 3.56–3.47 (m, 1H), 3.44–3.23 (m, 4H), 3.19–3.12 (m, 1H), 2.92–2.84 (m, 6H), 1.96–1.91 (m, 2H), 1.90–1.83 (m, 2H), 1.81–1.73 (m, 2H), 1.43–1.38 (m, 1H), 1.36–1.27 (m, 2H), 1.22–1.12 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 330.8 [M + H]<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-(<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-diethylurea (<b>17</b>)</h3><div class="NLM_p last">Diethylcarbamoyl chloride was used to afford a powder (yield 54%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.35–7.26 (m, 3H), 7.23–7.19 (m, 1H), 4.69–4.27 (m, 2H), 3.88–3.48 (m, 3H), 3.38–3.31 (m, 8H), 1.96–1.89 (m, 2H), 1.85 (d, <i>J</i> = 12.5 Hz, 2H), 1.79–1.70 (m, 2H), 1.42–1.25 (m, 3H), 1.22–1.05 (m, 8H). MS (ESI) <i>m</i>/<i>z</i> 358.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-(<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-diisopropylurea (<b>18</b>)</h3><div class="NLM_p last">Diisopropylcarbamoyl chloride was used to afford a powder (yield 60%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.34–7.25 (m, 3H), 7.21 (d, <i>J</i> = 7.4 Hz, 1H), 4.65–4.51 (m, 2H), 3.81–3.73 (m, 2H), 3.57–3.42 (m, 3H), 3.41–3.26 (m, 2H), 3.24–3.10 (m, 2H), 1.93 (d, <i>J</i> = 12.2 Hz, 2H), 1.88–1.81 (m, 2H), 1.80–1.68 (m, 2H), 1.43–1.34 (m, 1H), 1.34–1.06 (m, 16H). MS (ESI) <i>m</i>/<i>z</i> 386.8 [M + H]<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)pyrrolidine-1-carboxamide (<b>19</b>)</h3><div class="NLM_p last">Pyrrolidine-1-carbonyl chloride was used to afford a powder (yield 39%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.38–7.24 (m, 3H), 7.24–7.19 (m, 1H), 4.70–4.27 (m, 2H), 3.90–3.49 (m, 3H), 3.46–3.39 (m, 4H), 3.25–3.06 (m, 4H), 2.01–1.81 (m, 8H), 1.78–1.72 (m, 2H), 1.45–1.35 (m, 1H), 1.33–1.26 (m, 2H), 1.24–1.13 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 356.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl (<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)carbamate (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was prepared by the same procedures as preparing compound <b>10</b>. 1,2,3,4-Tetrahydroisoquinoline (266 mg, 2 mmol), compound <b>4</b> (482 mg, 2 mmol) and sodium triacetoxyborohydride (848 mg, 4 mmol) were used to give the title compound as an oil (460 mg, yield 49%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.40–7.14 (m, 4H), 4.62 (d, <i>J</i> = 15.0 Hz, 1H), 4.34 (d, <i>J</i> = 15.1 Hz, 1H), 3.94–3.62 (m, 3H), 3.43–2.98 (m, 4H), 2.13–1.63 (m, 6H), 1.48–1.28 (m, 10H), 1.27–1.06 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 359.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Isopropyl (<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)carbamate (<b>21</b>)</h3><div class="NLM_p last">Isopropyl chloroformate was used to afford a powder (yield 74%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.34–7.24 (m, 3H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 4.57–4.32 (m, 2H), 3.74–3.40 (m, 3H), 3.37–3.28 (m, 3H), 3.23–3.12 (m, 2H), 1.94 (d, <i>J</i> = 12.5 Hz, 2H), 1.85 (d, <i>J</i> = 12.8 Hz, 2H), 1.79–1.71 (m, 2H), 1.42–1.33 (m, 1H), 1.31–1.07 (m, 10H). MS (ESI) <i>m</i>/<i>z</i> 345.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Ethyl (<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)carbamate (<b>22</b>)</h3><div class="NLM_p last">Ethyl chloroformate was used to afford a powder (yield 41%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.35–7.23 (m, 3H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 4.67–4.24 (m, 2H), 4.10–3.98 (m, 2H), 3.93–3.55 (m, 3H), 3.48–3.09 (m, 4H), 1.94 (d, <i>J</i> = 12.3 Hz, 2H), 1.87 (dd, <i>J</i> = 27.4, 13.1 Hz, 2H), 1.80–1.70 (m, 2H), 1.43–1.36 (m, 2H), 1.29–1.07 (m, 6H). MS (ESI) <i>m</i>/<i>z</i> 331.7 [M + H]<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)benzamide (<b>23</b>)</h3><div class="NLM_p last">Benzoyl chloride was used to afford a powder (yield 59%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.82–7.77 (m, 2H), 7.54–7.49 (m, 1H), 7.44 (dd, <i>J</i> = 8.4, 7.0 Hz, 2H), 7.35–7.26 (m, 3H), 7.22 (d, <i>J</i> = 7.2 Hz, 1H), 4.64–4.58 (m, 1H), 4.36–4.30 (m, 1H), 3.90–3.77 (m, 1H), 3.43–3.21 (m, 5H), 3.17 (s, 1H), 2.06–1.99 (m, 2H), 1.91 (d, <i>J</i> = 13.1 Hz, 2H), 1.84–1.74 (m, 2H), 1.47–1.40 (m, 3H), 1.28–1.18 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 363.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)propionamide (<b>24</b>)</h3><div class="NLM_p last">Propionyl chloride was used to afford a powder (yield 74%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.34–7.26 (m, 3H), 7.23–7.17 (m, 1H), 4.78–4.42 (m, 2H), 3.70–3.54 (m, 3H), 3.42–3.30 (m, 2H), 3.24–3.14 (m, 2H), 2.16 (q, <i>J</i> = 7.5 Hz, 2H), 1.92 (d, <i>J</i> = 12.2 Hz, 2H), 1.86 (d, <i>J</i> = 12.6 Hz, 2H), 1.78–1.72 (m, 2H), 1.41–1.35 (m, 1H), 1.34–1.15 (m, 4H), 1.11 (t, <i>J</i> = 7.7 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 315.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(<i>trans</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)acetamide (<b>25</b>)</h3><div class="NLM_p last">Acetic anhydride was used to afford a powder (yield 58%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.35–7.23 (m, 3H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 4.65–4.26 (m, 2H), 3.84–3.43 (m, 3H), 3.36–3.29 (m, 2H), 3.24–3.13 (m, 2H), 1.96–1.89 (m, 5H), 1.88–1.81 (m, 2H), 1.79–1.69 (m, 2H), 1.43–1.33 (m, 1H), 1.28–1.12 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 301.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-(<i>cis</i>-4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> (21 mg, yield 64%) was prepared using the same procedures as preparing compound <b>16</b>–<b>19</b> and <b>21</b>–<b>25</b> from 1,2,3,4-tetrahydroisoquinoline (13.3 mg, 0.1 mmol), compound <b>4</b> (24.1 mg, 0.1 mmol) and sodium triacetoxyborohydride (42.4 mg, 0.2 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.37–7.27 (m, 3H), 7.26–7.20 (m, 1H), 4.64 (d, <i>J</i> = 15.1 Hz, 1H), 4.36 (d, <i>J</i> = 15.1 Hz, 1H), 3.87–3.83 (m, 1H), 3.75–3.67 (m, 1H), 3.46–3.39 (m, 1H), 3.36–3.26 (m, 3H), 3.21–3.12 (m, 1H), 2.93 (s, 6H), 1.89 (t, <i>J</i> = 7.1 Hz, 2H), 1.74–1.59 (m, 7H), 1.59–1.45 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 330.8 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl (<i>trans</i>-4-((3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)methyl)cyclohexyl)carbamate (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> (31 mg, yield 15%) was prepared using the same procedures as preparing compound <b>14</b> from 1,2,3,4-tetrahydroisoquinoline (133 mg, 1 mmol) and compound <b>6</b> (100 mg, 0.44 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.34–7.22 (m, 3H), 7.21 (dd, <i>J</i> = 7.5, 1.4 Hz, 1H), 4.59 (d, <i>J</i> = 15.4 Hz, 1H), 4.32 (d, <i>J</i> = 15.3 Hz, 1H), 3.93–3.69 (m, 1H), 3.43–3.34 (m, 1H), 3.30 (d, <i>J</i> = 1.6 Hz, 3H), 3.19–3.08 (m, 2H), 2.01–1.82 (m, 5H), 1.43 (s, 9H), 1.34–1.25 (m, 2H), 1.24–1.12 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 345.6 [M + H]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-(<i>trans</i>-4-((3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)methyl)cyclohexyl)-1,1-dimethylurea (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> (15 mg, yield 68%) was prepared using the same procedures as preparing compound <b>15</b> from compound <b>27</b> (31 mg, 0.07 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.33–7.25 (m, 3H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 4.64–4.54 (m, 1H), 4.37–4.29 (m, 1H), 3.87–3.75 (m, 1H), 3.56–3.48 (m, 1H), 3.44–3.36 (m, 1H), 3.32–3.24 (m, 2H), 3.19–3.10 (m, 2H), 2.88 (s, 6H), 2.01–1.84 (m, 5H), 1.43–1.33 (m, 2H), 1.26–1.14 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 316.6 [M + H]<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-(4-(2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)phenyl)-1,1-dimethylurea (<b>30</b>)</h3><div class="NLM_p last">To a solution of compound <b>29</b> (40 mg, 0.16 mmol) and triethylamine (32 mg, 0.32 mmol) in dichloromethane (5 mL) was added methanesulfonyl chloride (22.8 mg, 0.2 mmol) dropwise at 0 °C. The solution was stirred for 2 h at rt before being quenched with saturated aqueous sodium bicarbonate. The mixture was diluted with water and extracted with dichloromethane. The organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was dissolved in acetonitrile (5 mL). To the resulting solution were added potassium carbonate (69 mg, 0.5 mmol) and 1,2,3,4-tetrahydroisoquinoline (65 mg, 0.5 mmol). The mixture was refluxed overnight before being diluted with water (10 mL) and extracted with ethyl acetate (3 × 10 mL). The organic phase was dried over anhydrous sodium sulfate and concentrated under reduce pressure. The resulting residue was purified by silica gel column (CH<sub>3</sub>OH/DCM, 0–10%) to give an oil intermediate (30 mg). The intermediate was treated with trifluoroacetic acid (1 mL) and dichloromethane (2 mL) for 3 h at rt before being condensed under reduced pressure. To a mixture of the resulting residue and potassium carbonate (40 mg, 0.3 mmol) in tetrahydrofuran (2 mL) was added dimethylcarbamoyl chloride (16.1 mg, 0.2 mmol). The mixture was stirred for 1 h before being condensed under reduced pressure. The resulting residue was purified by preparative HPLC (10–100% methanol/0.1% TFA in H<sub>2</sub>O) to give the title compound as white powder (17 mg, yield 23%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.37 (d, <i>J</i> = 8.2 Hz, 2H), 7.35–7.26 (m, 3H), 7.23 (dd, <i>J</i> = 12.3, 7.8 Hz, 3H), 4.51 (d, <i>J</i> = 105.7 Hz, 2H), 3.99–3.64 (m, 1H), 3.54–3.44 (m, 3H), 3.27–3.17 (m, 2H), 3.12 (dd, <i>J</i> = 10.4, 6.3 Hz, 2H), 3.01 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 324.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-(5-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)pentyl)-1,1-dimethylurea (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> (40 mg, yield 10%) was prepared using the same procedures as preparing compound <b>15</b> from 1,2,3,4-tetrahydroisoquinoline (133 mg, 1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.34–7.24 (m, 3H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 4.44 (s, 2H), 3.61–3.55 (m, 2H), 3.28–3.24 (m, 2H), 3.23–3.17 (m, 4H), 2.87 (s, 6H), 1.89–1.83 (m, 2H), 1.63–1.55 (m, 2H), 1.47–1.42 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 290.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3-(<i>trans</i>-4-(2-(5,6-Dichloro-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> (27 mg, 53%) was prepared using the same procedures as preparing compound <b>12</b> from 5,6-dichloro-1,2,3,4-tetrahydroisoquinoline (20.2 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.51 (d, <i>J</i> = 8.3 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 4.65–4.30 (m, 2H), 3.83–3.45 (m, 3H), 3.37–3.32 (m, 2H), 3.26–3.17 (m, 2H), 2.87 (s, 6H), 1.92 (dd, <i>J</i> = 13.4, 3.7 Hz, 2H), 1.85 (d, <i>J</i> = 12.5 Hz, 2H), 1.78–1.71 (m, 2H), 1.42–1.35 (m, 1H), 1.34–1.29 (m, 2H), 1.19–1.12 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 398.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-(<i>trans</i>-4-(2-(7,8-Dihydro-[1,3]dioxolo[4,5-<i>g</i>]isoquinolin-6(5<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> (24 mg, 49%) was prepared using the same procedures as preparing compound <b>12</b> from 5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-<i>g</i>]isoquinoline (17.7 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 6.72 (s, 1H), 6.67 (s, 1H), 5.95 (s, 2H), 4.52–4.39 (m, 1H), 4.25–4.12 (m, 1H), 3.82–3.67 (m, 1H), 3.51–3.45 (m, 1H), 3.35–3.26 (m, 3H), 3.17–2.98 (m, 2H), 2.87 (s, 6H), 1.92 (dd, <i>J</i> = 13.5, 3.8 Hz, 2H), 1.87–1.81 (m, 2H), 1.76–1.71 (m, 2H), 1.39–1.33 (m, 1H), 1.34–1.26 (m, 2H), 1.18–1.09 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 374.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-(<i>trans</i>-4-(2-(5-Chloro-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> (23 mg, 48%) was prepared using the same procedures as preparing compound <b>12</b> from 5-chloro-1,2,3,4-tetrahydroisoquinoline (13.3 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.43 (d, <i>J</i> = 7.9 Hz, 1H), 7.34–7.29 (m, 1H), 7.20 (d, <i>J</i> = 7.7 Hz, 1H), 4.64–4.28 (m, 2H), 3.87–3.45 (m, 3H), 3.35–3.29 (m, 2H), 3.20–3.13 (m, 2H), 2.87 (s, 6H), 1.94–1.89 (m, 2H), 1.85 (d, <i>J</i> = 13.1 Hz, 2H), 1.78–1.72 (m, 2H), 1.43–1.35 (m, 1H), 1.33–1.27 (m, 2H), 1.19–1.12 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 364.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-(<i>trans</i>-4-(2-(6-Chloro-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> (19 mg, 40%) was prepared using the same procedures as preparing compound <b>12</b> from 6-chloro-1,2,3,4-tetrahydroisoquinoline (13.3 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.32 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.29–7.25 (m, 2H), 4.71–4.13 (m, 2H), 3.92–3.41 (m, 3H), 3.34–3.30 (m, 2H), 3.24–3.10 (m, 2H), 2.87 (s, 6H), 1.94–1.89 (m, 2H), 1.85 (d, <i>J</i> = 12.5 Hz, 2H), 1.77–1.72 (m, 2H), 1.42–1.35 (m, 1H), 1.34–1.26 (m, 2H), 1.17–1.12 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 364.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-(<i>trans</i>-4-(2-(7-Chloro-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> (19 mg, 42%) was prepared using the same procedures as preparing compound <b>12</b> from 7-chloro-1,2,3,4-tetrahydroisoquinoline (13.3 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.35–7.29 (m, 2H), 7.21 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 4.56–4.31 (m, 2H), 3.79–3.44 (m, 3H), 3.34–3.27 (m, 2H), 3.23–3.11 (m, 2H), 2.87 (s, 6H), 1.92–1.93 (m, 2H), 1.85 (d, <i>J</i> = 13.1 Hz, 2H), 1.77–1.69 (m, 2H), 1.42–1.35 (m, 1H), 1.34–1.25 (m, 2H), 1.18–1.12 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 364.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3-(<i>trans</i>-4-(2-(8-Chloro-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> (25 mg, 52%) was prepared using the same procedures as preparing compound <b>12</b> from 8-chloro-1,2,3,4-tetrahydroisoquinoline (13.3 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). A portion of compound <b>38</b> was converted to free base form with aqueous sodium bicarbonate for <sup>1</sup>H NMR and <sup>13</sup>C NMR. <sup>1</sup>H NMR (800 MHz, CD<sub>3</sub>OD) δ 7.22 (d, <i>J</i> = 7.9 Hz, 1H), 7.19–7.15 (m, 1H), 7.10 (d, <i>J</i> = 7.6 Hz, 1H), 3.66 (s, 2H), 3.56–3.49 (m, 1H), 2.95 (t, <i>J</i> = 6.1 Hz, 2H), 2.89 (s, 6H), 2.76 (t, <i>J</i> = 6.0 Hz, 2H), 2.66–2.61 (m, 2H), 1.93 (dd, <i>J</i> = 13.1, 4.0 Hz, 2H), 1.89–1.84 (m, 2H), 1.59–1.53 (m, 2H), 1.36–1.29 (m, 3H), 1.12 (dd, <i>J</i> = 12.3, 3.3 Hz, 2H). <sup>13</sup>C NMR (201 MHz, CD<sub>3</sub>OD) δ 159.1, 136.7, 131.9, 131.8, 127.1, 127.1, 126.2, 56.0, 53.6, 50.0, 49.7, 35.4, 35.1, 33.4, 33.0, 32.1, 28.5. MS (ESI) <i>m</i>/<i>z</i> 364.2 [M + H]<sup>+</sup>. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>31</sub>ClN<sub>3</sub>O<sup>+</sup> 364.2150, found 364.2165.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1,1-Dimethyl-3-(<i>trans</i>-4-(2-(8-methyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)urea (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> (19 mg, 42%) was prepared using the same procedures as preparing compound <b>12</b> from 8-methyl-1,2,3,4-tetrahydroisoquinoline (14.7 mg, 0.1 mmol) and compound <b>8</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.22–7.16 (m, 1H), 7.10 (dd, <i>J</i> = 17.3, 7.5 Hz, 2H), 4.55 (d, <i>J</i> = 15.5 Hz, 1H), 4.20 (d, <i>J</i> = 15.5 Hz, 1H), 3.80 (d, <i>J</i> = 11.1 Hz, 1H), 3.54–3.46 (m, 1H), 3.44–3.20 (m, 4H), 3.10 (d, <i>J</i> = 16.5 Hz, 1H), 2.87 (s, 6H), 2.27 (s, 3H), 1.98–1.89 (m, 2H), 1.86 (d, <i>J</i> = 13.1 Hz, 2H), 1.81–1.75 (m, 2H), 1.43–1.35 (m, 1H), 1.34–1.26 (m, 2H), 1.21–1.09 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 344.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-(<i>trans</i>-4-(2-(8-Bromo-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> (24 mg, 46%) was prepared using the same procedures as preparing compound <b>12</b> from 8-bromo-1,2,3,4-tetrahydroisoquinoline (21.2 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.30 (d, <i>J</i> = 7.7 Hz, 1H), 7.25 (t, <i>J</i> = 7.8 Hz, 1H), 4.64–4.18 (m, 2H), 3.85–3.44 (m, 3H), 3.42–3.37 (m, 2H), 3.26–3.20 (m, 2H), 2.87 (s, 6H), 1.92 (dd, <i>J</i> = 13.4, 3.7 Hz, 2H), 1.86 (d, <i>J</i> = 12.3 Hz, 2H), 1.77 (q, <i>J</i> = 7.4 Hz, 2H), 1.43–1.36 (m, 1H), 1.35–1.28 (m, 2H), 1.19-1.13 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 408.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 3-(<i>trans</i>-4-(2-(8-Fluoro-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> (20 mg, 43%) was prepared using the same procedures as preparing compound <b>12</b> from 8-fluoro-1,2,3,4-tetrahydroisoquinoline (15.1 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.39–7.34 (m, 1H), 7.11 (d, <i>J</i> = 7.8 Hz, 1H), 7.06 (dd, <i>J</i> = 9.9, 8.3 Hz, 1H), 4.33 (s, 2H), 3.85–3.44 (m, 3H), 3.40–3.35 (m, 2H), 3.27–3.19 (m, 2H), 2.87 (s, 6H), 1.93–1.89 (m, 2H), 1.88–1.82 (m, 2H), 1.80–1.73 (m, 2H), 1.43–1.35 (m, 1H), 1.34–1.26 (m, 2H), 1.19–1.12 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 348.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1,1-Dimethyl-3-(<i>trans</i>-4-(2-(8-(trifluoromethyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)urea (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> (15 mg, 29%) was prepared using the same procedures as preparing compound <b>12</b> from 8-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline (15.1 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.68 (d, <i>J</i> = 7.6 Hz, 1H), 7.57 (d, <i>J</i> = 7.7 Hz, 1H), 7.54–7.49 (m, 1H), 4.78–4.42 (m, 2H), 4.03–3.69 (m, 1H), 3.53–3.46 (m, 1H), 3.45–3.28 (m, 5H), 2.87 (s, 6H), 1.95–1.89 (m, 2H), 1.88–1.83 (m, 2H), 1.81–1.69 (m, 2H), 1.44–1.35 (m, 1H), 1.34–1.24 (m, 2H), 1.19–1.10 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 398.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-(<i>trans</i>-4-(2-(8-Methoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethyl)cyclohexyl)-1,1-dimethylurea (<b>43</b>)</h3><div class="NLM_p">Compound <b>43</b> (19 mg, 40%) was prepared using the same procedures as preparing compound <b>12</b> from 8-methoxy-1,2,3,4-tetrahydroisoquinoline (16.3 mg, 0.1 mmol) and compound <b>4</b> (24.1 mg, 0.1 mmol). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.12 (d, <i>J</i> = 8.5 Hz, 1H), 6.88–6.82 (m, 1H), 6.81 (d, <i>J</i> = 2.6 Hz, 1H), 4.59–4.17 (m, 2H), 3.78 (s, 3H), 3.53–3.34 (m, 1H), 3.33–3.24 (m, 4H), 3.23–3.11 (m, 2H), 2.87 (d, <i>J</i> = 1.3 Hz, 6H), 1.92 (dd, <i>J</i> = 12.9, 3.7 Hz, 2H), 1.87–1.82 (m, 2H), 1.76–1.70 (m, 2H), 1.42–1.34 (m, 1H), 1.34–1.23 (m, 2H), 1.19–1.06 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 360.4 [M + H]<sup>+</sup>.</div><div id="sec4_40_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Experimental Procedures for in Vitro Biochemical Assays</h4></div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> D<sub>2</sub>R G<sub>i/o</sub>-Mediated cAMP Inhibition Assay</h3><div class="NLM_p last">D<sub>2</sub>R or D<sub>3</sub>R G<sub>i/o</sub>-mediated cAMP inhibition assays were performed in parallel with D<sub>2</sub>R or D<sub>3</sub>R β-Arrestin recruitment Tango assays. Human D<sub>2</sub>R or D<sub>3</sub>R transfected HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) were seeded (15 000 cells/40 μL/well) into white 384 clear-bottom, tissue culture plates in Dulbecco’s modified Eagle’s medium (DMEM) containing 1% dialyzed fetal bovine serum (FBS). Next day, drug dilutions were made in drug buffer (Hank’s balanced salt solution (HBSS), 20 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES), 0.1% bovine serum albumin (BSA), 0.01% ascorbic acid, pH 7.4), and the same drug dilutions used for the G<sub>i/o</sub>-mediated cAMP inhibition assays were also used for β-arrestin recruitment Tango assay. Media were removed and 20 μL of drug buffer was added per well and allowed to equilibrate for at least 15 min room temperature. To start the assay, cells were treated with 5 μL/well of 5× drug using a FLIPR (Molecular Devices). After 15 min, cAMP accumulation was initiated by the addition of 5 μL/well of either 0.3 μM isoproterenol (final concentration) for D<sub>2</sub>R or 1 μM of Forskolin for D<sub>3</sub>R diluted in GloSensor reagent. Luminescence per well per second was read on a MicroBeta plate counter (PerkinElmer). Data were normalized to maximum cAMP inhibition by quinpirole (100%) and basal cAMP accumulation by isoproterenol (0%). Data were analyzed using the sigmoidal dose–response function built into GraphPad Prism 5.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD<sub>2</sub>R) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP, either by quinpirole or by the test compounds, suggesting that the effect observed in hD<sub>2L</sub>-expressing cells was due to compound acting via the recombinant receptor.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> D<sub>2</sub>R β-Arrestin Recruitment Tango Assay</h3><div class="NLM_p last">Recruitment of β-arrestin to agonist-stimulated D<sub>2L</sub> or D<sub>3</sub> receptors was performed using Tango.<a onclick="showRef(event, 'ref41 ref56'); return false;" href="javascript:void(0);" class="ref ref41 ref56">(41,56)</a> Briefly, HTLA cells stably expressing β-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15 cm dishes in DMEM containing 10% FBS and transfected (via calcium phosphate) with 10 μg of a D<sub>2</sub>V<sub>2</sub>-TCS-tTA or D<sub>3</sub>V<sub>2</sub>-TCS-tTA construct. The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner; 15 000 cells/well, 40 μL/well) in DMEM containing 1% dialyzed FBS. The following day, media were decanted and exchanged for fresh DMEM media containing 1% dialyzed FBS. Importantly, the same drug dilutions used for the G<sub>i/o</sub>-mediated cAMP inhibition assay were used for the Tango assay to prevent compound solubility variability between assays. Cells were treated with 10 μL/well of drug using a FLIPR and for D<sub>2</sub>R antagonist assays, antagonists were diluted in 10 nM dopamine. After at least 20–22 h, the medium were removed and replaced with 1:20 diluted BrightGlo reagent (Promega), and luminescence per well was read using a MicroBeta plate counter (PerkinElmer). Data were normalized to vehicle (0%) and quinpirole or dopamine-stimulated controls (100%) and analyzed using the sigmoidal dose–response function built into GraphPad Prism 5.0.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> D<sub>2</sub>R β-Arrestin Recruitment BRET Assay</h3><div class="NLM_p last">To measure D<sub>2</sub>R-mediated β-arrestin recruitment, HEK293T cells were co-transfected in a 1:1:15 ratio with human D<sub>2long</sub> containing a C-terminal renilla luciferase (RLuc8), GRK2, and Venus-tagged N-terminal β-arrestin2. Next day, transfected cells were plated in polylysine coated 96-well white clear-bottom cell culture plates in plating media (DMEM + 1% dialyzed FBS) at a density of 30 000–40 000 cells in 200 μL/well and incubated overnight. Next day, media was decanted and cells were washed twice with 60 μL of drug buffer (1× HBSS, 20 mM HEPES, 0.1% BSA, 0.01% ascorbic acid, pH 7.4). Then 60 μL of drug buffer was added per well and drug stimulation was initiated with addition of 30 μL of drug (3×) per well. Then 10 μL/well of RLuc substrate, coelenterazine h (Promega, 5 μM final concentration) was added and read 15 min post drug addition, which is the same time point for D<sub>2</sub>R Gαi1-γ2 dissociation BRET assay. Plates were read for both luminescence at 485 nm and fluorescent eYFP emission at 530 nm for 1 s/well using a Mithras LB940. The ratio of eYFP/RLuc was calculated per well and the net BRET ratio was calculated by subtracting the eYFP/RLuc per well from the eYFP/RLuc ratio in wells without Venus-β-arrestin2 present. The net BRET ratio was plotted as a function of drug concentration using GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA). Data were normalized to % quinpirole or dopamine stimulation and analyzed using nonlinear regression log(agonist) versus response.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> D<sub>2</sub>R Gαi1-γ2 Dissociation BRET Assay</h3><div class="NLM_p last">To measure D<sub>2</sub>R-mediated Gαi1-γ2 dissociation, HEK293T cells were co-transfected in a 1:1:1:1 ratio of Gαi1-RLuc, Gβ1, GFP<sub>2</sub>-Gγ2, and human D<sub>2long</sub>, respectively. Gαi1-RLuc, Gβ1, and Gγ2-GFP<sub>2</sub> constructs were generously provided by Dr. Michel Bouvier. Cells were plated and assays were performed exactly similar to the BRET arrestin assay, except the substrate used was Coelenterazine 400a (NanoLight, 5 μM final concentration). Plates were read after 15 min drug incubation, which is the same time point for D<sub>2</sub>R β-arrestin recruitment BRET assay, measuring luminescence at 400 nm and fluorescent GFP<sub>2</sub> emission at 515 nm for 1 s/well using a Mithras LB940. The ratio of GFP<sub>2</sub>/RLuc was calculated per well and plotted as a function of drug concentration using GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA). Data were normalized to % quinpirole stimulation and analyzed using nonlinear regression log(agonist) versus response.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Bias Calculation</h3><div class="NLM_p last">Transduction coefficients (log(τ/<i>K</i><sub>A</sub>)) were calculated using the Black and Leff operational model in GraphPad Prism 5.0, where τ is agonist efficacy and <i>K</i><sub>A</sub> is the equilibrium dissociation constant and were calculated with respect to quinpirole, the D2 full agonist reference. Transduction coefficients were calculated for both pathways and averaged across experiments. Calculation of bias factors utilized the method by Kenakin et al.,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> where the Δlog(τ/<i>K</i><sub>A</sub>) was calculated relative to the reference and the ΔΔlog(τ/<i>K</i><sub>A</sub>) was calculated by subtracting the β-arrestin2 from the G<sub>i/o</sub> transduction coefficient to yield the antilog transformed bias factors with respect to G<sub>i/o</sub> activity.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Molecular Docking of Compounds <b>1</b>, <b>16</b>, and <b>38</b></h3><div class="NLM_p">The crystal structure of the dopamine D<sub>2</sub> receptor (D<sub>2</sub>R) in complex with risperidone was retrieved from the Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>) by its identifying code (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4">6CM4</a>). The structure was then manually edited to remove the T4 lysozyme, oleic acid, and the di(hydroxyethyl)ether. The structure also contained three thermostabilizing mutations: I122<sup>3.40</sup>A, L375<sup>6.37</sup>A, and L379<sup>6.41</sup>A, which were retained, as these residue positions are not near the ligand binding site and were not predicted to impact binding pose. Risperidone was retained for purposes of maintaining an orthosteric site that was conducive to ligand binding during the modeling process. Because antagonists, such as risperidone, are known to stabilize different receptor conformations compared to agonists, we sought to compare this structure to that of a previous D<sub>2</sub>R model that was successfully implemented to model functionally selective D<sub>2</sub> agonists.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The two structures were aligned and superimposed in PyMol 2.2.0. The all-atom binding site root-mean-square deviation (RMSD) was computed in PyMol after overlaying the two D<sub>2</sub>R structures and selecting the atoms in the transmembrane helices and extracellular domains that border the orthosteric binding pocket of the receptor. The RMSD was calculated to ensure sufficient similarity between the atom positions of the residues important for binding. The all-atom binding site RMSD between our model and this previous D<sub>2</sub>R model was 0.74 Å,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> which indicates a high degree of similarity between the arrangements of the atoms lining the binding pockets of both structures (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Compounds <b>1</b>, <b>16</b>, and <b>38</b> were docked to the orthosteric binding site of our D<sub>2</sub>R model using DOCK3.7.2.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> As previously described,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> the Dock 3.7.2 program superimposes atoms of each molecule onto matching spheres to dock flexible ligands into a binding site. Matching spheres represent favorable positions for individual ligand atoms, and in this study, 45 was used, based on the atom positions of the original risperidone complex. For docking, the receptor structure was prepared, and AMBER united-atom charges were assigned. Reduce<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> was utilized to protonate receptor structures, whereas partial charges from the united-atom AMBER<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> force field were used for all receptor atoms. Energy grids were used to assess the various energy terms of the DOCK scoring function including AMBER van der Waals potential, Poisson–Boltzmann electrostatic potentials using QNIFFT, and ligand desolvation from the occluded volume of the target for different ligand orientations. Prior to docking, ligand conformations and protonation states were calculated, and ligands were prepared in an energy-minimized state. Marvin (version 18.12, ChemAxon, 2018; <a href="https://www.chemaxon.com" class="extLink">https://www.chemaxon.com</a>) was used to protonate each ligand at pH 7.4. Corina<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (Molecular Networks GmbH) was then used to create a three-dimensional rendering of each protomer before conformational sampling via Omega (OpenEye Scientific Software).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Finally, AMSOL<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> was used to compute the charges and initial solvation energies of the ligands. Following docking to the matching spheres, the lowest energy poses for each ligand were visualized and compared with existing crystal structures of ligands bound to aminergic GPCRs.<a onclick="showRef(event, 'ref38 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref38 ref65 ref66">(38,65,66)</a></div><div id="sec4_46_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Experimental Procedures for in Vivo Studies in Mice</h4></div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Receptor Occupancy Assay</h3><div class="NLM_p">In vivo receptor occupancy was assessed in male c57 mice. All procedures performed on animals were in accordance with regulations and established guidelines and were reviewed and approved by an Institutional Animal Care and Use Committee.</div><div class="NLM_p last">Mice were dosed with vehicle (5% DMSO: 5% Cremophor: 90% saline plus 1 mequiv of HCl) or <b>38</b> (0.32, 1, 3.2, 10, or 32 mg/kg) subcutaneously at a dose volume of 10 mL/kg. After 20 min of the subcutaneous dose, the mice were dosed retro-orbitally with 100 μCi [<sup>3</sup>H]raclopride at a dose volume of 5 mL/kg. After a 30 min drug pretreatment period, the animals were euthanized by live decapitation. Trunk blood was collected and centrifuged at 7500 rpm for 10 min, and the plasma was collected and stored at −80 °C until exposure level analysis. The striatum and the cerebellum (used to define nonspecific binding) were immediately dissected and homogenized in 20 mg/mL of assay buffer (20 mM HEPES, 4.16 mM NaHCO<sub>3</sub>, 0.44 mM KH<sub>2</sub>PO<sub>4</sub>, 0.63 mM NaH<sub>2</sub>PO<sub>4</sub>, 127 mM NaCl, 5.36 mM KCl, 1.26 mM CaCl<sub>2</sub>, 0.98 mM MgCl<sub>2</sub>) with a polytron for 10 s. The rest of the brain was immediately frozen on dry ice and stored at −80 °C until exposure level analysis. Striatum or cerebellum (400 μL) was filtered through presoaked Whatman GF/B filter circles followed by 2 × 5 mL of assay buffer. Filters were transferred to scintillation vials containing Ultima Gold MV scintillation cocktail. Radioactivity was measured using the PerkinElmer TriCarb liquid scintillation counter.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Locomotor Activity Assay</h3><div class="NLM_p last">Adult male and female C57BL/6 mice were housed 3–5/cage on a 14:10 h light/dark cycle (lights on 0700 h) in a humidity- and temperature-controlled room with food and water provided ad libitum. All experiments were conducted with an approved protocol from the Duke University Institutional Animal Care and Use Committee. Motor activity was assessed in a 21 × 21 × 30 cm<sup>3</sup> open field (Omnitech Inc., Columbus, OH) under 340 lx illumination. C57BL/6 mice were housed in the test room 24 h prior to testing. Animals were injected (i.p.) with vehicle or different doses of <b>38</b> and immediately placed into the open field. After 30 min, mice were removed from the test arena and given (i.p.) the vehicle or 6 mg/kg PCP (Sigma-Aldrich, St. Louis, MO) and returned immediately to the open field for an additional 90 min. Horizontal distance traveled (cm) was quantitated with Fusion software (Omnitech) and scored in 5 min bins across testing. The behavioral data are presented as means and standard errors of the mean and analyzed by repeated measures ANOVA followed by Bonferroni-corrected pair-wise comparisons where a <i>p</i> < 0.05 was considered significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00508" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00508" class="ext-link">10.1021/acs.jmedchem.9b00508</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra of compound <b>38</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00508/suppl_file/jm9b00508_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00508/suppl_file/jm9b00508_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00508/suppl_file/jm9b00508_si_001.pdf">jm9b00508_si_001.pdf (424.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00508/suppl_file/jm9b00508_si_002.csv">jm9b00508_si_002.csv (3.06 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00508" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Liu</span> - <span class="hlFld-Affiliation affiliation">Mount
Sinai Center for Therapeutics Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#442e2d252a6a2e2d2a04293737296a212031"><span class="__cf_email__" data-cfemail="5a30333b34743033341a37292937743f3e2f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan L. Roth</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and National Institute of Mental Health Psychoactive
Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0561-6520" title="Orcid link">http://orcid.org/0000-0002-0561-6520</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d4b6a6adb5ba8ba6bba0bc94b9b1b0faa1bab7fab1b0a1"><span class="__cf_email__" data-cfemail="81e3f3f8e0efdef3eef5e9c1ece4e5aff4efe2afe4e5f4">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Jin</span> - <span class="hlFld-Affiliation affiliation">Mount
Sinai Center for Therapeutics Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2387-3862" title="Orcid link">http://orcid.org/0000-0002-2387-3862</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3c5655525b125055497c514f4f5112595849"><span class="__cf_email__" data-cfemail="345e5d5a531a585d4174594747591a515041">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yudao Shen</span> - <span class="hlFld-Affiliation affiliation">Mount
Sinai Center for Therapeutics Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. McCorvy</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and National Institute of Mental Health Psychoactive
Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael L. Martini</span> - <span class="hlFld-Affiliation affiliation">Mount
Sinai Center for Therapeutics Discovery, Departments of Pharmacological
Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramona M. Rodriguiz</span> - <span class="hlFld-Affiliation affiliation">Departments
of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimir M. Pogorelov</span> - <span class="hlFld-Affiliation affiliation">Departments
of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen M. Ward</span> - <span class="hlFld-Affiliation affiliation">Worldwide
Research and Development, Internal Medicine
Research Unit, Pfizer, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William C. Wetsel</span> - <span class="hlFld-Affiliation affiliation">Departments
of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.S. and J.D.M. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): K.M.W. was an employee of Pfizer.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4424-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The research described here was supported in part by the grant U19MH082441 (to J.J. and B.L.R.) from the U.S. National Institutes of Health. J.J. and B.L.R. acknowledge the support by the grant U24DK116195 from the U.S. National Institutes of Health. J.J. also acknowledges the support by the grant R01NS100930 from the U.S. National Institutes of Health. M.L.M. acknowledges the support by the NIGMS-funded Integrated Pharmacological Sciences Training Program T32 GM062754 and the MSTP training grants at the Icahn School of Mount Sinai (NIH T32 GM007280). We thank Dr. Xufen Yu for detailedly reading synthetic procedures and characterization data. We thank Drs. Brian K. Shoichet and Isha Singh for strictly reading molecular docking method and Dr. Xin Chen for helpful discussions.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">SFSR</td><td class="NLM_def"><p class="first last">structure–functional selectivity relationships</p></td></tr><tr><td class="NLM_term">D<sub>2</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>2</sub> receptor</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">LHS</td><td class="NLM_def"><p class="first last">left-hand side</p></td></tr><tr><td class="NLM_term">RHS</td><td class="NLM_def"><p class="first last">right-hand side</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">GRK2</td><td class="NLM_def"><p class="first last">G protein-coupled receptor kinase 2</p></td></tr><tr><td class="NLM_term">D<sub>1</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>1</sub> receptor</p></td></tr><tr><td class="NLM_term">D<sub>3</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>3</sub> receptor</p></td></tr><tr><td class="NLM_term">D<sub>4</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>4</sub> receptor</p></td></tr><tr><td class="NLM_term">D<sub>4</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>5</sub> receptor</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 66 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">How ligands illuminate GPCR molecular pharmacology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.cell.2017.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=28753422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GisLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2017&pages=414-427&author=D.+Wackerauthor=R.+C.+Stevensauthor=B.+L.+Roth&title=How+ligands+illuminate+GPCR+molecular+pharmacology&doi=10.1016%2Fj.cell.2017.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How ligands illuminate GPCR molecular pharmacology</span></div><div class="casAuthors">Wacker, Daniel; Stevens, Raymond C.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-427</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs), which are modulated by a variety of endogenous and synthetic ligands, represent the largest family of druggable targets in the human genome.  Recent structural and mol. studies have both transformed and expanded classical concepts of receptor pharmacol. and have begun to illuminate the distinct mechanisms by which structurally, chem., and functionally diverse ligands modulate GPCR function.  These mol. insights into ligand engagement and action have enabled new computational methods and accelerated the discovery of novel ligands and tool compds., esp. for understudied and orphan GPCRs.  These advances promise to streamline the development of GPCR-targeted medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCNWK2Zg6HebVg90H21EOLACvtfcHk0lhAODYTu045eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GisLvF&md5=d4f7f48d757cf3d13a980d2f7f1be138</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DHow%2520ligands%2520illuminate%2520GPCR%2520molecular%2520pharmacology%26jtitle%3DCell%26date%3D2017%26volume%3D170%26spage%3D414%26epage%3D427%26doi%3D10.1016%2Fj.cell.2017.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheffler, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span> <span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1038/nrd1346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnrd1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=15060530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353-359&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia&doi=10.1038%2Fnrd1346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span></div><div class="casAuthors">Roth, Bryan L.; Sheffler, Douglas J.; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-359</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most common central nervous system disorders - such as depression, bipolar disorder, and schizophrenia - seem to be polygenic in origin, and the most effective medications have exceedingly complex pharmacologies.  Attempts to develop more effective treatments for diseases such as schizophrenia and depression by discovering drugs selective for single mol. targets (i.e., 'magic bullets') have, not surprisingly, been largely unsuccessful.  Here the authors propose that designing selectively non-selective drugs (i.e., 'magic shotguns') that interact with several mol. targets will lead to new and more effective medications for a variety of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSsuUXzmbirVg90H21EOLACvtfcHk0lhAODYTu045eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D&md5=77196583acccca65457fec7a67218463</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1346%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353%26epage%3D359%26doi%3D10.1038%2Fnrd1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Duenas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedros, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciruela, F.</span></span> <span> </span><span class="NLM_article-title">An update on adenosine A2A receptors as drug target in Parkinson’s disease</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.2174/187152711797247803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.2174%2F187152711797247803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=21838670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12hurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=659-669&author=A.+Vallanoauthor=V.+Fernandez-Duenasauthor=C.+Pedrosauthor=J.+M.+Arnauauthor=F.+Ciruela&title=An+update+on+adenosine+A2A+receptors+as+drug+target+in+Parkinson%E2%80%99s+disease&doi=10.2174%2F187152711797247803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An update on adenosine A2A receptors as drug target in Parkinson's disease</span></div><div class="casAuthors">Vallano, Antoni; Fernandez-Duenas, Victor; Pedros, Consuelo; Arnau, Josep Maria; Ciruela, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-669</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors are G protein-coupled receptors (GPCRs) that mediate the physiol. functions of adenosine.  In the central nervous system adenosine A2A receptors (A2ARs) are highly enriched in striatopallidal neurons where they form functional oligomeric complexes with other GPCRs such us the dopamine D2 receptor (D2R).  Furthermore, it is assumed that the formation of balanced A2AR/D2R receptor oligomers are essential for correct striatal function as the allosteric receptor-receptor interactions established within the oligomer are needed for properly sensing adenosine and dopamine.  Interestingly, A2AR activation reduces the affinity of striatal D2R for dopamine and the blockade of A2AR with specific antagonists facilitates function of the D2R.  Thus, it may be postulated that A2AR antagonists are pro-dopaminergic agents.  Therefore, A2AR antagonists will potentially reduce the effects assocd. with dopamine depletion in Parkinson's disease (PD).  Accordingly, this class of compds. have recently attracted considerable attention as potential therapeutic agents for PD pharmacotherapy as they have shown potential effectiveness in counteracting motor dysfunctions and also displayed neuroprotective and anti-inflammatory effects in animal models of PD.  Overall, we provide here an update of the current state of the art of these A2AR-based approaches that are under clin. study as agents devoted to alleviate PD symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj7ubJ3_biTLVg90H21EOLACvtfcHk0lhAODYTu045eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12hurfF&md5=bdefa325c832869f0dca03a75bf9e925</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F187152711797247803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152711797247803%26sid%3Dliteratum%253Aachs%26aulast%3DVallano%26aufirst%3DA.%26aulast%3DFernandez-Duenas%26aufirst%3DV.%26aulast%3DPedros%26aufirst%3DC.%26aulast%3DArnau%26aufirst%3DJ.%2BM.%26aulast%3DCiruela%26aufirst%3DF.%26atitle%3DAn%2520update%2520on%2520adenosine%2520A2A%2520receptors%2520as%2520drug%2520target%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2011%26volume%3D10%26spage%3D659%26epage%3D669%26doi%3D10.2174%2F187152711797247803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, E. J.</span></span> <span> </span><span class="NLM_article-title">D<sub>2</sub> dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2009.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.nbd.2009.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=19840852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=228-236&author=X.+Fanauthor=M.+Xuauthor=E.+J.+Hess&title=D2+dopamine+receptor+subtype-mediated+hyperactivity+and+amphetamine+responses+in+a+model+of+ADHD&doi=10.1016%2Fj.nbd.2009.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD</span></div><div class="casAuthors">Fan, Xue-Liang; Xu, Ming; Hess, Ellen J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">228-236</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Low doses of psychostimulants produce beneficial behavioral effects in ADHD patients but the mechanisms underlying the response are not understood.  Here we use the hyperactive mouse mutant coloboma to identify D2-like dopamine receptor subtypes that mediate the hyperactivity and response to amphetamine; we have previously demonstrated that D1-like dopamine receptors are not involved.  Targeted deletion of the D2, but not the D3 or the D4, dopamine receptor in coloboma mice eliminated the hyperactivity; depleting D2 dopamine receptors also restored the excess dopamine overflow that may drive the hyperactivity to normal concns.  Similar to its effects on ADHD patients, amphetamine reduced the hyperactivity of coloboma mice.  The D2 dopamine receptor-selective antagonist L-741,626, but not D3 or D4 dopamine receptor-selective antagonists, blocked the amphetamine-induced redn. in locomotor activity.  Thus, the D2 dopamine receptor subtype mediates both the hyperactivity and response to amphetamine, suggesting a specific target for novel therapeutics in ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUwUaV6iqprVg90H21EOLACvtfcHk0lghakugNjt1cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7vI&md5=beac1924be92f794c4ead36e58d5ef19</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DE.%2BJ.%26atitle%3DD2%2520dopamine%2520receptor%2520subtype-mediated%2520hyperactivity%2520and%2520amphetamine%2520responses%2520in%2520a%2520model%2520of%2520ADHD%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26spage%3D228%26epage%3D236%26doi%3D10.1016%2Fj.nbd.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span> <span> </span><span class="NLM_article-title">G protein-coupled receptors as new therapeutic targets for type 2 diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1007/s00125-015-3825-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1007%2Fs00125-015-3825-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=26661410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrsb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=229-233&author=F.+Reimannauthor=F.+M.+Gribble&title=G+protein-coupled+receptors+as+new+therapeutic+targets+for+type+2+diabetes&doi=10.1007%2Fs00125-015-3825-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptors as new therapeutic targets for type 2 diabetes</span></div><div class="casAuthors">Reimann, Frank; Gribble, Fiona M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) in the gut-brain-pancreatic axis are key players in the postprandial control of metab. and food intake.  A no. of intestinally located receptors have been implicated in the chemo-detection of ingested nutrients, and in the pancreatic islets and nervous system GPCRs play essential roles in the detection of many hormones and neurotransmitters.  Because of the diversity, cell-specific expression and 'druggability' of the GPCR superfamily, these receptors are popular targets for therapeutic development.  This review will outline current and potential future approaches to develop GPCR agonists for the treatment of type 2 diabetes.  This review summarises a presentation given at the 'Novel approaches to treating type 2 diabetes' symposium at the 2015 annual meeting of the EASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru_vDlfL96TrVg90H21EOLACvtfcHk0lghakugNjt1cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrsb%252FL&md5=ed9065e6d1c4330e6f5debf333553585</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00125-015-3825-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-015-3825-z%26sid%3Dliteratum%253Aachs%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26atitle%3DG%2520protein-coupled%2520receptors%2520as%2520new%2520therapeutic%2520targets%2520for%2520type%25202%2520diabetes%26jtitle%3DDiabetologia%26date%3D2016%26volume%3D59%26spage%3D229%26epage%3D233%26doi%3D10.1007%2Fs00125-015-3825-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuho, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahn, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martemyanov, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, M. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacogenomics of GPCR drug targets</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.cell.2017.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29249361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2js7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=41-54&author=A.+S.+Hauserauthor=S.+Chavaliauthor=I.+Masuhoauthor=L.+J.+Jahnauthor=K.+A.+Martemyanovauthor=D.+E.+Gloriamauthor=M.+M.+Babu&title=Pharmacogenomics+of+GPCR+drug+targets&doi=10.1016%2Fj.cell.2017.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenomics of GPCR Drug Targets</span></div><div class="casAuthors">Hauser, Alexander S.; Chavali, Sreenivas; Masuho, Ikuo; Jahn, Leonie J.; Martemyanov, Kirill A.; Gloriam, David E.; Babu, M. Madan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">41-54.e19</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Natural genetic variation in the human genome is a cause of individual differences in responses to medications and is an underappreciated burden on public health.  Although 108 G-protein-coupled receptors (GPCRs) are the targets of 475 (∼34%) Food and Drug Administration (FDA)-approved drugs and account for a global sales vol. of over 180 billion US dollars annually, the prevalence of genetic variation among GPCRs targeted by drugs is unknown.  By analyzing data from 68,496 individuals, we find that GPCRs targeted by drugs show genetic variation within functional regions such as drug- and effector-binding sites in the human population.  We exptl. show that certain variants of μ-opioid and Cholecystokinin-A receptors could lead to altered or adverse drug response.  By analyzing UK National Health Service drug prescription and sales data, we suggest that characterizing GPCR variants could increase prescription precision, improving patients' quality of life, and relieve the economic and societal burden due to variable drug responsiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqLQcECb2nm7Vg90H21EOLACvtfcHk0lghakugNjt1cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2js7rE&md5=aea194a723f8704cdcf4f05773c4880e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DA.%2BS.%26aulast%3DChavali%26aufirst%3DS.%26aulast%3DMasuho%26aufirst%3DI.%26aulast%3DJahn%26aufirst%3DL.%2BJ.%26aulast%3DMartemyanov%26aufirst%3DK.%2BA.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26aulast%3DBabu%26aufirst%3DM.%2BM.%26atitle%3DPharmacogenomics%2520of%2520GPCR%2520drug%2520targets%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D41%26epage%3D54%26doi%3D10.1016%2Fj.cell.2017.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of new GPCR ligands to illuminate new biology</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnchembio.2490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29045379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1OhsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1143-1151&author=B.+L.+Rothauthor=J.+J.+Irwinauthor=B.+K.+Shoichet&title=Discovery+of+new+GPCR+ligands+to+illuminate+new+biology&doi=10.1038%2Fnchembio.2490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new GPCR ligands to illuminate new biology</span></div><div class="casAuthors">Roth, Bryan L.; Irwin, John J.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1143-1151</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Although a plurality of drugs target G-protein-coupled receptors (GPCRs), most have emerged from classical medicinal chem. and pharmacol. programs and resemble one another structurally and functionally.  Though effective, these drugs are often promiscuous.  With the realization that GPCRs signal via multiple pathways, and with the emergence of crystal structures for this family of proteins, there is an opportunity to target GPCRs with new chemotypes and confer new signaling modalities.  The authors consider structure-based and phys. screening methods that have led to the discovery of new reagents, focusing particularly on the former.  The authors illustrate their use against previously untargeted or orphan GPCRs, against allosteric sites, and against classical orthosteric sites that selectively activate one downstream pathway over others.  The ligands that emerge are often chem. novel, which can lead to new biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0g7QvZBYzkLVg90H21EOLACvtfcHk0li5_X_LVSFijQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1OhsrnK&md5=6b1682d6b1475dc1a0e8834895c4ae6c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2490%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%2520of%2520new%2520GPCR%2520ligands%2520to%2520illuminate%2520new%2520biology%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3D1143%26epage%3D1151%26doi%3D10.1038%2Fnchembio.2490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furchgott, R. F.</span></span> <span> </span><span class="NLM_article-title">The Use of Haloalkylamines in the Differentiation of Receptors and in the Determination of Dissociation Constants of Agonist-Receptor Complexes</span>. In  <i>Advances in Drug Research</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, N.</span>, <span class="NLM_string-name">Simmonds, A.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1966</span>; Vol.  <span class="NLM_volume">3</span>, pp  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">55</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1966&pages=21-55&author=R.+F.+Furchgottauthor=N.+Harper&author=A.+Simmonds&title=Advances+in+Drug+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFurchgott%26aufirst%3DR.%2BF.%26atitle%3DThe%2520Use%2520of%2520Haloalkylamines%2520in%2520the%2520Differentiation%2520of%2520Receptors%2520and%2520in%2520the%2520Determination%2520of%2520Dissociation%2520Constants%2520of%2520Agonist-Receptor%2520Complexes%26btitle%3DAdvances%2520in%2520Drug%2520Research%26aulast%3DHarper%26aufirst%3DN.%26pub%3DAcademic%2520Press%26date%3D1966%26volume%3D3%26spage%3D21%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity at GPCRs: new opportunities in psychiatric drug discovery</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1038/npp.2013.205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnpp.2013.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=24317323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCqtLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=248-249&author=S.+D.+Changauthor=M.+R.+Bruchas&title=Functional+selectivity+at+GPCRs%3A+new+opportunities+in+psychiatric+drug+discovery&doi=10.1038%2Fnpp.2013.205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery</span></div><div class="casAuthors">Chang, Steven D.; Bruchas, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-249</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The superfamily of G-protein coupled receptors (GPCRs) is one of the largest gene families in the mammalian genome.  GPCRs represent >50% of all current drug targets for treating numerous diseases that affect both peripheral and central nervous systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXBo3IaC3SEbVg90H21EOLACvtfcHk0li5_X_LVSFijQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqtLvM&md5=285ec31f14cb03c999102d427dc2bd43</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.205%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%2BD.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26atitle%3DFunctional%2520selectivity%2520at%2520GPCRs%253A%2520new%2520opportunities%2520in%2520psychiatric%2520drug%2520discovery%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D248%26epage%3D249%26doi%3D10.1038%2Fnpp.2013.205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity and biased receptor signaling</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.173948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.110.173948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=21030484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=296-302&author=T.+Kenakin&title=Functional+selectivity+and+biased+receptor+signaling&doi=10.1124%2Fjpet.110.173948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and biased receptor signaling</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">296-302</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  With the emergence of information describing functional selectivity and biased agonists and antagonists has come a lack of confidence in "one size fits all" assays for detection of agonism.  Seven-transmembrane receptors are pleiotropic with respect to the signaling protein to which they couple in a cell, and many conformations of the receptor can be formed; this leads to systems where ligands can stabilize unique conformations that go on to selectively activate signaling pathways.  Thus, such "biased" ligands can produce cell-specific agonism that may require targeted assays to detect and quantify.  It also predicts that ligands can have many different efficacies for the many behaviors that the receptor can exhibit (referred to as "pluridimensional efficacy"), leading to a breakdown in the common classifications of agonist and antagonist.  This all poses unique challenges to the pharmacol. nomenclature of drugs, the detection and optimization of new drugs, and the assocn. of phenotypic clin. profiles with pharmacol. properties of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDmshypfoNALVg90H21EOLACvtfcHk0li5_X_LVSFijQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D&md5=83d2c05fec2f9ef9a6e97a98bc0a3616</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.173948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.173948%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DFunctional%2520selectivity%2520and%2520biased%2520receptor%2520signaling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D296%26epage%3D302%26doi%3D10.1124%2Fjpet.110.173948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span> <span> </span><span class="NLM_article-title">Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity</span>. <i>J. Biomol. Screen.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1177/1087057108330115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1177%2F1087057108330115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=19211780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFWlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=246-255&author=M.+F.+Petersauthor=C.+W.+Scott&title=Evaluating+cellular+impedance+assays+for+detection+of+GPCR+pleiotropic+signaling+and+functional+selectivity&doi=10.1177%2F1087057108330115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity</span></div><div class="casAuthors">Peters, Matthew F.; Scott, Clay W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">246-255</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">G-protein-coupled receptors can couple to different signal transduction pathways in different cell types (termed cell-specific signaling) and can activate different signaling pathways depending on the receptor conformation(s) stabilized by the activating ligand (functional selectivity).  These concepts offer potential for developing pathway-specific drugs that increase efficacy and reduce side effects.  Despite significant interest, functional selectivity has been difficult to exploit in drug discovery, in part due to the burden of multiple assays.  Cellular impedance assays use an emerging technol. that can qual. distinguish Gs, Gi/o, and Gq signaling in a single assay and is thereby suited for studying these pharmacol. concepts.  Cellular impedance confirmed cell-specific Gs and Gq coupling for the melanocortin-4 receptor and dual Gi and Gs signaling with the cannabinoid-1 (CB1) receptor.  The balance of Gi vs. Gs signaling depended on the cell line.  In CB1-HEKs, Gi-and Gs-like responses combined to yield a novel impedance profile demonstrating the dynamic nature of these traces.  Cell-specific signaling was obsd. with endogenous D1 receptor in U-2 cells and SK-N-MC cells, yet the pharmacol. profile of partial and full agonists was similar in both cell lines.  We conclude that the dynamic impedance profile encodes valuable relative signaling information and is sufficiently robust to help evaluate cell-specific signaling and functional selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqjs8kQ8_SpbVg90H21EOLACvtfcHk0li5_X_LVSFijQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFWlurc%253D&md5=2b6e31b75547eb4b92c645b4f30e1294</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1087057108330115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057108330115%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DM.%2BF.%26aulast%3DScott%26aufirst%3DC.%2BW.%26atitle%3DEvaluating%2520cellular%2520impedance%2520assays%2520for%2520detection%2520of%2520GPCR%2520pleiotropic%2520signaling%2520and%2520functional%2520selectivity%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2009%26volume%3D14%26spage%3D246%26epage%3D255%26doi%3D10.1177%2F1087057108330115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span> <span> </span><span class="NLM_article-title">Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9841-9878&author=L.+Tanauthor=W.+Yanauthor=J.+D.+McCorvyauthor=J.+Cheng&title=Biased+ligands+of+G+protein-coupled+receptors+%28GPCRs%29%3A+structure-functional+selectivity+relationships+%28SFSRs%29+and+therapeutic+potential&doi=10.1021%2Facs.jmedchem.8b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential</span></div><div class="casAuthors">Tan, Liang; Yan, Wenzhong; McCorvy, John D.; Cheng, Jianjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9841-9878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-protein-independent pathways, and β-arrestin recruitment is the most recognized one of the latter.  Biased ligands selective for either pathway are expected to regulate biol. functions of GPCRs in a more precise way, therefore providing new drug mols. with superior efficacy and/or reduced side effects.  During the past decade, biased ligands have been discovered and developed for many GPCRs, such as the μ opioid receptor, the angiotensin II receptor type 1, the dopamine D2 receptor, and many others.  In this Perspective, recent advances in this field are reviewed by discussing the structure-functional selectivity relationships (SFSRs) of GPCR biased ligands and the therapeutic potential of these mols.  Further understanding of the biol. functions assocd. with each signaling pathway and structural basis for biased signaling will facilitate future drug design in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFjkAvar29LVg90H21EOLACvtfcHk0ljLeVI6bvcw8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N&md5=a7bd605b82666357f5a0a209002225e5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DCheng%26aufirst%3DJ.%26atitle%3DBiased%2520ligands%2520of%2520G%2520protein-coupled%2520receptors%2520%2528GPCRs%2529%253A%2520structure-functional%2520selectivity%2520relationships%2520%2528SFSRs%2529%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9841%26epage%3D9878%26doi%3D10.1021%2Facs.jmedchem.8b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity and classical concepts of quantitative pharmacology</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>320</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.104463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.106.104463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=16803859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1-13&author=J.+D.+Urbanauthor=W.+P.+Clarkeauthor=M.+von+Zastrowauthor=D.+E.+Nicholsauthor=B.+Kobilkaauthor=H.+Weinsteinauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=A.+Christopoulosauthor=P.+M.+Sextonauthor=K.+J.+Millerauthor=M.+Speddingauthor=R.+B.+Mailman&title=Functional+selectivity+and+classical+concepts+of+quantitative+pharmacology&doi=10.1124%2Fjpet.106.104463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and classical concepts of quantitative pharmacology</span></div><div class="casAuthors">Urban, Jonathan D.; Clarke, William P.; von Zastrow, Mark; Nichols, David E.; Kobilka, Brian; Weinstein, Harel; Javitch, Jonathan A.; Roth, Bryan L.; Christopoulos, Arthur; Sexton, Patrick M.; Miller, Keith J.; Spedding, Michael; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The concept of intrinsic efficacy has been enshrined in pharmacol. for half of a century, yet recent data have revealed that many ligands can differentially activate signaling pathways mediated via a single G protein-coupled receptor in a manner that challenges the traditional definition of intrinsic efficacy.  Some terms for this phenomenon include functional selectivity, agonist-directed trafficking, and biased agonism.  At the extreme, functionally selective ligands may be both agonists and antagonists at different functions mediated by the same receptor.  Data illustrating this phenomenon are presented from serotonin, opioid, dopamine, vasopressin, and adrenergic receptor systems.  A variety of mechanisms may influence this apparently ubiquitous phenomenon.  It may be initiated by differences in ligand-induced intermediate conformational states, as shown for the β2-adrenergic receptor.  Subsequent mechanisms that may play a role include diversity of G proteins, scaffolding and signaling partners, and receptor oligomers.  Clearly, expanded research is needed to elucidate the proximal (e.g., how functionally selective ligands cause conformational changes that initiate differential signaling), intermediate (mechanisms that translate conformation changes into differential signaling), and distal mechanisms (differential effects on target tissue or organism).  Besides the heuristically interesting nature of functional selectivity, there is a clear impact on drug discovery, because this mechanism raises the possibility of selecting or designing novel ligands that differentially activate only a subset of functions of a single receptor, thereby optimizing therapeutic action.  It also may be timely to revise classic concepts in quant. pharmacol. and relevant pharmacol. conventions to incorporate these new concepts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5GzdtvWZRkbVg90H21EOLACvtfcHk0ljLeVI6bvcw8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFersw%253D%253D&md5=54465473b5996d0755baeee89eeb0ba9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.104463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.104463%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DKobilka%26aufirst%3DB.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520and%2520classical%2520concepts%2520of%2520quantitative%2520pharmacology%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1%26epage%3D13%26doi%3D10.1124%2Fjpet.106.104463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Signalling bias in new drug discovery: detection, quantification and therapeutic impact</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1038/nrd3954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnrd3954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=23411724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=205-216&author=T.+Kenakinauthor=A.+Christopoulos&title=Signalling+bias+in+new+drug+discovery%3A+detection%2C+quantification+and+therapeutic+impact&doi=10.1038%2Fnrd3954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling bias in new drug discovery: detection, quantification and therapeutic impact</span></div><div class="casAuthors">Kenakin, Terry; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Agonists of seven-transmembrane receptors, also known as G protein-coupled receptors (GPCRs), do not uniformly activate all cellular signalling pathways linked to a given seven-transmembrane receptor (a phenomenon termed ligand or agonist bias); this discovery has changed how high-throughput screens are designed and how lead compds. are optimized for therapeutic activity.  The ability to exptl. detect ligand bias has necessitated the development of methods for quantifying agonist bias in a way that can be used to guide structure-activity studies and the selection of drug candidates.  Here, we provide a viewpoint on which methods are appropriate for quantifying bias, based on knowledge of how cellular and intracellular signalling proteins control the conformation of seven-transmembrane receptors.  We also discuss possible predictions of how biased mols. may perform in vivo, and what potential therapeutic advantages they may provide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkDNsO17tty7Vg90H21EOLACvtfcHk0ljaNxviZbs_YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7c%253D&md5=712258b9158f753689e35fa31f1b67f0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd3954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3954%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DSignalling%2520bias%2520in%2520new%2520drug%2520discovery%253A%2520detection%252C%2520quantification%2520and%2520therapeutic%2520impact%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D205%26epage%3D216%26doi%3D10.1038%2Fnrd3954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span> <span> </span><span class="NLM_article-title">When 7 transmembrane receptors are not G protein-coupled receptors</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">2971</span>– <span class="NLM_lpage">2974</span>, <span class="refDoi"> DOI: 10.1172/JCI26950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1172%2FJCI26950" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2971-2974&author=K.+Rajagopalauthor=R.+J.+Lefkowitzauthor=H.+A.+Rockman&title=When+7+transmembrane+receptors+are+not+G+protein-coupled+receptors&doi=10.1172%2FJCI26950"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1172%2FJCI26950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI26950%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopal%26aufirst%3DK.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26atitle%3DWhen%25207%2520transmembrane%2520receptors%2520are%2520not%2520G%2520protein-coupled%2520receptors%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D2971%26epage%3D2974%26doi%3D10.1172%2FJCI26950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiber, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Premont, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">16284</span>– <span class="NLM_lpage">16289</span>, <span class="refDoi"> DOI: 10.1073/pnas.0607583103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1073%2Fpnas.0607583103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=16284-16289&author=K.+Rajagopalauthor=E.+J.+Whalenauthor=J.+D.+Violinauthor=J.+A.+Stiberauthor=P.+B.+Rosenbergauthor=R.+T.+Premontauthor=T.+M.+Coffmanauthor=H.+A.+Rockmanauthor=R.+J.+Lefkowitz&title=Beta-arrestin2-mediated+inotropic+effects+of+the+angiotensin+II+type+1A+receptor+in+isolated+cardiac+myocytes&doi=10.1073%2Fpnas.0607583103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0607583103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0607583103%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopal%26aufirst%3DK.%26aulast%3DWhalen%26aufirst%3DE.%2BJ.%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DStiber%26aufirst%3DJ.%2BA.%26aulast%3DRosenberg%26aufirst%3DP.%2BB.%26aulast%3DPremont%26aufirst%3DR.%2BT.%26aulast%3DCoffman%26aufirst%3DT.%2BM.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DBeta-arrestin2-mediated%2520inotropic%2520effects%2520of%2520the%2520angiotensin%2520II%2520type%25201A%2520receptor%2520in%2520isolated%2520cardiac%2520myocytes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D16284%26epage%3D16289%26doi%3D10.1073%2Fpnas.0607583103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1038/35047086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2F35047086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=11130073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVCrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=720-723&author=L.+M.+Bohnauthor=R.+R.+Gainetdinovauthor=F.+T.+Linauthor=R.+J.+Lefkowitzauthor=M.+G.+Caron&title=Mu-opioid+receptor+desensitization+by+beta-arrestin-2+determines+morphine+tolerance+but+not+dependence&doi=10.1038%2F35047086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence</span></div><div class="casAuthors">Bohn, Laura M.; Gainetdinov, Raul R.; Lin, Fang-Tsyr; Lefkowitz, Robert J.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6813</span>),
    <span class="NLM_cas:pages">720-723</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is a powerful pain reliever, but also a potent inducer of tolerance and dependence.  The development of opiate tolerance occurs on continued use of the drug such that the amt. of drug required to elicit pain relief must be increased to compensate for diminished responsiveness.  In many systems, decreased responsiveness to agonists has been correlated with the desensitization of G-protein-coupled receptors.  In vitro evidence indicates that this process involves phosphorylation of G-protein-coupled receptors and subsequent binding of regulatory proteins called β-arrestins.  Using a knockout mouse lacking β-arrestin-2 (βarr2-/-), we have assessed the contribution of desensitization of the μ-opioid receptor to the development of morphine antinociceptive tolerance and the subsequent onset of phys. dependence.  Here we show that in mice lacking β-arrestin-2, desensitization of the μ-opioid receptor does not occur after chronic morphine treatment, and that these animals fail to develop antinociceptive tolerance.  However, the deletion of β-arrestin-2 does not prevent the chronic morphine-induced up-regulation of adenylyl cyclase activity, a cellular marker of dependence, and the mutant mice still become phys. dependent on the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOyilKuNxt7Vg90H21EOLACvtfcHk0ljaNxviZbs_YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVCrs7c%253D&md5=6c54b96c15fec1c9620d1fd90d24a1eb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2F35047086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35047086%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DLin%26aufirst%3DF.%2BT.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DMu-opioid%2520receptor%2520desensitization%2520by%2520beta-arrestin-2%2520determines%2520morphine%2520tolerance%2520but%2520not%2520dependence%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D720%26epage%3D723%26doi%3D10.1038%2F35047086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cas, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Lenarda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole-Wilson, P.</span></span> <span> </span><span class="NLM_article-title">Beta-blockers in heart failure: are pharmacological differences clinically important?</span>. <i>Heart Fail. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1023/B:HREV.0000046367.99002.a4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1023%2FB%3AHREV.0000046367.99002.a4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=15516860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFegu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=123-130&author=M.+Metraauthor=L.+D.+Casauthor=A.+di+Lenardaauthor=P.+Poole-Wilson&title=Beta-blockers+in+heart+failure%3A+are+pharmacological+differences+clinically+important%3F&doi=10.1023%2FB%3AHREV.0000046367.99002.a4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-Blockers in Heart Failure: Are Pharmacological Differences Clinically Important?</span></div><div class="casAuthors">Metra, Marco; Cas, Livio Dei; Di Lenarda, Andrea; Poole-Wilson, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Heart Failure Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-130</span>CODEN:
                <span class="NLM_cas:coden">HFREFC</span>;
        ISSN:<span class="NLM_cas:issn">1382-4147</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Beta-blockers are not an homogeneous group of agents.  Only three beta-blockers, carvedilol, bisoprolol and metoprolol succinate, have had favorable effects on prognosis in controlled clin. trials in the patients with chronic heart failure.  However, pharmacol. differences exist between them.  Metoprolol and bisoprolol are selective for beta1-adrenergic receptors while carvedilol blocks also beta2-, and alpha1- adrenergic receptors, and has assocd. antioxidant, anti-endothelin and antiproliferative properties.  In COMET carvedilol was assocd. with a significant redn. in mortality compared to metoprolol tartrate further showing that different beta-blockers may have different effects on the outcome.  These differences may be related to the ancillary properties of carvedilol or to its broader antiadrenergic profile.  However, also more effective and prolonged blockade of beta1 adrenergic receptors may occur with carvedilol compared to metoprolol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIbtD4AnPzyLVg90H21EOLACvtfcHk0ljaNxviZbs_YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFegu7Y%253D&md5=7c43820be08572ce3e692644e020fb64</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1023%2FB%3AHREV.0000046367.99002.a4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AHREV.0000046367.99002.a4%26sid%3Dliteratum%253Aachs%26aulast%3DMetra%26aufirst%3DM.%26aulast%3DCas%26aufirst%3DL.%2BD.%26aulast%3Ddi%2BLenarda%26aufirst%3DA.%26aulast%3DPoole-Wilson%26aufirst%3DP.%26atitle%3DBeta-blockers%2520in%2520heart%2520failure%253A%2520are%2520pharmacological%2520differences%2520clinically%2520important%253F%26jtitle%3DHeart%2520Fail.%2520Rev.%26date%3D2004%26volume%3D9%26spage%3D123%26epage%3D130%26doi%3D10.1023%2FB%3AHREV.0000046367.99002.a4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wisler, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWire, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenoy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">16657</span>– <span class="NLM_lpage">16662</span>, <span class="refDoi"> DOI: 10.1073/pnas.0707936104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1073%2Fpnas.0707936104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=17925438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Wmu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=16657-16662&author=J.+W.+Wislerauthor=S.+M.+DeWireauthor=E.+J.+Whalenauthor=J.+D.+Violinauthor=M.+T.+Drakeauthor=S.+Ahnauthor=S.+K.+Shenoyauthor=R.+J.+Lefkowitz&title=A+unique+mechanism+of+beta-blocker+action%3A+Carvedilol+stimulates+beta-arrestin+signaling&doi=10.1073%2Fpnas.0707936104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A unique mechanism of β-blocker action: carvedilol stimulates β-arrestin signaling</span></div><div class="casAuthors">Wisler, James W.; Dewire, Scott M.; Whalen, Erin J.; Violin, Jonatan D.; Drake, Matthew T.; Ahn, Seungkirl; Shenoy, Sudha K.; Lefkowitz, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">16657-16662</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">For many years, β-adrenergic receptor antagonists (β-blockers or βAR antagonists) have provided significant morbidity and mortality benefits in patients who have sustained acute myocardial infarction.  More recently, β-adrenergic receptor antagonists have been found to provide survival benefits in patients suffering from heart failure, although the efficacy of different β-blockers varies widely in this condition.  One drug, carvedilol, a nonsubtype-selective βAR antagonist, has proven particularly effective in the treatment of heart failure, although the mechanism(s) responsible for this are controversial.  Here, we report that among 16 clin. relevant βAR antagonists, carvedilol displays a unique profile of in vitro signaling characteristics.  We obsd. that in β2 adrenergic receptor (β2AR)-expressing HEK-293 cells, carvedilol has inverse efficacy for stimulating Gs-dependent adenylyl cyclase but, nonetheless, stimulates (i) phosphorylation of the receptor's cytoplasmic tail on previously documented G protein-coupled receptor kinase sites; (ii) recruitment of β-arrestin to the β2AR; (iii) receptor internalization; and (iv) activation of extracellular regulated kinase 1/2 (ERK 1/2), which is maintained in the G protein-uncoupled mutant β2ART68F,Y132G,Y219A (β2ARTYY) and abolished by β-arrestin2 siRNA.  Taken together, these data indicate that carvedilol is able to stabilize a receptor conformation which, although uncoupled from Gs, is nonetheless able to stimulate β-arrestin-mediated signaling.  We hypothesize that such signaling may contribute to the special efficacy of carvedilol in the treatment of heart failure and may serve as a prototype for a new generation of therapeutic β2AR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo93wOR8ANKWbVg90H21EOLACvtfcHk0lhV7V84gcyw_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Wmu7%252FJ&md5=cd03ae4a87363d9bca28b14dce173589</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0707936104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0707936104%26sid%3Dliteratum%253Aachs%26aulast%3DWisler%26aufirst%3DJ.%2BW.%26aulast%3DDeWire%26aufirst%3DS.%2BM.%26aulast%3DWhalen%26aufirst%3DE.%2BJ.%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DDrake%26aufirst%3DM.%2BT.%26aulast%3DAhn%26aufirst%3DS.%26aulast%3DShenoy%26aufirst%3DS.%2BK.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DA%2520unique%2520mechanism%2520of%2520beta-blocker%2520action%253A%2520Carvedilol%2520stimulates%2520beta-arrestin%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D16657%26epage%3D16662%26doi%3D10.1073%2Fpnas.0707936104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aryal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corder, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lober, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of opioid analgesics with reduced side effects</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>537</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1038/nature19112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnature19112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=27533032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKmsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=185-190&author=A.+Manglikauthor=H.+Linauthor=D.+K.+Aryalauthor=J.+D.+McCorvyauthor=D.+Denglerauthor=G.+Corderauthor=A.+Levitauthor=R.+C.+Klingauthor=V.+Bernatauthor=H.+Hubnerauthor=X.+P.+Huangauthor=M.+F.+Sassanoauthor=P.+M.+Giguereauthor=S.+Loberauthor=D.+Daauthor=G.+Scherrerauthor=B.+K.+Kobilkaauthor=P.+Gmeinerauthor=B.+L.+Rothauthor=B.+K.+Shoichet&title=Structure-based+discovery+of+opioid+analgesics+with+reduced+side+effects&doi=10.1038%2Fnature19112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based discovery of opioid analgesics with reduced side effects</span></div><div class="casAuthors">Manglik, Aashish; Lin, Henry; Aryal, Dipendra K.; McCorvy, John D.; Dengler, Daniela; Corder, Gregory; Levit, Anat; Kling, Ralf C.; Bernat, Viachaslau; Hubner, Harald; Huang, Xi-Ping; Sassano, Maria F.; Giguere, Patrick M.; Lober, Stefan; Da Duan; Scherrer, Gregory; Kobilka, Brian K.; Gmeiner, Peter; Roth, Bryan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7619</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is an alkaloid from the opium poppy used to treat pain.  The potentially lethal side effects of morphine and related opioids-which include fatal respiratory depression-are thought to be mediated by μ-opioid-receptor (μOR) signalling through the β-arrestin pathway or by actions at other receptors.  Conversely, G-protein μOR signalling is thought to confer analgesia.  Here we computationally dock over 3 million mols. against the μOR structure and identify new scaffolds unrelated to known opioids.  Structure-based optimization yields PZM21-a potent Gi activator with exceptional selectivity for μOR and minimal β-arrestin-2 recruitment.  Unlike morphine, PZM21 is more efficacious for the affective component of analgesia vs. the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses.  PZM21 thus serves as both a probe to disentangle μOR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiCff2w3U8iLVg90H21EOLACvtfcHk0lhV7V84gcyw_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKmsbvI&md5=b8bb2d8575dadf4a6dc74d94c26d2c1a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature19112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19112%26sid%3Dliteratum%253Aachs%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DAryal%26aufirst%3DD.%2BK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DDengler%26aufirst%3DD.%26aulast%3DCorder%26aufirst%3DG.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DBernat%26aufirst%3DV.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DGiguere%26aufirst%3DP.%2BM.%26aulast%3DLober%26aufirst%3DS.%26aulast%3DDa%26aufirst%3DD.%26aulast%3DScherrer%26aufirst%3DG.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DStructure-based%2520discovery%2520of%2520opioid%2520analgesics%2520with%2520reduced%2520side%2520effects%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D185%26epage%3D190%26doi%3D10.1038%2Fnature19112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilts, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connery, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrington, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawler, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oxford, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Malley, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D<sub>2</sub>L receptor-transfected MN9D cells and pituitary lactotrophs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.1124/jpet.301.3.1179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.301.3.1179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=12023553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1179-1189&author=J.+D.+Kiltsauthor=H.+S.+Conneryauthor=E.+G.+Arringtonauthor=M.+M.+Lewisauthor=C.+P.+Lawlerauthor=G.+S.+Oxfordauthor=K.+L.+O%27Malleyauthor=R.+D.+Toddauthor=B.+L.+Blakeauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Functional+selectivity+of+dopamine+receptor+agonists.+II.+Actions+of+dihydrexidine+in+D2L+receptor-transfected+MN9D+cells+and+pituitary+lactotrophs&doi=10.1124%2Fjpet.301.3.1179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs</span></div><div class="casAuthors">Kilts, Jason D.; Connery, Hilary S.; Arrington, Elaine G.; Lewis, Mechelle M.; Lawler, Cindy P.; Oxford, Gerry S.; O'Malley, Karen L.; Todd, Richard D.; Blake, Bonita L.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1189</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">D2-like dopamine receptors mediate functional changes via activation of inhibitory G proteins, including those that affect adenylate cyclase activity, and potassium and calcium channels.  Although it is assumed that the binding of a drug to a single isoform of a D2-like receptor will cause similar changes in all receptor-mediated functions, it has been demonstrated in brain that the dopamine agonists dihydrexidine (DHX) and N-n-propyl-DHX are "functionally selective".  The current study explores the underlying mechanism using transfected MN9D cells and D2-producing anterior pituitary lactotrophs.  Both dopamine and DHX inhibited adenylate cyclase activity in a concn.-dependent manner in both systems, effects blocked by D2, but not D1, antagonists.  In the MN9D cells, quinpirole and R-(-)-N-propylnorapomorphine (NPA) also inhibited the K+-stimulated release of [3H]dopamine in a concn.-responsive, antagonist-reversible manner.  Conversely, neither DHX, nor its analogs, inhibited K+-stimulated [3H]dopamine release, although they antagonized the effects of quinpirole.  S-(+)-NPA actually had the reverse functional selectivity profile from DHX (i.e., it was a full agonist at D2L receptors coupled to inhibition of dopamine release, but a weak partial agonist at D2L receptor-mediated inhibition of adenylate cyclase).  In lactotrophs, DHX had little intrinsic activity at D2 receptors coupled to G protein-coupled inwardly rectifying potassium channels, and actually antagonized the effects of dopamine at these D2 receptors.  Together, these findings provide compelling evidence for agonist-induced functional selectivity with the D2L receptor.  Although the underlying mol. mechanism is controversial (e.g., "conformational induction" vs. "drug-active state selection"), such data are irreconcilable with the widely held view that drugs have "intrinsic efficacy".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxKyo-BPUi-LVg90H21EOLACvtfcHk0lhpVBxbwMMsNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrc%253D&md5=6686ca6fae277969b216781088d74a87</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1179%26sid%3Dliteratum%253Aachs%26aulast%3DKilts%26aufirst%3DJ.%2BD.%26aulast%3DConnery%26aufirst%3DH.%2BS.%26aulast%3DArrington%26aufirst%3DE.%2BG.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DOxford%26aufirst%3DG.%2BS.%26aulast%3DO%2527Malley%26aufirst%3DK.%2BL.%26aulast%3DTodd%26aufirst%3DR.%2BD.%26aulast%3DBlake%26aufirst%3DB.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520II.%2520Actions%2520of%2520dihydrexidine%2520in%2520D2L%2520receptor-transfected%2520MN9D%2520cells%2520and%2520pituitary%2520lactotrophs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1179%26epage%3D1189%26doi%3D10.1124%2Fjpet.301.3.1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">GPCR functional selectivity has therapeutic impact</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">390</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2007.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.tips.2007.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=17629962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=390-396&author=R.+B.+Mailman&title=GPCR+functional+selectivity+has+therapeutic+impact&doi=10.1016%2Fj.tips.2007.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">GPCR functional selectivity has therapeutic impact</span></div><div class="casAuthors">Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">390-396</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Many in vitro data show that some ligands can cause the differential activation of signaling pathways mediated by a single receptor (termedfunctional selectivity').  It remains unclear, however, whether functionally selective properties are meaningful in vivo.  Data obtained with exptl. compds. that are functionally selective at the dopamine D2L receptor in vitro suggest that these properties might predict atypical behavioral actions.  Moreover, the antipsychotic drug aripiprazole is commonly thought to be a D2 partial agonist, but data clearly show that aripiprazole is functionally selective in vitro.  It is proposed that the effects of aripiprazole in animal models and humans can be reconciled only with its functionally selective D2 properties, not its partial D2 agonism.  Together, these data provide support for the hypothesis that compds. with functionally selective properties in vitro are likely to have novel actions in vivo, opening doors to new avenues of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGT3wJMrwLmrVg90H21EOLACvtfcHk0lhpVBxbwMMsNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltLg%253D&md5=e4647d1af70505c4711dd2d57d0b4cfd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DGPCR%2520functional%2520selectivity%2520has%2520therapeutic%2520impact%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D390%26epage%3D396%26doi%3D10.1016%2Fj.tips.2007.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Aripiprazole has functionally selective actions at dopamine D<sub>2</sub> receptor-mediated signaling pathways</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1301071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fsj.npp.1301071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=16554739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=67-77&author=J.+D.+Urbanauthor=G.+A.+Vargasauthor=M.+von+Zastrowauthor=R.+B.+Mailman&title=Aripiprazole+has+functionally+selective+actions+at+dopamine+D2+receptor-mediated+signaling+pathways&doi=10.1038%2Fsj.npp.1301071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways</span></div><div class="casAuthors">Urban, Jonathan D.; Vargas, Gabriel A.; von Zastrow, Mark; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-77</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aripiprazole is a unique atypical antipsychotic drug with an excellent side-effect profile presumed, in part, to be due to lack of typical D2 dopamine receptor antagonist properties.  Whether aripiprazole is a typical D2 partial agonist, or a functionally selective D2 ligand, remains controversial (eg D2-mediated inhibition of adenylate cyclase is system dependent; aripiprazole antagonizes D2 receptor-mediated G-protein-coupled inwardly rectifying potassium channels and guanosine triphosphate nucleotide (GTP)γS coupling).  The current study examd. the D2L receptor binding properties of aripiprazole, as well as the effects of the drug on three downstream D2 receptor-mediated functional effectors: mitogen-activated protein kinase (MAPK) phosphorylation, potentiation of arachidonic acid (AA) release, and D2 receptor internalization.  Unlike quinpirole (a full D2 agonist) or (-)3PPP (S(-)-3-(3-hydroxyphenyl)-N-propylpiperidine hydrochloride, a D2 partial agonist), the apparent D2 affinity of aripiprazole was not decreased significantly by GTP.  Moreover, full or partial agonists are expected to have Hill slopes <1.0, yet that of aripiprazole was significantly >1.0.  Whereas aripiprazole partially activated both the MAPK and AA pathways, its potency vs MAPK phosphorylation was much lower relative to potencies in assays either of AA release or inhibition of cyclic adenosine 3',5'-cyclic monophosphate accumulation.  In addn., unlike typical agonists, neither aripiprazole nor (-)3PPP produced significant internalization of the D2L receptor.  These data are clear evidence that aripiprazole affects D2L-mediated signaling pathways in a differential manner.  The results are consistent with the hypothesis that aripiprazole is a functionally selective D2 ligand rather than a simple partial agonist.  Such data may be useful in understanding the novel clin. actions of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-qAW7cvG3i7Vg90H21EOLACvtfcHk0lhpVBxbwMMsNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqtbrJ&md5=20b9edb05787dadb09fb4c778205f0b2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301071%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DAripiprazole%2520has%2520functionally%2520selective%2520actions%2520at%2520dopamine%2520D2%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D67%26epage%3D77%26doi%3D10.1038%2Fsj.npp.1301071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin-biased ligands at seven-transmembrane receptors</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2007.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.tips.2007.06.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=416-422&author=J.+D.+Violinauthor=R.+J.+Lefkowitz&title=Beta-arrestin-biased+ligands+at+seven-transmembrane+receptors&doi=10.1016%2Fj.tips.2007.06.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DBeta-arrestin-biased%2520ligands%2520at%2520seven-transmembrane%2520receptors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D416%26epage%3D422%26doi%3D10.1016%2Fj.tips.2007.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gesty-Palmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span> <span> </span><span class="NLM_article-title">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">1ra1</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.3000071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1126%2Fscitranslmed.3000071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=20368153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&author=D.+Gesty-Palmerauthor=P.+Flanneryauthor=L.+Yuanauthor=L.+Corsinoauthor=R.+Spurneyauthor=R.+J.+Lefkowitzauthor=L.+M.+Luttrell&title=A+beta-arrestin-biased+agonist+of+the+parathyroid+hormone+receptor+%28PTH1R%29+promotes+bone+formation+independent+of+G+protein+activation&doi=10.1126%2Fscitranslmed.3000071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span></div><div class="casAuthors">Gesty-Palmer Diane; Flannery Pat; Yuan Ling; Corsino Leonor; Spurney Robert; Lefkowitz Robert J; Luttrell Louis M</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1ra1</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">About 40% of the therapeutic agents in use today exert their effects through seven-transmembrane receptors (7TMRs).  When activated by ligands, these receptors trigger two pathways that independently transduce signals to the cell: one through heterotrimeric GTP-binding proteins (G proteins) and one through beta-arrestins; so-called biased agonists can selectively activate these distinct pathways.  Here, we investigate selective activation of these pathways through the use of a biased agonist for the type 1 parathyroid hormone (PTH)-PTH-related protein receptor (PTH1R), (D-Trp(12),Tyr(34))-PTH(7-34) (PTH-betaarr), which activates beta-arrestin but not classic G protein signaling.  In mice, PTH-betaarr induces anabolic bone formation, as does the nonselective agonist PTH(1-34), which activates both mechanisms.  In beta-arrestin2-null mice, the increase in bone mineral density evoked by PTH(1-34) is attenuated and that stimulated by PTH-betaarr is ablated.  The beta-arrestin2-dependent pathway contributes primarily to trabecular bone formation and does not stimulate bone resorption.  These results show that a biased agonist selective for the beta-arrestin pathway can elicit a response in vivo distinct from that elicited by nonselective agonists.  Ligands with these properties may form the basis for improved 7TMR-directed pharmacologic agents with enhanced therapeutic specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmuM4aCIxthdXdcedVHT5tfW6udTcc2eY0F4YphfhR_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D&md5=748e4367ded72b6b7e10fd759521ba62</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3000071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3000071%26sid%3Dliteratum%253Aachs%26aulast%3DGesty-Palmer%26aufirst%3DD.%26aulast%3DFlannery%26aufirst%3DP.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DCorsino%26aufirst%3DL.%26aulast%3DSpurney%26aufirst%3DR.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26atitle%3DA%2520beta-arrestin-biased%2520agonist%2520of%2520the%2520parathyroid%2520hormone%2520receptor%2520%2528PTH1R%2529%2520promotes%2520bone%2520formation%2520independent%2520of%2520G%2520protein%2520activation%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2009%26volume%3D1%26doi%3D10.1126%2Fscitranslmed.3000071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franceschini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borriello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceres, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ros, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coccone, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorini, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennini, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandager-Nielsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel-Kruger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkelsen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattorusso, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D<sub>3</sub> and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1021/jm800689g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800689g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=151-169&author=S.+Butiniauthor=S.+Gemmaauthor=G.+Campianiauthor=S.+Franceschiniauthor=F.+Trottaauthor=M.+Borrielloauthor=N.+Ceresauthor=S.+Rosauthor=S.+S.+Cocconeauthor=M.+Bernettiauthor=M.+De+Angelisauthor=M.+Brindisiauthor=V.+Nacciauthor=I.+Fioriniauthor=E.+Novellinoauthor=A.+Cagnottoauthor=T.+Menniniauthor=K.+Sandager-Nielsenauthor=J.+T.+Andreasenauthor=J.+Scheel-Krugerauthor=J.+D.+Mikkelsenauthor=C.+Fattorusso&title=Discovery+of+a+new+class+of+potential+multifunctional+atypical+antipsychotic+agents+targeting+dopamine+D3+and+serotonin+5-HT1A+and+5-HT2A+receptors%3A+design%2C+synthesis%2C+and+effects+on+behavior&doi=10.1021%2Fjm800689g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm800689g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800689g%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DCeres%26aufirst%3DN.%26aulast%3DRos%26aufirst%3DS.%26aulast%3DCoccone%26aufirst%3DS.%2BS.%26aulast%3DBernetti%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DNacci%26aufirst%3DV.%26aulast%3DFiorini%26aufirst%3DI.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DMennini%26aufirst%3DT.%26aulast%3DSandager-Nielsen%26aufirst%3DK.%26aulast%3DAndreasen%26aufirst%3DJ.%2BT.%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26aulast%3DFattorusso%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520new%2520class%2520of%2520potential%2520multifunctional%2520atypical%2520antipsychotic%2520agents%2520targeting%2520dopamine%2520D3%2520and%2520serotonin%25205-HT1A%2520and%25205-HT2A%2520receptors%253A%2520design%252C%2520synthesis%252C%2520and%2520effects%2520on%2520behavior%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D151%26epage%3D169%26doi%3D10.1021%2Fjm800689g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herenbrink, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span> <span> </span><span class="NLM_article-title">A structure-activity analysis of biased agonism at the dopamine D<sub>2</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9199</span>– <span class="NLM_lpage">9221</span>, <span class="refDoi"> DOI: 10.1021/jm401318w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401318w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9199-9221&author=J.+Shonbergauthor=C.+K.+Herenbrinkauthor=L.+Lopezauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=J.+R.+Lane&title=A+structure-activity+analysis+of+biased+agonism+at+the+dopamine+D2+receptor&doi=10.1021%2Fjm401318w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Structure-Activity Analysis of Biased Agonism at the Dopamine D2 Receptor</span></div><div class="casAuthors">Shonberg, Jeremy; Herenbrink, Carmen Klein; Lopez, Laura; Christopoulos, Arthur; Scammells, Peter J.; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9199-9221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased agonism offers an opportunity for the medicinal chemist to discover pathway-selective ligands for GPCRs.  A no. of studies have suggested that biased agonism at the dopamine D2 receptor (D2R) may be advantageous for the treatment of neuropsychiatric disorders, including schizophrenia.  As such, it is of great importance to gain insight into the SAR of biased agonism at this receptor.  The authors have generated SAR based on a novel D2R partial agonist, tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate.  This ligand shares structural similarity to cariprazine, a drug awaiting FDA approval for the treatment of schizophrenia, yet displays a distinct bias toward two different signaling end points.  The authors synthesized a no. of derivs. of tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate with subtle structural modifications, including incorporation of cariprazine fragments.  By combining pharmacol. profiling with anal. methodol. to identify and to quantify bias, the authors have demonstrated that efficacy and biased agonism can be finely tuned by minor structural modifications to the head group contg. the tertiary amine, a tail group that extends away from this moiety, and the orientation and length of a spacer region between these two moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocktbsOBHWB7Vg90H21EOLACvtfcHk0lgEpdE7_9g-Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ&md5=124b940132336819740ec30d2962a3a3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401318w%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DHerenbrink%26aufirst%3DC.%2BK.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DA%2520structure-activity%2520analysis%2520of%2520biased%2520agonism%2520at%2520the%2520dopamine%2520D2%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9199%26epage%3D9221%26doi%3D10.1021%2Fjm401318w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally selective dopamine D<sub>2</sub>/D<sub>3</sub> receptor agonists comprising an enyne moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5130</span>– <span class="NLM_lpage">5141</span>, <span class="refDoi"> DOI: 10.1021/jm400520c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400520c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5130-5141&author=C.+Hillerauthor=R.+C.+Klingauthor=F.+W.+Heinemannauthor=K.+Meyerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D2%2FD3+receptor+agonists+comprising+an+enyne+moiety&doi=10.1021%2Fjm400520c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</span></div><div class="casAuthors">Hiller, Christine; Kling, Ralf C.; Heinemann, Frank W.; Meyer, Karsten; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5130-5141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonracemic ethynylcyclohexynylamines I and ent-I {R = 1,1'-biphenyl-4-yl, pyrazolo[1,5-a]pyridin-2-yl, pyrazolo[1,5-a]pyridin-3-yl, 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl, benzo[b]thiophene-2-yl, ferrocenyl} were prepd. as dopamine receptor agonists with atypical catechol isosteres; their selectivities for dopamine receptors and for activating receptors through G-protein subunits Go and Gi and the metabolic stability of rac-I (R = 4-PhC6H4) were detd.  The ethynylcyclohexynylamines bound to D2-like receptors with high affinities.  Ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) selectively activated D2slow-promoted Go activation over Gi coupling; the most significant functional bias obsd. was for ent-I {R = 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl} which selectively activated Go over Gi coupling at D2long receptors.  Functional selectivity for β-arrestin recruitment over Gi activation was obsd. for I (R = 1,1'-biphenyl-4-yl) and ent-I (R = benzothiophene-2-yl), while ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) preferred β-arrestin recruitment compared to Go coupling.  The structure of a nonracemic N-(ethynylcyclohexenyl)dinitrobenzamide was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXn2SrS-IBCrVg90H21EOLACvtfcHk0lg9HD_nXCS8cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D&md5=3855de949f505a83ed3aa561ca182e75</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400520c%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DHeinemann%26aufirst%3DF.%2BW.%26aulast%3DMeyer%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D2%252FD3%2520receptor%2520agonists%2520comprising%2520an%2520enyne%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5130%26epage%3D5141%26doi%3D10.1021%2Fjm400520c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein Herenbrink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D(2) receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4924</span>– <span class="NLM_lpage">4939</span>, <span class="refDoi"> DOI: 10.1021/jm500457x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500457x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4924-4939&author=M.+Szaboauthor=C.+Klein+Herenbrinkauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=B.+Capuano&title=Structure-activity+relationships+of+privileged+structures+lead+to+the+discovery+of+novel+biased+ligands+at+the+dopamine+D%282%29+receptor&doi=10.1021%2Fjm500457x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm500457x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500457x%26sid%3Dliteratum%253Aachs%26aulast%3DSzabo%26aufirst%3DM.%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DStructure-activity%2520relationships%2520of%2520privileged%2520structures%2520lead%2520to%2520the%2520discovery%2520of%2520novel%2520biased%2520ligands%2520at%2520the%2520dopamine%2520D%25282%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4924%26epage%3D4939%26doi%3D10.1021%2Fjm500457x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally selective dopamine D(2), D(3) receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4861</span>– <span class="NLM_lpage">4875</span>, <span class="refDoi"> DOI: 10.1021/jm5004039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5004039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4861-4875&author=D.+M%C3%B6lerauthor=R.+C.+Klingauthor=M.+Skultetyauthor=K.+Leunerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D%282%29%2C+D%283%29+receptor+partial+agonists&doi=10.1021%2Fjm5004039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004039%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ler%26aufirst%3DD.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DLeuner%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D%25282%2529%252C%2520D%25283%2529%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4861%26epage%3D4875%26doi%3D10.1021%2Fjm5004039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzuneser, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzheimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased dopaminergics with a pyrazolo[1,5-a]pyridine substructure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2908</span>– <span class="NLM_lpage">2929</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2908-2929&author=D.+M%C3%B6llerauthor=A.+Banerjeeauthor=T.+C.+Uzuneserauthor=M.+Skultetyauthor=T.+Huthauthor=B.+Plouffeauthor=H.+H%C3%BCbnerauthor=C.+Alzheimerauthor=K.+Friedlandauthor=C.+P.+Mullerauthor=M.+Bouvierauthor=P.+Gmeiner&title=Discovery+of+G+protein-biased+dopaminergics+with+a+pyrazolo%5B1%2C5-a%5Dpyridine+substructure&doi=10.1021%2Facs.jmedchem.6b01857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure</span></div><div class="casAuthors">Moller Dorothee; Banerjee Ashutosh; Skultety Marika; Hubner Harald; Gmeiner Peter; Uzuneser Taygun C; Muller Christian P; Huth Tobias; Alzheimer Christian; Plouffe Bianca; Bouvier Michel; Friedland Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2908-2929</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors.  Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties.  In particular, incorporation of a pyrazolo[1,5-a]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists.  Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably Go) over β-arrestin recruitment at dopamine D2 receptors.  The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine 16c, which unequivocally displayed antipsychotic activity in vivo.  Moreover, combination of the pyrazolo[1,5-a]pyridine appendage with a 5-hydroxy-N-propyl-2-aminotetraline unit led to balanced or G protein-biased dopaminergic ligands depending on the stereochemistry of the headgroup, illustrating the complex structure-functional selectivity relationships at dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSsvEaQplNsM25P7XSLhESfW6udTcc2eYGzb56uPMDKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D&md5=208855de29fed6b821fd6e4a5bfb412f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DUzuneser%26aufirst%3DT.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DHuth%26aufirst%3DT.%26aulast%3DPlouffe%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DAlzheimer%26aufirst%3DC.%26aulast%3DFriedland%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DC.%2BP.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520dopaminergics%2520with%2520a%2520pyrazolo%255B1%252C5-a%255Dpyridine%2520substructure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2908%26epage%3D2929%26doi%3D10.1021%2Facs.jmedchem.6b01857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Männel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Hydroxy-substituted heteroarylpiperazines: novel scaffolds for beta-arrestin-biased D<sub>2</sub>R agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4693</span>– <span class="NLM_lpage">4713</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00363</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4693-4713&author=B.+M%C3%A4nnelauthor=D.+Denglerauthor=J.+Shonbergauthor=H.+H%C3%BCbnerauthor=D.+M%C3%B6llerauthor=P.+Gmeiner&title=Hydroxy-substituted+heteroarylpiperazines%3A+novel+scaffolds+for+beta-arrestin-biased+D2R+agonists&doi=10.1021%2Facs.jmedchem.7b00363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00363%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnel%26aufirst%3DB.%26aulast%3DDengler%26aufirst%3DD.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHydroxy-substituted%2520heteroarylpiperazines%253A%2520novel%2520scaffolds%2520for%2520beta-arrestin-biased%2520D2R%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4693%26epage%3D4713%26doi%3D10.1021%2Facs.jmedchem.7b00363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Männel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiteh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeifman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randakova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, J.</span></span> <span> </span><span class="NLM_article-title">Structure-guided screening for functionally selective D<sub>2</sub> dopamine receptor ligands from a virtual chemical library</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2652</span>– <span class="NLM_lpage">2661</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00493</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00493" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A280%3ADC%252BC1cbitFOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2652-2661&author=B.+M%C3%A4nnelauthor=M.+Jaitehauthor=A.+Zeifmanauthor=A.+Randakovaauthor=D.+M%C3%B6llerauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=J.+Carlsson&title=Structure-guided+screening+for+functionally+selective+D2+dopamine+receptor+ligands+from+a+virtual+chemical+library&doi=10.1021%2Facschembio.7b00493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library</span></div><div class="casAuthors">Mannel Barbara; Randakova Alena; Moller Dorothee; Hubner Harald; Gmeiner Peter; Jaiteh Mariama; Zeifman Alexey; Carlsson Jens</div><div class="citationInfo"><span class="NLM_cas:title">ACS chemical biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2652-2661</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Functionally selective ligands stabilize conformations of G protein-coupled receptors (GPCRs) that induce a preference for signaling via a subset of the intracellular pathways activated by the endogenous agonists.  The possibility to fine-tune the functional activity of a receptor provides opportunities to develop drugs that selectively signal via pathways associated with a therapeutic effect and avoid those causing side effects.  Animal studies have indicated that ligands displaying functional selectivity at the D2 dopamine receptor (D2R) could be safer and more efficacious drugs against neuropsychiatric diseases.  In this work, computational design of functionally selective D2R ligands was explored using structure-based virtual screening.  Molecular docking of known functionally selective ligands to a D2R homology model indicated that such compounds were anchored by interactions with the orthosteric site and extended into a common secondary pocket.  A tailored virtual library with close to 13 000 compounds bearing 2,3-dichlorophenylpiperazine, a privileged orthosteric scaffold, connected to diverse chemical moieties via a linker was docked to the D2R model.  Eighteen top-ranked compounds that occupied both the orthosteric and allosteric site were synthesized, leading to the discovery of 16 partial agonists.  A majority of the ligands had comparable maximum effects in the G protein and β-arrestin recruitment assays, but a subset displayed preference for a single pathway.  In particular, compound 4 stimulated β-arrestin recruitment (EC50 = 320 nM, Emax = 16%) but had no detectable G protein signaling.  The use of structure-based screening and virtual libraries to discover GPCR ligands with tailored functional properties will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRW136So_JwDo2y4bB4mnvYfW6udTcc2eYPePuFV2tyqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbitFOhtg%253D%253D&md5=6fce6cbe07e10f7707b349c1de9c07d3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00493%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnel%26aufirst%3DB.%26aulast%3DJaiteh%26aufirst%3DM.%26aulast%3DZeifman%26aufirst%3DA.%26aulast%3DRandakova%26aufirst%3DA.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DCarlsson%26aufirst%3DJ.%26atitle%3DStructure-guided%2520screening%2520for%2520functionally%2520selective%2520D2%2520dopamine%2520receptor%2520ligands%2520from%2520a%2520virtual%2520chemical%2520library%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D2652%26epage%3D2661%26doi%3D10.1021%2Facschembio.7b00493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Männel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin biased dopamine D<sub>2</sub> receptor partial agonists: Synthesis and pharmacological evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5613</span>– <span class="NLM_lpage">5628</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.bmc.2017.08.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5613-5628&author=B.+M%C3%A4nnelauthor=H.+H%C3%BCbnerauthor=D.+M%C3%B6llerauthor=P.+Gmeiner&title=Beta-arrestin+biased+dopamine+D2+receptor+partial+agonists%3A+Synthesis+and+pharmacological+evaluation&doi=10.1016%2Fj.bmc.2017.08.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnel%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DBeta-arrestin%2520biased%2520dopamine%2520D2%2520receptor%2520partial%2520agonists%253A%2520Synthesis%2520and%2520pharmacological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5613%26epage%3D5628%26doi%3D10.1016%2Fj.bmc.2017.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of beta-arrestin-biased dopamine D<sub>2</sub> ligands for probing signal transduction pathways essential for antipsychotic efficacy</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">18488</span>– <span class="NLM_lpage">18493</span>, <span class="refDoi"> DOI: 10.1073/pnas.1104807108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1073%2Fpnas.1104807108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=22025698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.+P.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+beta-arrestin-biased+dopamine+D2+ligands+for+probing+signal+transduction+pathways+essential+for+antipsychotic+efficacy&doi=10.1073%2Fpnas.1104807108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy</span></div><div class="casAuthors">Allen, John A.; Yost, Julianne M.; Setola, Vincent; Chen, Xin; Sassano, Maria F.; Chen, Meng; Peterson, Sean; Yadav, Prem N.; Huang, Xi-Ping; Feng, Bo; Jensen, Niels H.; Che, Xin; Bai, Xu; Frye, Stephen V.; Wetsel, William C.; Caron, Marc G.; Javitch, Jonathan A.; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18488-18493, S18488/1-S18488/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Elucidating the key signal transduction pathways essential for both antipsychotic efficacy and side-effect profiles is essential for developing safer and more effective therapies.  Recent work has highlighted noncanonical modes of dopamine D2 receptor (D2R) signaling via β-arrestins as being important for the therapeutic actions of both antipsychotic and antimanic agents.  We thus sought to create unique D2R agonists that display signaling bias via β-arrestinergic signaling.  Through a robust diversity-oriented modification of the scaffold represented by aripiprazole (1), we discovered UNC9975 (2), UNC0006 (3); and UNC9994 (4) as unprecedented β-arrestin-biased D2R ligands.  These compds. also represent unprecedented β-arrestin-biased ligands for a Gi-coupled G protein-coupled receptor (GPCR).  Significantly, UNC9975, UNC0006, and UNC9994 are simultaneously antagonists of Gi-regulated cAMP prodn. and partial agonists for D2R/β-arrestin-2 interactions.  Importantly, VNC9975 displayed potent antipsychotic-like activity without inducing motoric side effects in inbred C57BL/6 mice in vivo.  Genetic deletion of β-arrestin-2 simultaneously attenuated the antipsychotic actions of UNC9975 and transformed it into a typical antipsychotic .drug with a high propensity to induce catalepsy.  Similarly, the antipsychotic-like activity displayed by UNC9994, an extremely β-arrestin-biased D2R agonist, in wild-type mice was completely abolished in β-arrestin-2 knockout mice.  Taken together, our results suggest that β-arrestin signaling and recruitment can be simultaneously a significant contributor to antipsychotic efficacy and protective against motoric side effects.  These functionally selective, β-arrestin-biased D2R ligands represent valuable chem. probes for further investigations of D2R signaling in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr87mjP6jm447Vg90H21EOLACvtfcHk0lgU_vvS7wtQgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK&md5=d5b06e4ac4d2cc4cd04fd1de760ec628</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104807108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104807108%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520beta-arrestin-biased%2520dopamine%2520D2%2520ligands%2520for%2520probing%2520signal%2520transduction%2520pathways%2520essential%2520for%2520antipsychotic%2520efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493%26doi%3D10.1073%2Fpnas.1104807108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupica, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Novel and potent dopamine D<sub>2</sub> receptor Go-protein biased agonists</span>. <i>ACS Pharmacol. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1021/acsptsci.8b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsptsci.8b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvF2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2019&pages=52-65&author=A.+Bonifaziauthor=H.+Yanoauthor=A.+M.+Guerreroauthor=V.+Kumarauthor=A.+F.+Hoffmanauthor=C.+R.+Lupicaauthor=L.+Shiauthor=A.+H.+Newman&title=Novel+and+potent+dopamine+D2+receptor+Go-protein+biased+agonists&doi=10.1021%2Facsptsci.8b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Potent Dopamine D2 Receptor Go-Protein Biased Agonists</span></div><div class="casAuthors">Bonifazi, Alessandro; Yano, Hideaki; Guerrero, Adrian M.; Kumar, Vivek; Hoffman, Alexander F.; Lupica, Carl R.; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">ACS Pharmacology & Translational Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-65</span>CODEN:
                <span class="NLM_cas:coden">APTSFN</span>;
        ISSN:<span class="NLM_cas:issn">2575-9108</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of functionally biased and physiol. beneficial ligands directed toward G-protein coupled receptors (GPCRs) has provided the impetus to design dopamine D2 receptor (D2R) targeted mols. that may be therapeutically advantageous for the treatment of certain neuropsychiatric or basal ganglia related disorders.  Here we describe the synthesis of a novel series of D2R agonists linking the D2R unbiased agonist sumanirole with privileged secondary mol. fragments.  The resulting ligands demonstrate improved D2R affinity and selectivity over sumanirole.  Extensive in vitro functional studies and bias factor anal. led to the identification of a novel class of highly potent Go-protein biased full D2R agonists with more than 10-fold and 1000-fold bias selectivity toward activation of specific G-protein subtypes and β-arrestin, resp.  Intracellular electrophysiol. recordings from midbrain dopamine neurons demonstrated that Go-protein selective agonists can elicit prolonged ligand-induced GIRK activity via D2Rs, which may be beneficial in the treatment of dyskinesias assocd. with dopamine system dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNIFl-FnvXCrVg90H21EOLACvtfcHk0lhh8LlylEXWLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvF2nuw%253D%253D&md5=5b67e76002f6ceb85293c961f698722a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsptsci.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsptsci.8b00060%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DGuerrero%26aufirst%3DA.%2BM.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DHoffman%26aufirst%3DA.%2BF.%26aulast%3DLupica%26aufirst%3DC.%2BR.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520and%2520potent%2520dopamine%2520D2%2520receptor%2520Go-protein%2520biased%2520agonists%26jtitle%3DACS%2520Pharmacol.%2520Transl.%2520Sci.%26date%3D2019%26volume%3D2%26spage%3D52%26epage%3D65%26doi%3D10.1021%2Facsptsci.8b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span> <span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.+M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lhh8LlylEXWLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the D<sub>2</sub> dopamine receptor bound to the atypical antipsychotic drug risperidone</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature25758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnature25758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29466326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2018&pages=269-273&author=S.+Wangauthor=T.+Cheauthor=A.+Levitauthor=B.+K.+Shoichetauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+D2+dopamine+receptor+bound+to+the+atypical+antipsychotic+drug+risperidone&doi=10.1038%2Fnature25758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span></div><div class="casAuthors">Wang, Sheng; Che, Tao; Levit, Anat; Shoichet, Brian K.; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">7695</span>),
    <span class="NLM_cas:pages">269-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metab. and hormonal secretion.  Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting.  The actions of dopamine are mediated by a family of five G-protein-coupled receptors.  The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease.  Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors.  Accordingly, a mol. understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications.  Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone.  The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actions of risperidone and related drugs at DRD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeo4Ov49kft7Vg90H21EOLACvtfcHk0lhh8LlylEXWLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D&md5=2842adc1893293ea8dbf98ae3270a1b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnature25758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25758%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520D2%2520dopamine%2520receptor%2520bound%2520to%2520the%2520atypical%2520antipsychotic%2520drug%2520risperidone%26jtitle%3DNature%26date%3D2018%26volume%3D555%26spage%3D269%26epage%3D273%26doi%3D10.1038%2Fnature25758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Structure-functional selectivity relationship studies of beta-arrestin-biased dopamine D(2) receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7141</span>– <span class="NLM_lpage">7153</span>, <span class="refDoi"> DOI: 10.1021/jm300603y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300603y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWhsbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7141-7153&author=X.+Chenauthor=M.+F.+Sassanoauthor=L.+Zhengauthor=V.+Setolaauthor=M.+Chenauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=B.+L.+Rothauthor=J.+Jin&title=Structure-functional+selectivity+relationship+studies+of+beta-arrestin-biased+dopamine+D%282%29+receptor+agonists&doi=10.1021%2Fjm300603y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists</span></div><div class="casAuthors">Chen, Xin; Sassano, Maria F.; Zheng, Lianyou; Setola, Vincent; Chen, Meng; Bai, Xu; Frye, Stephen V.; Wetsel, William C.; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7141-7153</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Functionally selective G protein-coupled receptor (GPCR) ligands, which differentially modulate canonical and noncanonical signaling, are extremely useful for elucidating key signal transduction pathways essential for both the therapeutic actions and side effects of drugs.  However, few such ligands have been created, and very little purposeful attention has been devoted to studying what we term: "structure-functional selectivity relationships" (SFSR).  We recently disclosed the first β-arrestin-biased dopamine D2 receptor (D2R) agonists UNC9975 (44) and UNC9994 (36), which have robust in vivo antipsychotic drug-like activities.  Here we report the first comprehensive SFSR studies focused on exploring four regions of the aripiprazole scaffold, which resulted in the discovery of these β-arrestin-biased D2R agonists.  These studies provide a successful proof-of-concept for how functionally selective ligands can be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwoG1fasQ6GLVg90H21EOLACvtfcHk0ljS7yw20wndlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWhsbfK&md5=00b0613e62ce7b5a4c98cb5212fea3b5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm300603y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300603y%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DStructure-functional%2520selectivity%2520relationship%2520studies%2520of%2520beta-arrestin-biased%2520dopamine%2520D%25282%2529%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7141%26epage%3D7153%26doi%3D10.1021%2Fjm300603y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased D<sub>2</sub> dopamine receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10601</span>– <span class="NLM_lpage">10618</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10601-10618&author=X.+Chenauthor=J.+D.+McCorvyauthor=M.+G.+Fischerauthor=K.+V.+Butlerauthor=Y.+Shenauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+G+protein-biased+D2+dopamine+receptor+partial+agonists&doi=10.1021%2Facs.jmedchem.6b01208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists</span></div><div class="casAuthors">Chen, Xin; McCorvy, John D.; Fischer, Matthew G.; Butler, Kyle V.; Shen, Yudao; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10601-10618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased ligands (also known as functionally selective ligands) of G protein-coupled receptors are valuable tools for dissecting the roles of G protein-dependent and independent signaling pathways in health and disease.  Biased ligands have also been increasingly pursued by the biomedical community as promising therapeutics with improved efficacy and reduced side effects compared with unbiased ligands.  The authors previously discovered first-in-class β-arrestin-biased agonists of dopamine D2 receptor (D2R) by extensively exploring multiple regions of aripiprazole, a balanced D2R agonist.  In the authors' continuing efforts to identify biased agonists of D2R, the authors unexpectedly discovered a G protein-biased agonist of D2R, compd. 1 (5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-methylbenzo[d]thiazole), which is the first G protein-biased D2R agonist from the aripiprazole scaffold.  The authors designed and synthesized novel analogs to explore two regions of 1 and conducted structure-functional selectivity relationship (SFSR) studies.  Here the authors report the discovery of 1, findings from the authors' SFSR studies, and characterization of novel G protein-biased D2R agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeKlhGCqSPxLVg90H21EOLACvtfcHk0ljS7yw20wndlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK&md5=81b1435b1ae82438aa3f270f7ee4f853</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DFischer%26aufirst%3DM.%2BG.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520D2%2520dopamine%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10601%26epage%3D10618%26doi%3D10.1021%2Facs.jmedchem.6b01208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure-inspired design of beta-arrestin-biased ligands for aminergic GPCRs</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnchembio.2527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29227473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=126-134&author=J.+D.+McCorvyauthor=K.+V.+Butlerauthor=B.+Kellyauthor=K.+Rechsteinerauthor=J.+Karpiakauthor=R.+M.+Betzauthor=B.+L.+Kormosauthor=B.+K.+Shoichetauthor=R.+O.+Drorauthor=J.+Jinauthor=B.+L.+Roth&title=Structure-inspired+design+of+beta-arrestin-biased+ligands+for+aminergic+GPCRs&doi=10.1038%2Fnchembio.2527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs</span></div><div class="casAuthors">McCorvy, John D.; Butler, Kyle V.; Kelly, Brendan; Rechsteiner, Katie; Karpiak, Joel; Betz, Robin M.; Kormos, Bethany L.; Shoichet, Brian K.; Dror, Ron O.; Jin, Jian; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-134</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Development of biased ligands targeting G protein-coupled receptors (GPCRs) is a promising approach for current drug discovery.  Although structure-based drug design of biased agonists remains challenging even with an abundance of GPCR crystal structures, the authors present an approach for translating GPCR structural data into β-arrestin-biased ligands for aminergic GPCRs.  The authors identified specific amino acid-ligand contacts at transmembrane helix 5 (TM5) and extracellular loop 2 (EL2) responsible for Gi/o and β-arrestin signaling, resp., and targeted those residues to develop biased ligands.  For these ligands, the authors found that bias is conserved at other aminergic GPCRs that retain similar residues at TM5 and EL2.  The authors' approach provides a template for generating arrestin-biased ligands by modifying predicted ligand interactions that block TM5 interactions and promote EL2 interactions.  This strategy may facilitate the structure-guided design of arrestin-biased ligands at other GPCRs, including polypharmacol. biased ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVs9TaoxiFubVg90H21EOLACvtfcHk0ljS7yw20wndlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGmur3I&md5=2725e8487638cc07ce5e6a655fcd29f2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2527%26sid%3Dliteratum%253Aachs%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKelly%26aufirst%3DB.%26aulast%3DRechsteiner%26aufirst%3DK.%26aulast%3DKarpiak%26aufirst%3DJ.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure-inspired%2520design%2520of%2520beta-arrestin-biased%2520ligands%2520for%2520aminergic%2520GPCRs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D126%26epage%3D134%26doi%3D10.1038%2Fnchembio.2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span> <span> </span><span class="NLM_article-title">The ants go marching two by two: oligomeric structure of G-protein-coupled receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1082</span>, <span class="refDoi"> DOI: 10.1124/mol.104.006320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fmol.104.006320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1077-1082&author=J.+A.+Javitch&title=The+ants+go+marching+two+by+two%3A+oligomeric+structure+of+G-protein-coupled+receptors&doi=10.1124%2Fmol.104.006320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.006320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.006320%26sid%3Dliteratum%253Aachs%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520ants%2520go%2520marching%2520two%2520by%2520two%253A%2520oligomeric%2520structure%2520of%2520G-protein-coupled%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1077%26epage%3D1082%26doi%3D10.1124%2Fmol.104.006320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mottola, D. M.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D<sub>2</sub> receptors linked to adenylate cyclase</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1124/jpet.301.3.1166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.301.3.1166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=12023552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1166-1178&author=D.+M.+Mottola&title=Functional+selectivity+of+dopamine+receptor+agonists.+I.+Selective+activation+of+postsynaptic+dopamine+D2+receptors+linked+to+adenylate+cyclase&doi=10.1124%2Fjpet.301.3.1166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span></div><div class="casAuthors">Mottola, David M.; Kilts, Jason D.; Lewis, Mechelle M.; Connory, Hilary S.; Walker, Q. David; Jones, Sara R.; Booth, Raymond G.; Hyslop, Deborah K.; Piercey, Monford; Wightman, R. Mark; Lawler, Cindy P.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1166-1179</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dihydrexidine (DHX), the first high-affinity D1 dopamine receptor full agonist, is only 10-fold selective for D1 vs. D2 receptors, having D2 affinity similar to the prototypical agonist quinpirole.  The D2 functional properties of DHX and its more D2 selective analog N-n-propyl-dihydrexidine (PrDHX) were explored in rat brain and pituitary.  DHX and PrDHX had binding characteristics to D2 receptors in rat striatum typical of D2 agonists, binding to both high- and low-affinity sites and being sensitive to guanine-nucleotides.  Consistent with these binding data, both DHX and PrDHX inhibited forskolin-stimulated cAMP synthesis in striatum with a potency and intrinsic activity equiv. to that of quinpirole.  Unexpectedly, however, DHX and PrDHX had little functional effect at D2 receptors expressed on dopaminergic neurons that mediate inhibition of cell firing, dopamine release, or dopamine synthesis.  Quant. receptor competition autoradiog. demonstrated that DHX bound to D2 receptors in striatum (predominantly postsynaptic receptor sites) with equal affinity as D2 sites in the substantia nigra (autoreceptor sites).  The data from these expts., coupled with what is known about the location of specific dopamine receptor isoforms, lead to the hypothesis that DHX, after binding to D2L and D2S receptors, causes agonist-typical functional changes only at some of these receptors.  This phenomenon (herein termed "functional selectivity") suggests that drugs may be targeted not only at specific receptor isoforms but also at sep. functions mediated by a single isoform, yielding novel approaches to drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpif5JbU-Rs9bVg90H21EOLACvtfcHk0lh3wXlE1Do2AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D&md5=b1d65ec3f66b3652deb9f9a4c76b70a3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1166%26sid%3Dliteratum%253Aachs%26aulast%3DMottola%26aufirst%3DD.%2BM.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520I.%2520Selective%2520activation%2520of%2520postsynaptic%2520dopamine%2520D2%2520receptors%2520linked%2520to%2520adenylate%2520cyclase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1166%26epage%3D1178%26doi%3D10.1124%2Fjpet.301.3.1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D<sub>2</sub>L receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1124/mol.110.068106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fmol.110.068106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=575-585&author=N.+Tschammerauthor=S.+Bollingerauthor=T.+Kenakinauthor=P.+Gmeiner&title=Histidine+6.55+is+a+major+determinant+of+ligand-biased+signaling+in+dopamine+D2L+receptor&doi=10.1124%2Fmol.110.068106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.068106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.068106%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DBollinger%26aufirst%3DS.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHistidine%25206.55%2520is%2520a%2520major%2520determinant%2520of%2520ligand-biased%2520signaling%2520in%2520dopamine%2520D2L%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D575%26epage%3D585%26doi%3D10.1124%2Fmol.110.068106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Free, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meade, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulcey, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant-Genevier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a G protein-biased agonist that inhibits beta-arrestin recruitment to the D<sub>2</sub> dopamine receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1124/mol.113.090563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fmol.113.090563" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=96-105&author=R.+B.+Freeauthor=L.+S.+Chunauthor=A.+E.+Moritzauthor=B.+N.+Millerauthor=T.+B.+Doyleauthor=J.+L.+Conroyauthor=A.+Padronauthor=J.+A.+Meadeauthor=J.+Xiaoauthor=X.+Huauthor=A.+E.+Dulceyauthor=Y.+Hanauthor=L.+Duanauthor=S.+Titusauthor=M.+Bryant-Genevierauthor=E.+Barnaevaauthor=M.+Ferrerauthor=J.+A.+Javitchauthor=T.+Beumingauthor=L.+Shiauthor=N.+T.+Southallauthor=J.+J.+Maruganauthor=D.+R.+Sibley&title=Discovery+and+characterization+of+a+G+protein-biased+agonist+that+inhibits+beta-arrestin+recruitment+to+the+D2+dopamine+receptor&doi=10.1124%2Fmol.113.090563"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.090563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.090563%26sid%3Dliteratum%253Aachs%26aulast%3DFree%26aufirst%3DR.%2BB.%26aulast%3DChun%26aufirst%3DL.%2BS.%26aulast%3DMoritz%26aufirst%3DA.%2BE.%26aulast%3DMiller%26aufirst%3DB.%2BN.%26aulast%3DDoyle%26aufirst%3DT.%2BB.%26aulast%3DConroy%26aufirst%3DJ.%2BL.%26aulast%3DPadron%26aufirst%3DA.%26aulast%3DMeade%26aufirst%3DJ.%2BA.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DDulcey%26aufirst%3DA.%2BE.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DTitus%26aufirst%3DS.%26aulast%3DBryant-Genevier%26aufirst%3DM.%26aulast%3DBarnaeva%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSouthall%26aufirst%3DN.%2BT.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520G%2520protein-biased%2520agonist%2520that%2520inhibits%2520beta-arrestin%2520recruitment%2520to%2520the%2520D2%2520dopamine%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D96%26epage%3D105%26doi%3D10.1124%2Fmol.113.090563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshitake, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshitake, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyertyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adham, N.</span></span> <span> </span><span class="NLM_article-title">Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">1593</span>– <span class="NLM_lpage">1607</span>, <span class="refDoi"> DOI: 10.1007/s00213-018-4874-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1007%2Fs00213-018-4874-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29637288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntlCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2018&pages=1593-1607&author=J.+Kehrauthor=T.+Yoshitakeauthor=F.+Ichinoseauthor=S.+Yoshitakeauthor=B.+Kissauthor=I.+Gyertyanauthor=N.+Adham&title=Effects+of+cariprazine+on+extracellular+levels+of+glutamate%2C+GABA%2C+dopamine%2C+noradrenaline+and+serotonin+in+the+medial+prefrontal+cortex+in+the+rat+phencyclidine+model+of+schizophrenia+studied+by+microdialysis+and+simultaneous+recordings+of+locomotor+activity&doi=10.1007%2Fs00213-018-4874-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity</span></div><div class="casAuthors">Kehr, Jan; Yoshitake, Takashi; Ichinose, Fumio; Yoshitake, Shimako; Kiss, Bela; Gyertyan, Istvan; Adham, Nika</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1593-1607</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Aberrant glutamatergic, dopaminergic, and GABAergic neurotransmission has been implicated in schizophrenia.  Cariprazine reverses the behavioral effects obsd. in the rat phencyclidine (PCP)-induced model of schizophrenia; however, little is known about its in vivo neurochem.  Objectives: The study aims to compare the effects of cariprazine and aripiprazole on PCP-induced changes in the extracellular levels of glutamate, dopamine, serotonin, noradrenaline, and GABA in the rat medial prefrontal cortex (mPFC), and on locomotor activation.  Methods: Microdialysis was performed in awake rats with probes placed into the mPFC.  Rats (n = 7/group) received vehicle (saline), cariprazine (0.05, 0.2, or 0.8 mg/kg), or aripiprazole (3 or 20 mg/kg) via gavage.  After 60 min, 5 mg/kg PCP was administered i.p. (i.p.).  Samples were taken before drug administration, during pretreatment, and after PCP injection.  Locomotor activity recording and microdialysis sampling occurred simultaneously.  Results: PCP treatment increased extracellular levels of all the neurotransmitters tested except GABA, for which there were no significant changes.  Cariprazine and aripiprazole dose-dependently inhibited the PCP-induced increases of tested neurotransmitters.  Overall effects were significant for higher cariprazine doses and both aripiprazole doses for glutamate and noradrenaline, for higher cariprazine doses and 20 mg/kg aripiprazole for dopamine, and for 0.8 mg/kg cariprazine and 20 mg/kg aripiprazole for serotonin and locomotor activity.  Conclusion: Both cariprazine and aripiprazole dose-dependently attenuated PCP-induced hyperlocomotion and acute increases in glutamate, dopamine, noradrenaline, and serotonin levels in the mPFC; cariprazine was approx. 5-fold more potent than aripiprazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyoFEZIupSQ7Vg90H21EOLACvtfcHk0lh3wXlE1Do2AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntlCisLs%253D&md5=3e26d680cccb822d23518dcd8a4ce360</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00213-018-4874-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-018-4874-z%26sid%3Dliteratum%253Aachs%26aulast%3DKehr%26aufirst%3DJ.%26aulast%3DYoshitake%26aufirst%3DT.%26aulast%3DIchinose%26aufirst%3DF.%26aulast%3DYoshitake%26aufirst%3DS.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DAdham%26aufirst%3DN.%26atitle%3DEffects%2520of%2520cariprazine%2520on%2520extracellular%2520levels%2520of%2520glutamate%252C%2520GABA%252C%2520dopamine%252C%2520noradrenaline%2520and%2520serotonin%2520in%2520the%2520medial%2520prefrontal%2520cortex%2520in%2520the%2520rat%2520phencyclidine%2520model%2520of%2520schizophrenia%2520studied%2520by%2520microdialysis%2520and%2520simultaneous%2520recordings%2520of%2520locomotor%2520activity%26jtitle%3DPsychopharmacology%26date%3D2018%26volume%3D235%26spage%3D1593%26epage%3D1607%26doi%3D10.1007%2Fs00213-018-4874-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diduch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C.</span></span> <span> </span><span class="NLM_article-title">Review of cariprazine in management of psychiatric illness</span>. <i>Ment. Health Clin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.9740/mhc.2017.09.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.9740%2Fmhc.2017.09.221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29955527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FjtVyqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=221-229&author=R.+H.+Campbellauthor=M.+Diduchauthor=K.+N.+Gardnerauthor=C.+Thomas&title=Review+of+cariprazine+in+management+of+psychiatric+illness&doi=10.9740%2Fmhc.2017.09.221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Review of cariprazine in management of psychiatric illness</span></div><div class="casAuthors">Campbell Rebecca H; Diduch Michael; Gardner Kristen N; Thomas Christopher</div><div class="citationInfo"><span class="NLM_cas:title">The mental health clinician</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">221-229</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Schizophrenia and bipolar disorder are severe and debilitating psychiatric disorders.  Despite the availability of numerous antipsychotic drugs, many patients still experience poor outcomes and treatment-limiting adverse side effects.  Cariprazine is a novel antipsychotic with unique pharmacodynamic and pharmacokinetic properties.  It is both a dopamine type 2 and dopamine type 3 partial agonist with 2 equipotent metabolites, desmethyl cariprazine and didesmethyl cariprazine, of which didesmethyl cariprazine has a half-life of 1 to 3 weeks.  The objective of this article is to review the literature regarding efficacy and tolerability of cariprazine in the management of psychiatric disorders to determine its current place in therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLMvzSzveQ3DEwO064Z95rfW6udTcc2eZaZPKAYVpSZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FjtVyqtQ%253D%253D&md5=4e77980d23dd7dfba03dfd2c1598df8c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.9740%2Fmhc.2017.09.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.9740%252Fmhc.2017.09.221%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DR.%2BH.%26aulast%3DDiduch%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DK.%2BN.%26aulast%3DThomas%26aufirst%3DC.%26atitle%3DReview%2520of%2520cariprazine%2520in%2520management%2520of%2520psychiatric%2520illness%26jtitle%3DMent.%2520Health%2520Clin.%26date%3D2017%26volume%3D7%26spage%3D221%26epage%3D229%26doi%3D10.9740%2Fmhc.2017.09.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguère, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciaky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnsmb.3014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=25895059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=362-369&author=W.+K.+Kroezeauthor=M.+F.+Sassanoauthor=X.-P.+Huangauthor=K.+Lansuauthor=J.+D.+McCorvyauthor=P.+M.+Gigu%C3%A8reauthor=N.+Sciakyauthor=B.+L.+Roth&title=PRESTO-Tango+as+an+open-source+resource+for+interrogation+of+the+druggable+human+GPCRome&doi=10.1038%2Fnsmb.3014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span></div><div class="casAuthors">Kroeze, Wesley K.; Sassano, Maria F.; Huang, Xi-Ping; Lansu, Katherine; McCorvy, John D.; Giguere, Patrick M.; Sciaky, Noah; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-369</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and are important targets of drug action.  Of the approx. 350 nonolfactory human GPCRs, more than 100 are still considered to be 'orphans' because their endogenous ligands remain unknown.  Here, we describe a unique open-source resource that allows interrogation of the druggable human GPCRome via a G protein-independent β-arrestin-recruitment assay.  We validate this unique platform at more than 120 nonorphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs and describe a method (parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation (PRESTO-Tango)) for the simultaneous and parallel interrogation of the entire human nonolfactory GPCRome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbl7caV9gUrVg90H21EOLACvtfcHk0liZ_LQmU2f2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D&md5=2a78b74a5f1425fa9e8b79b730c16be6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3014%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGigu%25C3%25A8re%26aufirst%3DP.%2BM.%26aulast%3DSciaky%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DPRESTO-Tango%2520as%2520an%2520open-source%2520resource%2520for%2520interrogation%2520of%2520the%2520druggable%2520human%2520GPCRome%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D362%26epage%3D369%26doi%3D10.1038%2Fnsmb.3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stemp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashmeade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadley, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thewlis, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vong, A. K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avenell, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyfield, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middlemiss, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reavill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routledge, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D<sub>3</sub> receptor antagonist with high oral bioavailability and CNS penetration in the rat</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1878</span>– <span class="NLM_lpage">1885</span>, <span class="refDoi"> DOI: 10.1021/jm000090i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000090i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVKksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1878-1885&author=G.+Stempauthor=T.+Ashmeadeauthor=C.+L.+Branchauthor=M.+S.+Hadleyauthor=A.+J.+Hunterauthor=C.+N.+Johnsonauthor=D.+J.+Nashauthor=K.+M.+Thewlisauthor=A.+K.+K.+Vongauthor=N.+E.+Austinauthor=P.+Jeffreyauthor=K.+Y.+Avenellauthor=I.+Boyfieldauthor=J.+J.+Haganauthor=D.+N.+Middlemissauthor=C.+Reavillauthor=G.+J.+Rileyauthor=C.+Routledgeauthor=M.+Wood&title=Design+and+synthesis+of+trans-N-%5B4-%5B2-%286-cyano-1%2C2%2C3%2C4-tetrahydroisoquinolin-2-yl%29ethyl%5Dcyclohexyl%5D-4-quinolinecarboxamide+%28SB-277011%29%3A+A+potent+and+selective+dopamine+D3+receptor+antagonist+with+high+oral+bioavailability+and+CNS+penetration+in+the+rat&doi=10.1021%2Fjm000090i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of trans-N-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat</span></div><div class="casAuthors">Stemp, Geoffrey; Ashmeade, Tracey; Branch, Clive L.; Hadley, Michael S.; Hunter, A. Jacqueline; Johnson, Christopher N.; Nash, David J.; Thewlis, Kevin M.; Vong, Antonio K. K.; Austin, Nigel E.; Jeffrey, Phillip; Avenell, Kim Y.; Boyfield, Izzy; Hagan, Jim J.; Middlemiss, Derek N.; Reavill, Charlie; Riley, Graham J.; Routledge, Carole; Wood, Martyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1878-1885</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A selective dopamine D3 receptor antagonist offers the potential for an effective antipsychotic therapy, free of the serious side effects of currently available drugs.  Using clearance and brain penetration studies as a screen, a series of 1,2,3,4-tetrahydroisoquinolines, exemplified by (I), was identified with high D3 affinity and selectivity against the D2 receptor.  Following examn. of mol. models, the flexible Bu linker present in I was replaced by a more conformationally constrained cyclohexylethyl linker, leading to compds. with improved oral bioavailability and selectivity over other receptors.  Subsequent optimization of this new series to improve the cytochrome P 450 inhibitory profile and CNS penetration gave trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011).  This compd. is a potent and selective dopamine D3 receptor antagonist with high oral bioavailability and brain penetration in the rat and represents an excellent new chem. tool for the investigation of the role of the dopamine D3 receptor in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXG1k3rEOlYLVg90H21EOLACvtfcHk0liZ_LQmU2f2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVKksLw%253D&md5=0b44d738bbd9d27d6a0fbc5e8333f0df</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm000090i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000090i%26sid%3Dliteratum%253Aachs%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DAshmeade%26aufirst%3DT.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHunter%26aufirst%3DA.%2BJ.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DNash%26aufirst%3DD.%2BJ.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DAvenell%26aufirst%3DK.%2BY.%26aulast%3DBoyfield%26aufirst%3DI.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DReavill%26aufirst%3DC.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DRoutledge%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520trans-N-%255B4-%255B2-%25286-cyano-1%252C2%252C3%252C4-tetrahydroisoquinolin-2-yl%2529ethyl%255Dcyclohexyl%255D-4-quinolinecarboxamide%2520%2528SB-277011%2529%253A%2520A%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520antagonist%2520with%2520high%2520oral%2520bioavailability%2520and%2520CNS%2520penetration%2520in%2520the%2520rat%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1878%26epage%3D1885%26doi%3D10.1021%2Fjm000090i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klein
Herenbrink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudrat, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span> <span> </span><span class="NLM_article-title">The role of kinetic context in apparent biased agonism at GPCRs</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">10842</span> <span class="refDoi"> DOI: 10.1038/ncomms10842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fncomms10842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=26905976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1emtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=C.+Klein%0AHerenbrinkauthor=D.+A.+Sykesauthor=P.+Donthamsettiauthor=M.+Canalsauthor=T.+Coudratauthor=J.+Shonbergauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=P.+M.+Sextonauthor=S.+J.+Charltonauthor=J.+A.+Javitchauthor=A.+Christopoulosauthor=J.+R.+Lane&title=The+role+of+kinetic+context+in+apparent+biased+agonism+at+GPCRs&doi=10.1038%2Fncomms10842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The role of kinetic context in apparent biased agonism at GPCRs</span></div><div class="casAuthors">Klein Herenbrink, Carmen; Sykes, David A.; Donthamsetti, Prashant; Canals, Meritxell; Coudrat, Thomas; Shonberg, Jeremy; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Charlton, Steven J.; Javitch, Jonathan A.; Christopoulos, Arthur; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10842</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Biased agonism describes the ability of ligands to stabilize different conformations of a GPCR linked to distinct functional outcomes and offers the prospect of designing pathway-specific drugs that avoid on-target side effects.  This mechanism is usually inferred from pharmacol. data with the assumption that the confounding influences of observational (i.e., assay dependent) and system (i.e., cell background dependent) bias are excluded by exptl. design and anal.  Here we reveal that 'kinetic context', as detd. by ligand-binding kinetics and the temporal pattern of receptor-signalling processes, can have a profound influence on the apparent bias of a series of agonists for the dopamine D2 receptor and can even lead to reversals in the direction of bias.  We propose that kinetic context must be acknowledged in the design and interpretation of studies of biased agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoboe6-_23rF7Vg90H21EOLACvtfcHk0ljC2p8NH2RHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1emtbk%253D&md5=3afdebd5ad1c8a8b1db93478e9b2c7d4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fncomms10842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10842%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DCoudrat%26aufirst%3DT.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520role%2520of%2520kinetic%2520context%2520in%2520apparent%2520biased%2520agonism%2520at%2520GPCRs%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fncomms10842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salahpour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didriksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghisi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Antagonism of dopamine D<sub>2</sub> receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">13656</span>– <span class="NLM_lpage">13661</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803522105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1073%2Fpnas.0803522105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13656-13661&author=B.+Masriauthor=A.+Salahpourauthor=M.+Didriksenauthor=V.+Ghisiauthor=J.+M.+Beaulieuauthor=R.+R.+Gainetdinovauthor=M.+G.+Caron&title=Antagonism+of+dopamine+D2+receptor%2Fbeta-arrestin+2+interaction+is+a+common+property+of+clinically+effective+antipsychotics&doi=10.1073%2Fpnas.0803522105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803522105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803522105%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DB.%26aulast%3DSalahpour%26aufirst%3DA.%26aulast%3DDidriksen%26aufirst%3DM.%26aulast%3DGhisi%26aufirst%3DV.%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAntagonism%2520of%2520dopamine%2520D2%2520receptor%252Fbeta-arrestin%25202%2520interaction%2520is%2520a%2520common%2520property%2520of%2520clinically%2520effective%2520antipsychotics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D13656%26epage%3D13661%26doi%3D10.1073%2Fpnas.0803522105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuho, I.</span>; <span class="NLM_string-name">Martemyanov, K. A.</span>; <span class="NLM_string-name">Lambert, N. A.</span></span> <span> </span><span class="NLM_article-title">Monitoring G protein activation in cells with BRET</span>. In  <i>G Protein-Coupled Receptors in Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filizola, M.</span></span>, Ed.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">NY</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">1335</span>, pp  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">113</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1007%2F978-1-4939-2914-6_8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=107-113&author=I.+Masuho&author=K.+A.+Martemyanov&author=N.+A.+Lambertauthor=M.+Filizola&title=G+Protein-Coupled+Receptors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2914-6_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4939-2914-6_8%26sid%3Dliteratum%253Aachs%26aulast%3DMasuho%26aufirst%3DI.%26atitle%3DMonitoring%2520G%2520protein%2520activation%2520in%2520cells%2520with%2520BRET%26btitle%3DG%2520Protein-Coupled%2520Receptors%2520in%2520Drug%2520Discovery%26aulast%3DFilizola%26aufirst%3DM.%26pub%3DHumana%2520Press%26date%3D2015%26volume%3D1335%26spage%3D107%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chun, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekariya, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Free, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namkung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aube, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankowski, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity investigation of a G protein-biased agonist reveals molecular determinants for biased signaling of the D<sub>2</sub> dopamine receptor</span>. <i>Front. Synaptic Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">2</span> <span class="refDoi"> DOI: 10.3389/fnsyn.2018.00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.3389%2Ffnsyn.2018.00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29515433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsl2qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=L.+S.+Chunauthor=R.+H.+Vekariyaauthor=R.+B.+Freeauthor=Y.+Liauthor=D.+T.+Linauthor=P.+Suauthor=F.+Liuauthor=Y.+Namkungauthor=S.+A.+Laporteauthor=A.+E.+Moritzauthor=J.+Aubeauthor=K.+J.+Frankowskiauthor=D.+R.+Sibley&title=Structure-activity+investigation+of+a+G+protein-biased+agonist+reveals+molecular+determinants+for+biased+signaling+of+the+D2+dopamine+receptor&doi=10.3389%2Ffnsyn.2018.00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity investigation of a G protein-biased agonist reveals molecular determinants for biased signaling of the D2 dopamine receptor</span></div><div class="casAuthors">Chun, Lani S.; Vekariya, Rakesh H.; Free, R. Benjamin; Li, Yun; Lin, Da-Ting; Su, Ping; Liu, Fang; Namkung, Yoon; Laporte, Stephane A.; Moritz, Amy E.; Aube, Jeffrey; Frankowski, Kevin J.; Sibley, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Synaptic Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2/1-2/18</span>CODEN:
                <span class="NLM_cas:coden">FSNRBS</span>;
        ISSN:<span class="NLM_cas:issn">1663-3563</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The dopamine D2 receptor (D2R) is known to elicit effects through activating two major signaling pathways mediated by either G proteins (Gi/o) or β-arrestins.  However, the specific role of each pathway in physiol. or therapeutic activities is not known with certainty.  One approach to the dissection of these pathways is through the use of drugs that can selectively modulate one pathway vs. the other through a mechanism known as functional selectivity or biased signaling.  Our lab. has previously described a G protein signaling-biased agonist, MLS1547, for the D2R using a variety of in vitro functional assays.  To further evaluate the biased signaling activity of this compd., we investigated its ability to promote D2R internalization, a process known to be mediated by β-arrestin.  Using multiple cellular systems and techniques, we found that MLS1547 promotes little D2R internalization, which is consistent with its inability to recruit β-arrestin.  Importantly, we validated these results in primary striatal neurons where the D2R is most highly expressed suggesting that MLS1547 will exhibit biased signaling activity in vivo.  In an effort to optimize and further explore structure-activity relationships (SAR) for this scaffold, we conducted an iterative chem. campaign to synthesize and characterize novel analogs of MLS1547.  The resulting anal. confirmed previously described SAR requirements for G protein-biased agonist activity and, importantly, elucidated new structural features that are crit. for agonist efficacy and signaling bias of the MLS1547 scaffold.  One of the most important determinants for G protein-biased signaling is the interaction of a hydrophobic moiety of the compd. with a defined pocket formed by residues within transmembrane five and extracellular loop two of the D2R.  These results shed new light on the mechanism of biased signaling of the D2R and may lead to improved functionally-selective mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeVtJsFm0PX7Vg90H21EOLACvtfcHk0ljC2p8NH2RHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsl2qtL0%253D&md5=a0863ff200b0081710af0fac19d992d5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3389%2Ffnsyn.2018.00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnsyn.2018.00002%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DL.%2BS.%26aulast%3DVekariya%26aufirst%3DR.%2BH.%26aulast%3DFree%26aufirst%3DR.%2BB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DD.%2BT.%26aulast%3DSu%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DNamkung%26aufirst%3DY.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26aulast%3DMoritz%26aufirst%3DA.%2BE.%26aulast%3DAube%26aufirst%3DJ.%26aulast%3DFrankowski%26aufirst%3DK.%2BJ.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26atitle%3DStructure-activity%2520investigation%2520of%2520a%2520G%2520protein-biased%2520agonist%2520reveals%2520molecular%2520determinants%2520for%2520biased%2520signaling%2520of%2520the%2520D2%2520dopamine%2520receptor%26jtitle%3DFront.%2520Synaptic%2520Neurosci.%26date%3D2018%26volume%3D10%26doi%3D10.3389%2Ffnsyn.2018.00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agegnehu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tribo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, R. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structural determinants of 5-HT2B receptor activation and biased agonism</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1038/s41594-018-0116-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fs41594-018-0116-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=30127358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGjtLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=787-796&author=J.+D.+McCorvyauthor=D.+Wackerauthor=S.+Wangauthor=B.+Agegnehuauthor=J.+Liuauthor=K.+Lansuauthor=A.+R.+Triboauthor=R.+H.+J.+Olsenauthor=T.+Cheauthor=J.+Jinauthor=B.+L.+Roth&title=Structural+determinants+of+5-HT2B+receptor+activation+and+biased+agonism&doi=10.1038%2Fs41594-018-0116-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of 5-HT2B receptor activation and biased agonism</span></div><div class="casAuthors">McCorvy, John D.; Wacker, Daniel; Wang, Sheng; Agegnehu, Bemnat; Liu, Jing; Lansu, Katherine; Tribo, Alexandra R.; Olsen, Reid H. J.; Che, Tao; Jin, Jian; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Serotonin (5-hydroxytryptamine; 5-HT) receptors modulate a variety of physiol. processes ranging from perception, cognition and emotion to vascular and smooth muscle contraction, platelet aggregation, gastrointestinal function and reprodn.  Drugs that interact with 5-HT receptors effectively treat diseases as diverse as migraine headaches, depression and obesity.  Here we present four structures of a prototypical serotonin receptor-the human 5-HT2B receptor-in complex with chem. and pharmacol. diverse drugs, including methysergide, methylergonovine, lisuride and LY266097.  A detailed anal. of these structures complemented by comprehensive interrogation of signaling illuminated key structural determinants essential for activation.  Addnl. structure-guided mutagenesis expts. revealed binding pocket residues that were essential for agonist-mediated biased signaling and β-arrestin2 translocation.  Given the importance of 5-HT receptors for a large no. of therapeutic indications, insights derived from these studies should accelerate the design of safer and more effective medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwC5QTOdEZhLVg90H21EOLACvtfcHk0liH6ewRGujqhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGjtLjM&md5=93be9401bc680249499fa3af5d40f395</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fs41594-018-0116-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-018-0116-7%26sid%3Dliteratum%253Aachs%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DAgegnehu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DTribo%26aufirst%3DA.%2BR.%26aulast%3DOlsen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructural%2520determinants%2520of%25205-HT2B%2520receptor%2520activation%2520and%2520biased%2520agonism%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D787%26epage%3D796%26doi%3D10.1038%2Fs41594-018-0116-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucaites, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threlkeld, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinzie, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, D. L.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo evidence for a lack of interaction with dopamine D<sub>2</sub> receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268)</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1126</span>– <span class="NLM_lpage">1136</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.160598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.109.160598" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=1126-1136&author=M.+J.+Fellauthor=K.+W.+Perryauthor=J.+F.+Falconeauthor=B.+G.+Johnsonauthor=V.+N.+Barthauthor=K.+S.+Rashauthor=V.+L.+Lucaitesauthor=P.+G.+Threlkeldauthor=J.+A.+Monnauthor=D.+L.+McKinzieauthor=G.+J.+Marekauthor=K.+A.+Svenssonauthor=D.+L.+Nelson&title=In+vitro+and+in+vivo+evidence+for+a+lack+of+interaction+with+dopamine+D2+receptors+by+the+metabotropic+glutamate+2%2F3+receptor+agonists+1S%2C2S%2C5R%2C6S-2-aminobicyclo%5B3.1.0%5Dhexane-2%2C6-bicaroxylate+monohydrate+%28LY354740%29+and+%28-%29-2-oxa-4-aminobicyclo%5B3.1.0%5D+Hexane-4%2C6-dicarboxylic+acid+%28LY379268%29&doi=10.1124%2Fjpet.109.160598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160598%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evidence%2520for%2520a%2520lack%2520of%2520interaction%2520with%2520dopamine%2520D2%2520receptors%2520by%2520the%2520metabotropic%2520glutamate%25202%252F3%2520receptor%2520agonists%25201S%252C2S%252C5R%252C6S-2-aminobicyclo%255B3.1.0%255Dhexane-2%252C6-bicaroxylate%2520monohydrate%2520%2528LY354740%2529%2520and%2520%2528-%2529-2-oxa-4-aminobicyclo%255B3.1.0%255D%2520Hexane-4%252C6-dicarboxylic%2520acid%2520%2528LY379268%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D33%26spage%3D1126%26epage%3D1136%26doi%3D10.1124%2Fjpet.109.160598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciaky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnsmb.3014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=25895059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=362-369&author=W.+K.+Kroezeauthor=M.+F.+Sassanoauthor=X.+P.+Huangauthor=K.+Lansuauthor=J.+D.+McCorvyauthor=P.+M.+Giguereauthor=N.+Sciakyauthor=B.+L.+Roth&title=PRESTO-Tango+as+an+open-source+resource+for+interrogation+of+the+druggable+human+GPCRome&doi=10.1038%2Fnsmb.3014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span></div><div class="casAuthors">Kroeze, Wesley K.; Sassano, Maria F.; Huang, Xi-Ping; Lansu, Katherine; McCorvy, John D.; Giguere, Patrick M.; Sciaky, Noah; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-369</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and are important targets of drug action.  Of the approx. 350 nonolfactory human GPCRs, more than 100 are still considered to be 'orphans' because their endogenous ligands remain unknown.  Here, we describe a unique open-source resource that allows interrogation of the druggable human GPCRome via a G protein-independent β-arrestin-recruitment assay.  We validate this unique platform at more than 120 nonorphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs and describe a method (parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation (PRESTO-Tango)) for the simultaneous and parallel interrogation of the entire human nonolfactory GPCRome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbl7caV9gUrVg90H21EOLACvtfcHk0liH6ewRGujqhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D&md5=2a78b74a5f1425fa9e8b79b730c16be6</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3014%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGiguere%26aufirst%3DP.%2BM.%26aulast%3DSciaky%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DPRESTO-Tango%2520as%2520an%2520open-source%2520resource%2520for%2520interrogation%2520of%2520the%2520druggable%2520human%2520GPCRome%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D362%26epage%3D369%26doi%3D10.1038%2Fnsmb.3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muniz-Medina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S.</span></span> <span> </span><span class="NLM_article-title">A simple method for quantifying functional selectivity and agonist bias</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1021/cn200111m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=193-203&author=T.+Kenakinauthor=C.+Watsonauthor=V.+Muniz-Medinaauthor=A.+Christopoulosauthor=S.+Novick&title=A+simple+method+for+quantifying+functional+selectivity+and+agonist+bias&doi=10.1021%2Fcn200111m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Method for Quantifying Functional Selectivity and Agonist Bias</span></div><div class="casAuthors">Kenakin, Terry; Watson, Christian; Muniz-Medina, Vanessa; Christopoulos, Arthur; Novick, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of seven-transmembrane (7TM) receptors by agonists does not always lead to uniform activation of all signaling pathways mediated by a given receptor.  Relative to other ligands, many agonists are "biased" toward producing subsets of receptor behaviors.  A hallmark of such "functional selectivity" is cell type dependence; this poses a particular problem for the profiling of agonists in whole cell test systems removed from the therapeutic one(s).  Such response-specific cell-based variability makes it difficult to guide medicinal chem. efforts aimed at identifying and optimizing therapeutically meaningful agonist bias.  For this reason, we present a scale, based on the Black and Leff operational model, that contains the key elements required to describe 7TM agonism, namely, affinity (KA-1) for the receptor and efficacy (τ) in activating a particular signaling pathway.  Utilizing a "transduction coeff." term, log(τ/KA), this scale can statistically evaluate selective agonist effects in a manner that can theor. inform structure-activity studies and/or drug candidate selection matrixes.  The bias of four chemokines for CCR5-mediated inositol phosphate prodn. vs. internalization is quantified to illustrate the practical application of this method.  The independence of this method with respect to receptor d. and the calcn. of statistical ests. of confidence of differences are specifically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxSkELs1bHQLVg90H21EOLACvtfcHk0lje61jFBNoKIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN&md5=270841d11f9720caaf3e59a6fe0aee74</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fcn200111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200111m%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DMuniz-Medina%26aufirst%3DV.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DNovick%26aufirst%3DS.%26atitle%3DA%2520simple%2520method%2520for%2520quantifying%2520functional%2520selectivity%2520and%2520agonist%2520bias%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D193%26epage%3D203%26doi%3D10.1021%2Fcn200111m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Ligand pose and orientational sampling in molecular docking</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e75992</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0075992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1371%2Fjournal.pone.0075992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=24098414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyrtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=R.+G.+Colemanauthor=M.+Carchiaauthor=T.+Sterlingauthor=J.+J.+Irwinauthor=B.+K.+Shoichet&title=Ligand+pose+and+orientational+sampling+in+molecular+docking&doi=10.1371%2Fjournal.pone.0075992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand pose and orientational sampling in molecular docking</span></div><div class="casAuthors">Coleman, Ryan G.; Carchia, Michael; Sterling, Teague; Irwin, John J.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e75992</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Mol. docking remains an important tool for structure-based screening to find new ligands and chem. probes.  As docking ambitions grow to include new scoring function terms and to address ever more targets, the reliability and extendability of the orientation sampling and the throughput of the method, become pressing.  Here we explore sampling techniques that eliminate stochastic behavior in DOCK3.6, allowing us to optimize the method for regularly variable sampling of orientations.  This also enabled a focused effort to optimize the code for efficiency, with a three-fold increase in the speed of the program.  This, in turn, facilitated extensive testing of the method on the 102 targets, 22,805 ligands and 1,411,214 decoys of the Directory of Useful Decoys - Enhanced (DUD-E) benchmarking set, at multiple levels of sampling.  Encouragingly, we observe that as sampling increases from 50 to 500 to 2000 to 5000 to 20000 mol. orientations in the binding site (and so from about 1 × 1010 to 4 × 1010 to 1 × 1011 to 2 × 1011 to 5 × 1011 mean atoms scored per target, since multiple conformations are sampled per orientation), the enrichment of ligands over decoys monotonically increases for most DUD-E targets.  Meanwhile, including internal electrostatics in the evaluation ligand conformational energies and restricting arom. hydroxyls to low energy rotamers, further improved enrichment values.  Several of the strategies used here to improve the efficiency of the code are broadly applicable in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfVPNbD-iOR7Vg90H21EOLACvtfcHk0lje61jFBNoKIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyrtbvE&md5=14ee7e84b0bfab5e646c0a7fea8a20d2</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0075992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0075992%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%2BG.%26aulast%3DCarchia%26aufirst%3DM.%26aulast%3DSterling%26aufirst%3DT.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DLigand%2520pose%2520and%2520orientational%2520sampling%2520in%2520molecular%2520docking%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0075992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Conformation guides molecular efficacy in docking screens of activated beta-2 adrenergic G protein coupled receptor</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1018</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1021/cb400103f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400103f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1018-1026&author=D.+R.+Weissauthor=S.+Ahnauthor=M.+F.+Sassanoauthor=A.+Kleistauthor=X.+Zhuauthor=R.+Strachanauthor=B.+L.+Rothauthor=R.+J.+Lefkowitzauthor=B.+K.+Shoichet&title=Conformation+guides+molecular+efficacy+in+docking+screens+of+activated+beta-2+adrenergic+G+protein+coupled+receptor&doi=10.1021%2Fcb400103f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcb400103f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400103f%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DD.%2BR.%26aulast%3DAhn%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DKleist%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DStrachan%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DConformation%2520guides%2520molecular%2520efficacy%2520in%2520docking%2520screens%2520of%2520activated%2520beta-2%2520adrenergic%2520G%2520protein%2520coupled%2520receptor%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1018%26epage%3D1026%26doi%3D10.1021%2Fcb400103f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Word, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">1735</span>– <span class="NLM_lpage">1747</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1998.2401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1006%2Fjmbi.1998.2401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=9917408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADyaK1MXhtV2ht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=1735-1747&author=J.+M.+Wordauthor=S.+C.+Lovellauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=Asparagine+and+glutamine%3A+using+hydrogen+atom+contacts+in+the+choice+of+side-chain+amide+orientation&doi=10.1006%2Fjmbi.1998.2401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Asparagine and Glutamine: Using Hydrogen Atom Contacts in the Choice of Side-chain Amide Orientation</span></div><div class="casAuthors">Word, J. Michael; Lovell, Simon C.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1735-1747</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Small-probe contact dot surface anal., with all explicit hydrogen atoms added and their van der Waals contacts included, was used to choose between the two possible orientations for each of 1554 asparagine (Asn) and glutamine (Gln) side-chain amide groups in a dataset of 100 unrelated, high-quality protein crystal structures at 0.9 to 1.7 Å resoln.  For the movable-H groups, each connected, closed set of local H-bonds was optimized for both H-bonds and van der Waals overlaps.  In addn. to the Asn/Gln "flips", this process included rotation of OH, SH, NH3+, and methionine Me H atoms, flip and protonation state of histidine rings, interaction with bound ligands, and a simple model of water interactions.  However, except for switching N and O identity for amide flips (or N and C identity for His flips), no non-H atoms were shifted.  Even in these very high-quality structures, about 20 % of the Asn/Gln side-chains required a 180° flip to optimize H-bonding and/or to avoid NH2 clashes with neighboring atoms (incorporating a conservative score penalty which, for marginal cases, favors the assignment in the original coordinate file).  The programs Reduce, Probe, and Mage provide not only a suggested amide orientation, but also a numerical score comparison, a categorization of the marginal cases, and a direct visualization of all relevant interactions in both orientations.  Visual examn. allowed confirmation of the raw score assignment for about 40 % of those Asn/Gln flips placed within the "marginal" penalty range by the automated algorithm, while uncovering only a small no. of cases whose automated assignment was incorrect because of special circumstances not yet handled by the algorithm.  It seems that the H-bond and the at.-clash criteria independently look at the same structural realities: when both criteria gave a clear answer, they agreed every time.  But consideration of van der Waals clashes settled many addnl. cases for which H-bonding was either absent or approx. equiv. for the two main alternatives.  With this extra information, 86 % of all side-chain amide groups could be oriented quite unambiguously.  In the absence of further exptl. data, it would probably be inappropriate to assign many more than this.  Some of the remaining 14 % are ambiguous because of coordinate error or inadequacy of the theor. model, but the great majority of ambiguous cases probably occur as a dynamic mix of both flip states in the actual protein mol.  The software and the 100 coordinate files with all H atoms added and optimized and with amide flips cor. are publicly available.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC6MEkiSKy07Vg90H21EOLACvtfcHk0lje61jFBNoKIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtV2ht7g%253D&md5=a3bd044a8652a5ac03e2eb7b9414c2e0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2401%26sid%3Dliteratum%253Aachs%26aulast%3DWord%26aufirst%3DJ.%2BM.%26aulast%3DLovell%26aufirst%3DS.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DAsparagine%2520and%2520glutamine%253A%2520using%2520hydrogen%2520atom%2520contacts%2520in%2520the%2520choice%2520of%2520side-chain%2520amide%2520orientation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D285%26spage%3D1735%26epage%3D1747%26doi%3D10.1006%2Fjmbi.1998.2401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Berryman, J. T.</span>; <span class="NLM_string-name">Betz, R. M.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham, T. E.,  III</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Giese, T. J.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A. W.</span>; <span class="NLM_string-name">Homeyer, N.</span>; <span class="NLM_string-name">Izadi, S.</span>; <span class="NLM_string-name">Janowski, P.</span>; <span class="NLM_string-name">Kaus, J.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Madej, B.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Monard, G.</span>; <span class="NLM_string-name">Needham, P.</span>; <span class="NLM_string-name">Nguyen, H.</span>; <span class="NLM_string-name">Nguyen, H. T.</span>; <span class="NLM_string-name">Omelyan, I.</span>; <span class="NLM_string-name">Onufriev, A.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Salomon-Ferrer, R.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Smith, W.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wolf, R.
M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">York, D. M.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> <i>AMBER 2015</i>; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco, CA</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+A.+Case&author=J.+T.+Berryman&author=R.+M.+Betz&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=T.+J.+Giese&author=H.+Gohlke&author=A.+W.+Goetz&author=N.+Homeyer&author=S.+Izadi&author=P.+Janowski&author=J.+Kaus&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=P.+Li&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=K.+M.+Merz&author=G.+Monard&author=P.+Needham&author=H.+Nguyen&author=H.+T.+Nguyen&author=I.+Omelyan&author=A.+Onufriev&author=D.+R.+Roe&author=A.+Roitberg&author=R.+Salomon-Ferrer&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.%0AM.+Wolf&author=X.+Wu&author=D.+M.+York&author=P.+A.+Kollman&title=AMBER+2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%25202015%26pub%3DUniversity%2520of%2520California%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Comparison of automatic three-dimensional model builders using 639 X-ray structures</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1008</span>, <span class="refDoi"> DOI: 10.1021/ci00020a039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci00020a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=1000-1008&author=J.+Sadowskiauthor=J.+Gasteigerauthor=G.+Klebe&title=Comparison+of+automatic+three-dimensional+model+builders+using+639+X-ray+structures&doi=10.1021%2Fci00020a039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures</span></div><div class="casAuthors">Sadowski, Jens; Gasteiger, Johann; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1000-8</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    </div><div class="casAbstract">Several criteria were defined to select a dataset of high-quality x-ray structures from the Cambridge file resulting in 639 mols.  Six currently available programs for automatic 3D structure generation were compared by converting the connectivity tables, including appropriate stereodescriptors from this dataset of 639 mol. structures into 3D geometries: CONCORD, ALCOGEN, Chem-X, MOLGEO, COBRA, and CORINA.  The geometries produced by the different programs were evaluated in terms of several quality criteria and discussed in detail.  These criteria measure how well the different programs reproduce the x-ray geometries of the 639 input structures.  Accordingly, the major strengths and weaknesses of the programs are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8vEtyDrrlq7Vg90H21EOLACvtfcHk0lhHrsRwRyZfqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D&md5=246e4d66f11178a18daad2563c48331c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fci00020a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci00020a039%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DComparison%2520of%2520automatic%2520three-dimensional%2520model%2520builders%2520using%2520639%2520X-ray%2520structures%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D1994%26volume%3D34%26spage%3D1000%26epage%3D1008%26doi%3D10.1021%2Fci00020a039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M. T.</span></span> <span> </span><span class="NLM_article-title">Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1021/ci100031x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100031x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=572-584&author=P.+C.+Hawkinsauthor=A.+G.+Skillmanauthor=G.+L.+Warrenauthor=B.+A.+Ellingsonauthor=M.+T.+Stahl&title=Conformer+generation+with+OMEGA%3A+algorithm+and+validation+using+high+quality+structures+from+the+Protein+Databank+and+Cambridge+Structural+Database&doi=10.1021%2Fci100031x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.; Ellingson, Benjamin A.; Stahl, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present the algorithm and validation for OMEGA, a systematic, knowledge-based conformer generator.  The algorithm consists of three phases: assembly of an initial 3D structure from a library of fragments; exhaustive enumeration of all rotatable torsions using values drawn from a knowledge-based list of angles, thereby generating a large set of conformations; and sampling of this set by geometric and energy criteria.  Validation of conformer generators like OMEGA has often been undertaken by comparing computed conformer sets to exptl. mol. conformations from crystallog., usually from the Protein Databank (PDB).  Such an approach is fraught with difficulty due to the systematic problems with small mol. structures in the PDB.  Methods are presented to identify a diverse set of small mol. structures from cocomplexes in the PDB that has maximal reliability.  A challenging set of 197 high quality, carefully selected ligand structures from well-solved models was obtained using these methods.  This set will provide a sound basis for comparison and validation of conformer generators in the future.  Validation results from this set are compared to the results using structures of a set of druglike mols. extd. from the Cambridge Structural Database (CSD).  OMEGA is found to perform very well in reproducing the crystallog. conformations from both these data sets using two complementary metrics of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1SOwPH1NzrVg90H21EOLACvtfcHk0lhHrsRwRyZfqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D&md5=fb87ecc9c51eddef63b41fffcd9babee</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fci100031x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100031x%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DEllingson%26aufirst%3DB.%2BA.%26aulast%3DStahl%26aufirst%3DM.%2BT.%26atitle%3DConformer%2520generation%2520with%2520OMEGA%253A%2520algorithm%2520and%2520validation%2520using%2520high%2520quality%2520structures%2520from%2520the%2520Protein%2520Databank%2520and%2520Cambridge%2520Structural%2520Database%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D572%26epage%3D584%26doi%3D10.1021%2Fci100031x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truhlar, D. G.</span></span> <span> </span><span class="NLM_article-title">Model for aqueous solvation based on class IV atomic charges and first solvation shell effects</span>. <i>J. Phys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">16385</span>– <span class="NLM_lpage">16398</span>, <span class="refDoi"> DOI: 10.1021/jp9610776</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp9610776" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADyaK28XlsFCqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1996&pages=16385-16398&author=C.+C.+Chambersauthor=G.+D.+Hawkinsauthor=C.+J.+Cramerauthor=D.+G.+Truhlar&title=Model+for+aqueous+solvation+based+on+class+IV+atomic+charges+and+first+solvation+shell+effects&doi=10.1021%2Fjp9610776"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Model for Aqueous Solvation Based on Class IV Atomic Charges and First Solvation Shell Effects</span></div><div class="casAuthors">Chambers, Candee C.; Cramer, Christopher J.; Truhlar, Donald G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16385-16398</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new set of geometry-based functional forms is presented for parameterizing effective Coulomb radii and at. surface tensions of org. solutes in water.  In particular, the radii and surface tensions depend in some cases on distances to nearby atoms.  Combining the surface tensions with electrostatic effects included in a Fock operator by the generalized Born model enables one to calc. free energies of solvation, and exptl. free energies of solvation are used to parametrize the theory for water.  At. charges are obtained by both the AM1-CM1A and PM3-CM1P class IV charge models, which yield similar results, and hence the same radii and surface tensions are used with both charge models.  The authors considered 215 neutral solutes contg. H, C, N, O, F, S, Cl, Br, and I and encompassing a very wide variety of org. functional groups, and a mean unsigned error in the free energy of hydration of 0.50 kcal/mol using CM1A charges and 0.48 kcal/mol using CM1P charges was obtained.  The predicted solvation energies for 12 cationic and 22 anionic solutes have mean unsigned deviations from expt. of 4.6 and 4.8 kcal/mol for models based on AM1 and PM3, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9qoDbYAXHbVg90H21EOLACvtfcHk0ljfia9q6-Cxgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFCqurw%253D&md5=2ff8cd5c0e9d4f37070c0cdf3829fe7e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjp9610776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp9610776%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DC.%2BC.%26aulast%3DHawkins%26aufirst%3DG.%2BD.%26aulast%3DCramer%26aufirst%3DC.%2BJ.%26aulast%3DTruhlar%26aufirst%3DD.%2BG.%26atitle%3DModel%2520for%2520aqueous%2520solvation%2520based%2520on%2520class%2520IV%2520atomic%2520charges%2520and%2520first%2520solvation%2520shell%2520effects%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1996%26volume%3D100%26spage%3D16385%26epage%3D16398%26doi%3D10.1021%2Fjp9610776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human dopamine D<sub>3</sub> receptor in complex with a D<sub>2</sub>/D<sub>3</sub> selective antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1126/science.1197410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+W.+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+dopamine+D3+receptor+in+complex+with+a+D2%2FD3+selective+antagonist&doi=10.1126%2Fscience.1197410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0ljfia9q6-Cxgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520in%2520complex%2520with%2520a%2520D2%252FD3%2520selective%2520antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095%26doi%3D10.1126%2Fscience.1197410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">D<sub>4</sub> dopamine receptor high-resolution structures enable the discovery of selective agonists</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1126/science.aan5468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1126%2Fscience.aan5468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29051383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&pages=381-386&author=S.+Wangauthor=D.+Wackerauthor=A.+Levitauthor=T.+Cheauthor=R.+M.+Betzauthor=J.+D.+McCorvyauthor=A.+J.+Venkatakrishnanauthor=X.+P.+Huangauthor=R.+O.+Drorauthor=B.+K.+Shoichetauthor=B.+L.+Roth&title=D4+dopamine+receptor+high-resolution+structures+enable+the+discovery+of+selective+agonists&doi=10.1126%2Fscience.aan5468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">D4 dopamine receptor high-resolution structures enable the discovery of selective agonists</span></div><div class="casAuthors">Wang, Sheng; Wacker, Daniel; Levit, Anat; Che, Tao; Betz, Robin M.; McCorvy, John D.; Venkatakrishnan, A. J.; Huang, Xi-Ping; Dror, Ron O.; Shoichet, Brian K.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">6361</span>),
    <span class="NLM_cas:pages">381-386</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine receptors are implicated in the pathogenesis and treatment of nearly every neuropsychiatric disorder.  Although thousands of drugs interact with these receptors, our mol. understanding of dopaminergic drug selectivity and design remains clouded.  To illuminate dopamine receptor structure, function, and ligand recognition, we detd. crystal structures of the D4 dopamine receptor in its inactive state bound to the antipsychotic drug nemonapride, with resolns. up to 1.95 angstroms.  These structures suggest a mechanism for the control of constitutive signaling, and their unusually high resoln. enabled a structure-based campaign for new agonists of the D4 dopamine receptor.  The ability to efficiently exploit structure for specific probe discovery-rapidly moving from elucidating receptor structure to discovering previously unrecognized, selective agonists-testifies to the power of structure-based approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8NDKhkv_ILbVg90H21EOLACvtfcHk0ljfia9q6-Cxgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns73I&md5=0bbb93e6bcb33577f9d9b7459273d896</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan5468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan5468%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DD4%2520dopamine%2520receptor%2520high-resolution%2520structures%2520enable%2520the%2520discovery%2520of%2520selective%2520agonists%26jtitle%3DScience%26date%3D2017%26volume%3D358%26spage%3D381%26epage%3D386%26doi%3D10.1126%2Fscience.aan5468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ana Mallo-Abreu, Irene Reyes-Resina, Jhonny Azuaje, Rafael Franco, Aitor García-Rey, Maria Majellaro, Darío Miranda-Pastoriza, Xerardo García-Mera, Willem Jespers, Hugo Gutiérrez-de-Terán, Gemma Navarro, <span class="NLM_string-name hlFld-ContribAuthor">Eddy Sotelo</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8710-8726. <a href="https://doi.org/10.1021/acs.jmedchem.1c00704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSubtype-Selective%252BDopamine%252BD2%252BReceptor%252BBiased%252BPartial%252BAgonists%252BDiscovered%252Bvia%252Ban%252BUgi-Based%252BApproach%26aulast%3DMallo-Abreu%26aufirst%3DAna%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19042021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8710%26epage%3D8726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amy Hauck Newman, Francisco O. Battiti, <span class="NLM_string-name hlFld-ContribAuthor">Alessandro Bonifazi</span>. </span><span class="cited-content_cbyCitation_article-title">2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1779-1797. <a href="https://doi.org/10.1021/acs.jmedchem.9b01105" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01105%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2016%252BPhilip%252BS.%252BPortoghese%252BMedicinal%252BChemistry%252BLectureship%25253A%252BDesigning%252BBivalent%252Bor%252BBitopic%252BMolecules%252Bfor%252BG-Protein%252BCoupled%252BReceptors.%252BThe%252BWhole%252BIs%252BGreater%252BThan%252Bthe%252BSum%252Bof%252BIts%252BParts%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D09072019%26date%3D24092019%26date%3D09092019%26volume%3D63%26issue%3D5%26spage%3D1779%26epage%3D1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael
L. Martini, Caroline Ray, Xufen Yu, Jing Liu, Vladimir M. Pogorelov, William C. Wetsel, Xi-Ping Huang, John D. McCorvy, Marc G. Caron, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 4160-4182. <a href="https://doi.org/10.1021/acschemneuro.9b00410" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00410%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesigning%252BFunctionally%252BSelective%252BNoncatechol%252BDopamine%252BD1%252BReceptor%252BAgonists%252Bwith%252BPotent%252BIn%252BVivo%252BAntiparkinsonian%252BActivity%26aulast%3DMartini%26aufirst%3DMichael%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D06082019%26date%3D20082019%26date%3D06082019%26volume%3D10%26issue%3D9%26spage%3D4160%26epage%3D4182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui-Xiang  Yuan</span>, <span class="hlFld-ContribAuthor ">Jun-Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Lian-Hua  Song</span>, <span class="hlFld-ContribAuthor ">Yang-Li  Qi</span>, <span class="hlFld-ContribAuthor ">Hong  Mou</span>, <span class="hlFld-ContribAuthor ">Jian-Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Ke-Yu  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiao-Wen  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient and practical synthesis of the
              cis
              isomer of the first orally active dopamine D
              3
              -Preferring D
              3
              -D
              2
              receptor partial agonist cariprazine. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>48 </em>, 1-8. <a href="https://doi.org/10.1080/00397911.2021.1919899" title="DOI URL">https://doi.org/10.1080/00397911.2021.1919899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2021.1919899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2021.1919899%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DA%252Bconvenient%252Band%252Bpractical%252Bsynthesis%252Bof%252Bthe%252Bcis%252Bisomer%252Bof%252Bthe%252Bfirst%252Borally%252Bactive%252Bdopamine%252BD%252B3%252B-Preferring%252BD%252B3%252B-D%252B2%252Breceptor%252Bpartial%252Bagonist%252Bcariprazine%26aulast%3DYuan%26aufirst%3DRui-Xiang%26date%3D2021%26date%3D2021%26volume%3D48%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Bock</span>, <span class="hlFld-ContribAuthor ">Marcel  Bermudez</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric coupling and biased agonism in G protein‐coupled receptors. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2021,</strong> <em>288 </em>
                                    (8)
                                     , 2513-2528. <a href="https://doi.org/10.1111/febs.15783" title="DOI URL">https://doi.org/10.1111/febs.15783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15783%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DAllosteric%252Bcoupling%252Band%252Bbiased%252Bagonism%252Bin%252BG%252Bprotein%2525E2%252580%252590coupled%252Breceptors%26aulast%3DBock%26aufirst%3DAndreas%26date%3D2021%26date%3D2021%26volume%3D288%26issue%3D8%26spage%3D2513%26epage%3D2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharonda S.  Harris</span>, <span class="hlFld-ContribAuthor ">Nikhil M.  Urs</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders. </span><span class="cited-content_cbyCitation_journal-name">CNS Drugs</span><span> <strong>2021,</strong> <em>35 </em>
                                    (3)
                                     , 253-264. <a href="https://doi.org/10.1007/s40263-021-00796-y" title="DOI URL">https://doi.org/10.1007/s40263-021-00796-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40263-021-00796-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40263-021-00796-y%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Drugs%26atitle%3DTargeting%252B%2525CE%2525B2-Arrestins%252Bin%252Bthe%252BTreatment%252Bof%252BPsychiatric%252Band%252BNeurological%252BDisorders%26aulast%3DHarris%26aufirst%3DSharonda%2BS.%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D3%26spage%3D253%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jokūbas  Preikša</span>, <span class="hlFld-ContribAuthor ">Paweł  Śliwa</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Fragment Molecular Orbital Method to investigate dopamine receptors. </span><span class="cited-content_cbyCitation_journal-name">Science, Technology and Innovation</span><span> <strong>2019,</strong> <em>6 </em>
                                    (3)
                                     , 24-32. <a href="https://doi.org/10.5604/01.3001.0013.5526" title="DOI URL">https://doi.org/10.5604/01.3001.0013.5526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5604/01.3001.0013.5526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5604%2F01.3001.0013.5526%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%252C%2520Technology%2520and%2520Innovation%26atitle%3DApplication%252Bof%252BFragment%252BMolecular%252BOrbital%252BMethod%252Bto%252Binvestigate%252Bdopamine%252Breceptors%26aulast%3DPreik%25C5%25A1a%26aufirst%3DJok%25C5%25ABbas%26date%3D2019%26volume%3D6%26issue%3D3%26spage%3D24%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Cariprazine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, reflux; (b) Boc<sub>2</sub>O, triethylamine (TEA), dichloromethane (DCM), 85–95% over two steps; (c) LiBH<sub>4</sub>, Et<sub>2</sub>O, MeOH, 94–95%; (d) MsCl, TEA, DCM; (e) NaCN, dimethyl sulfoxide (DMSO), 90 °C, 90–96% over two steps; (f) DIBAL-H, DCM, −78 °C, 76–80%; (g) NaBH(OAc)<sub>3</sub>, DCM, 75%; (h) trifluoroacetic acid (TFA), DCM, 58%; (i) dimethylcarbamoyl chloride, TEA, DCM, 33–47%; (j) 1-(2,3-dichlorophenyl)piperazine, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 12%.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>6</b> and Its Analogues <b>16</b>–<b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) NaBH(OAc)<sub>3</sub>, DCM, 73%; (b) TFA, DCM; (c) TEA, DCM, 41–74% over two steps.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds for Exploring the Middle Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) NaBH(OAc)<sub>3</sub>, DCM; (b) TFA, DCM; (c) dimethylcarbamoyl chloride, TEA, DCM, 64% over three steps; (d) MsCl, TEA, DCM; (e) 1,2,3,4-tetrahydroisoquinoline, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 95 °C, 15–43%; (f) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, tetrahydrofuran (THF), 80%; (g) dimethylcarbamoyl chloride, K<sub>2</sub>CO<sub>3</sub>, THF, 23% over four steps.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds with Various Substituents on the LHS Phenyl Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) NaBH(OAc)<sub>3</sub>, DCM; (b) TFA, DCM; (c) dimethylcarbamoyl chloride, TEA, DCM, 29–53% over three steps.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Further confirmation that compound <b>38</b> is a G protein-biased D<sub>2</sub>R partial agonist. (A) D<sub>2</sub>R-mediated BRET β-arrestin recruitment activity of compounds <b>38</b> and quinpirole (EC<sub>50</sub> = 115 nM). (B) D<sub>2</sub>R-mediated Gi1 BRET activity of compounds <b>38</b> (EC<sub>50</sub> = 0.37 nM, <i>E</i><sub>max</sub> = 47%) and quinpirole (EC<sub>50</sub> = 2.4 nM). Data are the average of at least three independent experiments performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Antagonist activity of compound <b>38</b> (IC<sub>50</sub> = 71 nM) on dopamine (DA)-stimulated D<sub>2</sub>R β-arrestin recruitment is similar to clozapine (IC<sub>50</sub> = 140 nM) as measured by Tango. Lack of D<sub>3</sub>R agonist activity of compound <b>38</b> compared to positive control quinpirole in the G<sub>i/o</sub>-mediated cAMP inhibition GloSensor assay (B) and β-arrestin recruitment Tango assay (C). Data are the average of three independent experiments performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In silico structure-based SFSR studies of D<sub>2</sub>R agonists. (A) When the D<sub>2</sub>R crystal structure utilized for this study (gold) is overlayed with a D<sub>2</sub>R homology model from a previous study that examined the structural determinants of D<sub>2</sub>R agonist functional selectivity (blue), a high degree of similarity was noted between the two structures (all-atom binding site RMSD = 0.74 Å).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (B) The docked pose of cariprazine suggests that together with I184<sup>EL2</sup>, F189<sup>5.38</sup> may function as a “lid” over the binding pocket leading to increase ligand residence times and β-arrestin recruitment. (C) Compound <b>16</b> engages D<sub>2</sub>R from deeper within the orthosteric site, and the steric constraints it imposes on TM5 may partially underlie its G<sub>i/o</sub> bias. (D) Compound <b>38</b>’s chloro substituent forms a hydrogen bond with conserved TM5 serines and angles with the rest of the scaffold away from extracellular loop 2 (EL2), which would be predicted to enhance its G<sub>i</sub> bias compared to <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>38</b> exhibits dose dependence to binding to D<sub>2</sub> receptor in male c57 mice. [<sup>3</sup>H]Raclopride in vivo binding assay was used.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/medium/jm-2019-00508z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>38</b> displays a potent antipsychotic-like activity in a hyperlocomotion study. C57Bl/6 mice were given the vehicle (Veh), 1, or 3.5 mg/kg <b>38</b> (intraperitoneally (i.p.)), followed 30 min later with the Veh or 6 mg/kg phencyclidine (PCP, i.p.). (A) Locomotor activities are shown as 5 min binned intervals. The repeated measures analysis of variance (RMANOVA) are provided for baseline [time: <i>F</i>(5, 145) = 12.731, <i>p</i> < 0.001; treatment: <i>F</i>(3, 29) = 2.722, <i>p</i> = 0.063; time by treatment: <i>F</i>(15, 145) = 1.878, <i>p</i> = 0.099] and for PCP-stimulated activity [time: <i>F</i>(17, 493) = 22.056, <i>P</i> < 0.001; treatment: <i>F</i>(3, 29) = 16.992, <i>p</i> < 0.001; time by treatment: <i>F</i>(51, 493) = 6.159, <i>p</i> = < 0.001]. (B) Locomotor activities presented as cumulative activity (0–30 min) and PCP-stimulated activity (31–90 min). A RMANOVA found the following: [pre–post: <i>F</i>(1, 29) = 55.625, <i>p</i> < 0.001; treatment: <i>F</i>(3, 29) = 20.004, <i>p</i> < 0.001; pre–post by treatment: <i>F</i>(3, 29) = 17.651, <i>p</i> < 0.001]. <i>N</i> = 8–9 mice/group; Bonferroni-corrected pair-wise comparisons—*<i>p</i> < 0.05, vs baseline within treatment; +<i>p</i> < 0.05, vs the Veh-PCP group within the post-stimulation interval; <sup>#</sup><i>p</i> < 0.05, 1 mg/kg compound vs 3.5 mg/kg compound <b>38</b> within the post-stimulation interval.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00508/20190502/images/large/jm-2019-00508z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00508&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 66 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">How ligands illuminate GPCR molecular pharmacology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.cell.2017.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=28753422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GisLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2017&pages=414-427&author=D.+Wackerauthor=R.+C.+Stevensauthor=B.+L.+Roth&title=How+ligands+illuminate+GPCR+molecular+pharmacology&doi=10.1016%2Fj.cell.2017.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How ligands illuminate GPCR molecular pharmacology</span></div><div class="casAuthors">Wacker, Daniel; Stevens, Raymond C.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-427</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs), which are modulated by a variety of endogenous and synthetic ligands, represent the largest family of druggable targets in the human genome.  Recent structural and mol. studies have both transformed and expanded classical concepts of receptor pharmacol. and have begun to illuminate the distinct mechanisms by which structurally, chem., and functionally diverse ligands modulate GPCR function.  These mol. insights into ligand engagement and action have enabled new computational methods and accelerated the discovery of novel ligands and tool compds., esp. for understudied and orphan GPCRs.  These advances promise to streamline the development of GPCR-targeted medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCNWK2Zg6HebVg90H21EOLACvtfcHk0lgBic4a6ss6vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GisLvF&md5=d4f7f48d757cf3d13a980d2f7f1be138</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DHow%2520ligands%2520illuminate%2520GPCR%2520molecular%2520pharmacology%26jtitle%3DCell%26date%3D2017%26volume%3D170%26spage%3D414%26epage%3D427%26doi%3D10.1016%2Fj.cell.2017.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheffler, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span> <span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1038/nrd1346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnrd1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=15060530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353-359&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia&doi=10.1038%2Fnrd1346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span></div><div class="casAuthors">Roth, Bryan L.; Sheffler, Douglas J.; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-359</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most common central nervous system disorders - such as depression, bipolar disorder, and schizophrenia - seem to be polygenic in origin, and the most effective medications have exceedingly complex pharmacologies.  Attempts to develop more effective treatments for diseases such as schizophrenia and depression by discovering drugs selective for single mol. targets (i.e., 'magic bullets') have, not surprisingly, been largely unsuccessful.  Here the authors propose that designing selectively non-selective drugs (i.e., 'magic shotguns') that interact with several mol. targets will lead to new and more effective medications for a variety of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSsuUXzmbirVg90H21EOLACvtfcHk0ljwI-ijhTVu3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D&md5=77196583acccca65457fec7a67218463</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1346%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353%26epage%3D359%26doi%3D10.1038%2Fnrd1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Duenas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedros, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciruela, F.</span></span> <span> </span><span class="NLM_article-title">An update on adenosine A2A receptors as drug target in Parkinson’s disease</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.2174/187152711797247803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.2174%2F187152711797247803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=21838670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12hurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=659-669&author=A.+Vallanoauthor=V.+Fernandez-Duenasauthor=C.+Pedrosauthor=J.+M.+Arnauauthor=F.+Ciruela&title=An+update+on+adenosine+A2A+receptors+as+drug+target+in+Parkinson%E2%80%99s+disease&doi=10.2174%2F187152711797247803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An update on adenosine A2A receptors as drug target in Parkinson's disease</span></div><div class="casAuthors">Vallano, Antoni; Fernandez-Duenas, Victor; Pedros, Consuelo; Arnau, Josep Maria; Ciruela, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-669</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors are G protein-coupled receptors (GPCRs) that mediate the physiol. functions of adenosine.  In the central nervous system adenosine A2A receptors (A2ARs) are highly enriched in striatopallidal neurons where they form functional oligomeric complexes with other GPCRs such us the dopamine D2 receptor (D2R).  Furthermore, it is assumed that the formation of balanced A2AR/D2R receptor oligomers are essential for correct striatal function as the allosteric receptor-receptor interactions established within the oligomer are needed for properly sensing adenosine and dopamine.  Interestingly, A2AR activation reduces the affinity of striatal D2R for dopamine and the blockade of A2AR with specific antagonists facilitates function of the D2R.  Thus, it may be postulated that A2AR antagonists are pro-dopaminergic agents.  Therefore, A2AR antagonists will potentially reduce the effects assocd. with dopamine depletion in Parkinson's disease (PD).  Accordingly, this class of compds. have recently attracted considerable attention as potential therapeutic agents for PD pharmacotherapy as they have shown potential effectiveness in counteracting motor dysfunctions and also displayed neuroprotective and anti-inflammatory effects in animal models of PD.  Overall, we provide here an update of the current state of the art of these A2AR-based approaches that are under clin. study as agents devoted to alleviate PD symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj7ubJ3_biTLVg90H21EOLACvtfcHk0ljwI-ijhTVu3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12hurfF&md5=bdefa325c832869f0dca03a75bf9e925</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F187152711797247803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152711797247803%26sid%3Dliteratum%253Aachs%26aulast%3DVallano%26aufirst%3DA.%26aulast%3DFernandez-Duenas%26aufirst%3DV.%26aulast%3DPedros%26aufirst%3DC.%26aulast%3DArnau%26aufirst%3DJ.%2BM.%26aulast%3DCiruela%26aufirst%3DF.%26atitle%3DAn%2520update%2520on%2520adenosine%2520A2A%2520receptors%2520as%2520drug%2520target%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2011%26volume%3D10%26spage%3D659%26epage%3D669%26doi%3D10.2174%2F187152711797247803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, E. J.</span></span> <span> </span><span class="NLM_article-title">D<sub>2</sub> dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2009.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.nbd.2009.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=19840852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=228-236&author=X.+Fanauthor=M.+Xuauthor=E.+J.+Hess&title=D2+dopamine+receptor+subtype-mediated+hyperactivity+and+amphetamine+responses+in+a+model+of+ADHD&doi=10.1016%2Fj.nbd.2009.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD</span></div><div class="casAuthors">Fan, Xue-Liang; Xu, Ming; Hess, Ellen J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">228-236</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Low doses of psychostimulants produce beneficial behavioral effects in ADHD patients but the mechanisms underlying the response are not understood.  Here we use the hyperactive mouse mutant coloboma to identify D2-like dopamine receptor subtypes that mediate the hyperactivity and response to amphetamine; we have previously demonstrated that D1-like dopamine receptors are not involved.  Targeted deletion of the D2, but not the D3 or the D4, dopamine receptor in coloboma mice eliminated the hyperactivity; depleting D2 dopamine receptors also restored the excess dopamine overflow that may drive the hyperactivity to normal concns.  Similar to its effects on ADHD patients, amphetamine reduced the hyperactivity of coloboma mice.  The D2 dopamine receptor-selective antagonist L-741,626, but not D3 or D4 dopamine receptor-selective antagonists, blocked the amphetamine-induced redn. in locomotor activity.  Thus, the D2 dopamine receptor subtype mediates both the hyperactivity and response to amphetamine, suggesting a specific target for novel therapeutics in ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUwUaV6iqprVg90H21EOLACvtfcHk0ljwI-ijhTVu3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7vI&md5=beac1924be92f794c4ead36e58d5ef19</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DE.%2BJ.%26atitle%3DD2%2520dopamine%2520receptor%2520subtype-mediated%2520hyperactivity%2520and%2520amphetamine%2520responses%2520in%2520a%2520model%2520of%2520ADHD%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26spage%3D228%26epage%3D236%26doi%3D10.1016%2Fj.nbd.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span> <span> </span><span class="NLM_article-title">G protein-coupled receptors as new therapeutic targets for type 2 diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1007/s00125-015-3825-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1007%2Fs00125-015-3825-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=26661410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrsb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=229-233&author=F.+Reimannauthor=F.+M.+Gribble&title=G+protein-coupled+receptors+as+new+therapeutic+targets+for+type+2+diabetes&doi=10.1007%2Fs00125-015-3825-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptors as new therapeutic targets for type 2 diabetes</span></div><div class="casAuthors">Reimann, Frank; Gribble, Fiona M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) in the gut-brain-pancreatic axis are key players in the postprandial control of metab. and food intake.  A no. of intestinally located receptors have been implicated in the chemo-detection of ingested nutrients, and in the pancreatic islets and nervous system GPCRs play essential roles in the detection of many hormones and neurotransmitters.  Because of the diversity, cell-specific expression and 'druggability' of the GPCR superfamily, these receptors are popular targets for therapeutic development.  This review will outline current and potential future approaches to develop GPCR agonists for the treatment of type 2 diabetes.  This review summarises a presentation given at the 'Novel approaches to treating type 2 diabetes' symposium at the 2015 annual meeting of the EASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru_vDlfL96TrVg90H21EOLACvtfcHk0ljwI-ijhTVu3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrsb%252FL&md5=ed9065e6d1c4330e6f5debf333553585</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00125-015-3825-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-015-3825-z%26sid%3Dliteratum%253Aachs%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26atitle%3DG%2520protein-coupled%2520receptors%2520as%2520new%2520therapeutic%2520targets%2520for%2520type%25202%2520diabetes%26jtitle%3DDiabetologia%26date%3D2016%26volume%3D59%26spage%3D229%26epage%3D233%26doi%3D10.1007%2Fs00125-015-3825-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuho, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahn, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martemyanov, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, M. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacogenomics of GPCR drug targets</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.cell.2017.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29249361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2js7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=41-54&author=A.+S.+Hauserauthor=S.+Chavaliauthor=I.+Masuhoauthor=L.+J.+Jahnauthor=K.+A.+Martemyanovauthor=D.+E.+Gloriamauthor=M.+M.+Babu&title=Pharmacogenomics+of+GPCR+drug+targets&doi=10.1016%2Fj.cell.2017.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenomics of GPCR Drug Targets</span></div><div class="casAuthors">Hauser, Alexander S.; Chavali, Sreenivas; Masuho, Ikuo; Jahn, Leonie J.; Martemyanov, Kirill A.; Gloriam, David E.; Babu, M. Madan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">41-54.e19</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Natural genetic variation in the human genome is a cause of individual differences in responses to medications and is an underappreciated burden on public health.  Although 108 G-protein-coupled receptors (GPCRs) are the targets of 475 (∼34%) Food and Drug Administration (FDA)-approved drugs and account for a global sales vol. of over 180 billion US dollars annually, the prevalence of genetic variation among GPCRs targeted by drugs is unknown.  By analyzing data from 68,496 individuals, we find that GPCRs targeted by drugs show genetic variation within functional regions such as drug- and effector-binding sites in the human population.  We exptl. show that certain variants of μ-opioid and Cholecystokinin-A receptors could lead to altered or adverse drug response.  By analyzing UK National Health Service drug prescription and sales data, we suggest that characterizing GPCR variants could increase prescription precision, improving patients' quality of life, and relieve the economic and societal burden due to variable drug responsiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqLQcECb2nm7Vg90H21EOLACvtfcHk0lgVUn_O0BMW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2js7rE&md5=aea194a723f8704cdcf4f05773c4880e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DA.%2BS.%26aulast%3DChavali%26aufirst%3DS.%26aulast%3DMasuho%26aufirst%3DI.%26aulast%3DJahn%26aufirst%3DL.%2BJ.%26aulast%3DMartemyanov%26aufirst%3DK.%2BA.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26aulast%3DBabu%26aufirst%3DM.%2BM.%26atitle%3DPharmacogenomics%2520of%2520GPCR%2520drug%2520targets%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D41%26epage%3D54%26doi%3D10.1016%2Fj.cell.2017.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of new GPCR ligands to illuminate new biology</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnchembio.2490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29045379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1OhsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1143-1151&author=B.+L.+Rothauthor=J.+J.+Irwinauthor=B.+K.+Shoichet&title=Discovery+of+new+GPCR+ligands+to+illuminate+new+biology&doi=10.1038%2Fnchembio.2490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new GPCR ligands to illuminate new biology</span></div><div class="casAuthors">Roth, Bryan L.; Irwin, John J.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1143-1151</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Although a plurality of drugs target G-protein-coupled receptors (GPCRs), most have emerged from classical medicinal chem. and pharmacol. programs and resemble one another structurally and functionally.  Though effective, these drugs are often promiscuous.  With the realization that GPCRs signal via multiple pathways, and with the emergence of crystal structures for this family of proteins, there is an opportunity to target GPCRs with new chemotypes and confer new signaling modalities.  The authors consider structure-based and phys. screening methods that have led to the discovery of new reagents, focusing particularly on the former.  The authors illustrate their use against previously untargeted or orphan GPCRs, against allosteric sites, and against classical orthosteric sites that selectively activate one downstream pathway over others.  The ligands that emerge are often chem. novel, which can lead to new biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0g7QvZBYzkLVg90H21EOLACvtfcHk0lhj50IQ9rOFuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1OhsrnK&md5=6b1682d6b1475dc1a0e8834895c4ae6c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2490%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%2520of%2520new%2520GPCR%2520ligands%2520to%2520illuminate%2520new%2520biology%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3D1143%26epage%3D1151%26doi%3D10.1038%2Fnchembio.2490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furchgott, R. F.</span></span> <span> </span><span class="NLM_article-title">The Use of Haloalkylamines in the Differentiation of Receptors and in the Determination of Dissociation Constants of Agonist-Receptor Complexes</span>. In  <i>Advances in Drug Research</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, N.</span>, <span class="NLM_string-name">Simmonds, A.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1966</span>; Vol.  <span class="NLM_volume">3</span>, pp  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">55</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1966&pages=21-55&author=R.+F.+Furchgottauthor=N.+Harper&author=A.+Simmonds&title=Advances+in+Drug+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFurchgott%26aufirst%3DR.%2BF.%26atitle%3DThe%2520Use%2520of%2520Haloalkylamines%2520in%2520the%2520Differentiation%2520of%2520Receptors%2520and%2520in%2520the%2520Determination%2520of%2520Dissociation%2520Constants%2520of%2520Agonist-Receptor%2520Complexes%26btitle%3DAdvances%2520in%2520Drug%2520Research%26aulast%3DHarper%26aufirst%3DN.%26pub%3DAcademic%2520Press%26date%3D1966%26volume%3D3%26spage%3D21%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity at GPCRs: new opportunities in psychiatric drug discovery</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1038/npp.2013.205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnpp.2013.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=24317323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCqtLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=248-249&author=S.+D.+Changauthor=M.+R.+Bruchas&title=Functional+selectivity+at+GPCRs%3A+new+opportunities+in+psychiatric+drug+discovery&doi=10.1038%2Fnpp.2013.205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery</span></div><div class="casAuthors">Chang, Steven D.; Bruchas, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-249</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The superfamily of G-protein coupled receptors (GPCRs) is one of the largest gene families in the mammalian genome.  GPCRs represent >50% of all current drug targets for treating numerous diseases that affect both peripheral and central nervous systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXBo3IaC3SEbVg90H21EOLACvtfcHk0lhj50IQ9rOFuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqtLvM&md5=285ec31f14cb03c999102d427dc2bd43</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.205%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%2BD.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26atitle%3DFunctional%2520selectivity%2520at%2520GPCRs%253A%2520new%2520opportunities%2520in%2520psychiatric%2520drug%2520discovery%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D248%26epage%3D249%26doi%3D10.1038%2Fnpp.2013.205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity and biased receptor signaling</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.173948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.110.173948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=21030484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=296-302&author=T.+Kenakin&title=Functional+selectivity+and+biased+receptor+signaling&doi=10.1124%2Fjpet.110.173948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and biased receptor signaling</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">296-302</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  With the emergence of information describing functional selectivity and biased agonists and antagonists has come a lack of confidence in "one size fits all" assays for detection of agonism.  Seven-transmembrane receptors are pleiotropic with respect to the signaling protein to which they couple in a cell, and many conformations of the receptor can be formed; this leads to systems where ligands can stabilize unique conformations that go on to selectively activate signaling pathways.  Thus, such "biased" ligands can produce cell-specific agonism that may require targeted assays to detect and quantify.  It also predicts that ligands can have many different efficacies for the many behaviors that the receptor can exhibit (referred to as "pluridimensional efficacy"), leading to a breakdown in the common classifications of agonist and antagonist.  This all poses unique challenges to the pharmacol. nomenclature of drugs, the detection and optimization of new drugs, and the assocn. of phenotypic clin. profiles with pharmacol. properties of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDmshypfoNALVg90H21EOLACvtfcHk0lhj50IQ9rOFuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D&md5=83d2c05fec2f9ef9a6e97a98bc0a3616</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.173948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.173948%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DFunctional%2520selectivity%2520and%2520biased%2520receptor%2520signaling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D296%26epage%3D302%26doi%3D10.1124%2Fjpet.110.173948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span> <span> </span><span class="NLM_article-title">Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity</span>. <i>J. Biomol. Screen.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1177/1087057108330115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1177%2F1087057108330115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=19211780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFWlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=246-255&author=M.+F.+Petersauthor=C.+W.+Scott&title=Evaluating+cellular+impedance+assays+for+detection+of+GPCR+pleiotropic+signaling+and+functional+selectivity&doi=10.1177%2F1087057108330115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity</span></div><div class="casAuthors">Peters, Matthew F.; Scott, Clay W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">246-255</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">G-protein-coupled receptors can couple to different signal transduction pathways in different cell types (termed cell-specific signaling) and can activate different signaling pathways depending on the receptor conformation(s) stabilized by the activating ligand (functional selectivity).  These concepts offer potential for developing pathway-specific drugs that increase efficacy and reduce side effects.  Despite significant interest, functional selectivity has been difficult to exploit in drug discovery, in part due to the burden of multiple assays.  Cellular impedance assays use an emerging technol. that can qual. distinguish Gs, Gi/o, and Gq signaling in a single assay and is thereby suited for studying these pharmacol. concepts.  Cellular impedance confirmed cell-specific Gs and Gq coupling for the melanocortin-4 receptor and dual Gi and Gs signaling with the cannabinoid-1 (CB1) receptor.  The balance of Gi vs. Gs signaling depended on the cell line.  In CB1-HEKs, Gi-and Gs-like responses combined to yield a novel impedance profile demonstrating the dynamic nature of these traces.  Cell-specific signaling was obsd. with endogenous D1 receptor in U-2 cells and SK-N-MC cells, yet the pharmacol. profile of partial and full agonists was similar in both cell lines.  We conclude that the dynamic impedance profile encodes valuable relative signaling information and is sufficiently robust to help evaluate cell-specific signaling and functional selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqjs8kQ8_SpbVg90H21EOLACvtfcHk0lhC5P49v8ObTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFWlurc%253D&md5=2b6e31b75547eb4b92c645b4f30e1294</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1087057108330115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057108330115%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DM.%2BF.%26aulast%3DScott%26aufirst%3DC.%2BW.%26atitle%3DEvaluating%2520cellular%2520impedance%2520assays%2520for%2520detection%2520of%2520GPCR%2520pleiotropic%2520signaling%2520and%2520functional%2520selectivity%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2009%26volume%3D14%26spage%3D246%26epage%3D255%26doi%3D10.1177%2F1087057108330115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span> <span> </span><span class="NLM_article-title">Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9841-9878&author=L.+Tanauthor=W.+Yanauthor=J.+D.+McCorvyauthor=J.+Cheng&title=Biased+ligands+of+G+protein-coupled+receptors+%28GPCRs%29%3A+structure-functional+selectivity+relationships+%28SFSRs%29+and+therapeutic+potential&doi=10.1021%2Facs.jmedchem.8b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential</span></div><div class="casAuthors">Tan, Liang; Yan, Wenzhong; McCorvy, John D.; Cheng, Jianjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9841-9878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-protein-independent pathways, and β-arrestin recruitment is the most recognized one of the latter.  Biased ligands selective for either pathway are expected to regulate biol. functions of GPCRs in a more precise way, therefore providing new drug mols. with superior efficacy and/or reduced side effects.  During the past decade, biased ligands have been discovered and developed for many GPCRs, such as the μ opioid receptor, the angiotensin II receptor type 1, the dopamine D2 receptor, and many others.  In this Perspective, recent advances in this field are reviewed by discussing the structure-functional selectivity relationships (SFSRs) of GPCR biased ligands and the therapeutic potential of these mols.  Further understanding of the biol. functions assocd. with each signaling pathway and structural basis for biased signaling will facilitate future drug design in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFjkAvar29LVg90H21EOLACvtfcHk0lhC5P49v8ObTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N&md5=a7bd605b82666357f5a0a209002225e5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DCheng%26aufirst%3DJ.%26atitle%3DBiased%2520ligands%2520of%2520G%2520protein-coupled%2520receptors%2520%2528GPCRs%2529%253A%2520structure-functional%2520selectivity%2520relationships%2520%2528SFSRs%2529%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9841%26epage%3D9878%26doi%3D10.1021%2Facs.jmedchem.8b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity and classical concepts of quantitative pharmacology</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>320</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.104463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.106.104463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=16803859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1-13&author=J.+D.+Urbanauthor=W.+P.+Clarkeauthor=M.+von+Zastrowauthor=D.+E.+Nicholsauthor=B.+Kobilkaauthor=H.+Weinsteinauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=A.+Christopoulosauthor=P.+M.+Sextonauthor=K.+J.+Millerauthor=M.+Speddingauthor=R.+B.+Mailman&title=Functional+selectivity+and+classical+concepts+of+quantitative+pharmacology&doi=10.1124%2Fjpet.106.104463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and classical concepts of quantitative pharmacology</span></div><div class="casAuthors">Urban, Jonathan D.; Clarke, William P.; von Zastrow, Mark; Nichols, David E.; Kobilka, Brian; Weinstein, Harel; Javitch, Jonathan A.; Roth, Bryan L.; Christopoulos, Arthur; Sexton, Patrick M.; Miller, Keith J.; Spedding, Michael; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The concept of intrinsic efficacy has been enshrined in pharmacol. for half of a century, yet recent data have revealed that many ligands can differentially activate signaling pathways mediated via a single G protein-coupled receptor in a manner that challenges the traditional definition of intrinsic efficacy.  Some terms for this phenomenon include functional selectivity, agonist-directed trafficking, and biased agonism.  At the extreme, functionally selective ligands may be both agonists and antagonists at different functions mediated by the same receptor.  Data illustrating this phenomenon are presented from serotonin, opioid, dopamine, vasopressin, and adrenergic receptor systems.  A variety of mechanisms may influence this apparently ubiquitous phenomenon.  It may be initiated by differences in ligand-induced intermediate conformational states, as shown for the β2-adrenergic receptor.  Subsequent mechanisms that may play a role include diversity of G proteins, scaffolding and signaling partners, and receptor oligomers.  Clearly, expanded research is needed to elucidate the proximal (e.g., how functionally selective ligands cause conformational changes that initiate differential signaling), intermediate (mechanisms that translate conformation changes into differential signaling), and distal mechanisms (differential effects on target tissue or organism).  Besides the heuristically interesting nature of functional selectivity, there is a clear impact on drug discovery, because this mechanism raises the possibility of selecting or designing novel ligands that differentially activate only a subset of functions of a single receptor, thereby optimizing therapeutic action.  It also may be timely to revise classic concepts in quant. pharmacol. and relevant pharmacol. conventions to incorporate these new concepts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5GzdtvWZRkbVg90H21EOLACvtfcHk0lhC5P49v8ObTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFersw%253D%253D&md5=54465473b5996d0755baeee89eeb0ba9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.104463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.104463%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DKobilka%26aufirst%3DB.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520and%2520classical%2520concepts%2520of%2520quantitative%2520pharmacology%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1%26epage%3D13%26doi%3D10.1124%2Fjpet.106.104463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Signalling bias in new drug discovery: detection, quantification and therapeutic impact</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1038/nrd3954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnrd3954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=23411724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=205-216&author=T.+Kenakinauthor=A.+Christopoulos&title=Signalling+bias+in+new+drug+discovery%3A+detection%2C+quantification+and+therapeutic+impact&doi=10.1038%2Fnrd3954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling bias in new drug discovery: detection, quantification and therapeutic impact</span></div><div class="casAuthors">Kenakin, Terry; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Agonists of seven-transmembrane receptors, also known as G protein-coupled receptors (GPCRs), do not uniformly activate all cellular signalling pathways linked to a given seven-transmembrane receptor (a phenomenon termed ligand or agonist bias); this discovery has changed how high-throughput screens are designed and how lead compds. are optimized for therapeutic activity.  The ability to exptl. detect ligand bias has necessitated the development of methods for quantifying agonist bias in a way that can be used to guide structure-activity studies and the selection of drug candidates.  Here, we provide a viewpoint on which methods are appropriate for quantifying bias, based on knowledge of how cellular and intracellular signalling proteins control the conformation of seven-transmembrane receptors.  We also discuss possible predictions of how biased mols. may perform in vivo, and what potential therapeutic advantages they may provide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkDNsO17tty7Vg90H21EOLACvtfcHk0liHOWUxapBFWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7c%253D&md5=712258b9158f753689e35fa31f1b67f0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd3954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3954%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DSignalling%2520bias%2520in%2520new%2520drug%2520discovery%253A%2520detection%252C%2520quantification%2520and%2520therapeutic%2520impact%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D205%26epage%3D216%26doi%3D10.1038%2Fnrd3954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span> <span> </span><span class="NLM_article-title">When 7 transmembrane receptors are not G protein-coupled receptors</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">2971</span>– <span class="NLM_lpage">2974</span>, <span class="refDoi"> DOI: 10.1172/JCI26950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1172%2FJCI26950" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2971-2974&author=K.+Rajagopalauthor=R.+J.+Lefkowitzauthor=H.+A.+Rockman&title=When+7+transmembrane+receptors+are+not+G+protein-coupled+receptors&doi=10.1172%2FJCI26950"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1172%2FJCI26950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI26950%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopal%26aufirst%3DK.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26atitle%3DWhen%25207%2520transmembrane%2520receptors%2520are%2520not%2520G%2520protein-coupled%2520receptors%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D2971%26epage%3D2974%26doi%3D10.1172%2FJCI26950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiber, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Premont, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">16284</span>– <span class="NLM_lpage">16289</span>, <span class="refDoi"> DOI: 10.1073/pnas.0607583103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1073%2Fpnas.0607583103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=16284-16289&author=K.+Rajagopalauthor=E.+J.+Whalenauthor=J.+D.+Violinauthor=J.+A.+Stiberauthor=P.+B.+Rosenbergauthor=R.+T.+Premontauthor=T.+M.+Coffmanauthor=H.+A.+Rockmanauthor=R.+J.+Lefkowitz&title=Beta-arrestin2-mediated+inotropic+effects+of+the+angiotensin+II+type+1A+receptor+in+isolated+cardiac+myocytes&doi=10.1073%2Fpnas.0607583103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0607583103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0607583103%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopal%26aufirst%3DK.%26aulast%3DWhalen%26aufirst%3DE.%2BJ.%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DStiber%26aufirst%3DJ.%2BA.%26aulast%3DRosenberg%26aufirst%3DP.%2BB.%26aulast%3DPremont%26aufirst%3DR.%2BT.%26aulast%3DCoffman%26aufirst%3DT.%2BM.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DBeta-arrestin2-mediated%2520inotropic%2520effects%2520of%2520the%2520angiotensin%2520II%2520type%25201A%2520receptor%2520in%2520isolated%2520cardiac%2520myocytes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D16284%26epage%3D16289%26doi%3D10.1073%2Fpnas.0607583103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1038/35047086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2F35047086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=11130073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVCrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=720-723&author=L.+M.+Bohnauthor=R.+R.+Gainetdinovauthor=F.+T.+Linauthor=R.+J.+Lefkowitzauthor=M.+G.+Caron&title=Mu-opioid+receptor+desensitization+by+beta-arrestin-2+determines+morphine+tolerance+but+not+dependence&doi=10.1038%2F35047086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence</span></div><div class="casAuthors">Bohn, Laura M.; Gainetdinov, Raul R.; Lin, Fang-Tsyr; Lefkowitz, Robert J.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6813</span>),
    <span class="NLM_cas:pages">720-723</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is a powerful pain reliever, but also a potent inducer of tolerance and dependence.  The development of opiate tolerance occurs on continued use of the drug such that the amt. of drug required to elicit pain relief must be increased to compensate for diminished responsiveness.  In many systems, decreased responsiveness to agonists has been correlated with the desensitization of G-protein-coupled receptors.  In vitro evidence indicates that this process involves phosphorylation of G-protein-coupled receptors and subsequent binding of regulatory proteins called β-arrestins.  Using a knockout mouse lacking β-arrestin-2 (βarr2-/-), we have assessed the contribution of desensitization of the μ-opioid receptor to the development of morphine antinociceptive tolerance and the subsequent onset of phys. dependence.  Here we show that in mice lacking β-arrestin-2, desensitization of the μ-opioid receptor does not occur after chronic morphine treatment, and that these animals fail to develop antinociceptive tolerance.  However, the deletion of β-arrestin-2 does not prevent the chronic morphine-induced up-regulation of adenylyl cyclase activity, a cellular marker of dependence, and the mutant mice still become phys. dependent on the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOyilKuNxt7Vg90H21EOLACvtfcHk0liHOWUxapBFWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVCrs7c%253D&md5=6c54b96c15fec1c9620d1fd90d24a1eb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2F35047086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35047086%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DLin%26aufirst%3DF.%2BT.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DMu-opioid%2520receptor%2520desensitization%2520by%2520beta-arrestin-2%2520determines%2520morphine%2520tolerance%2520but%2520not%2520dependence%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D720%26epage%3D723%26doi%3D10.1038%2F35047086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cas, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Lenarda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole-Wilson, P.</span></span> <span> </span><span class="NLM_article-title">Beta-blockers in heart failure: are pharmacological differences clinically important?</span>. <i>Heart Fail. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1023/B:HREV.0000046367.99002.a4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1023%2FB%3AHREV.0000046367.99002.a4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=15516860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFegu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=123-130&author=M.+Metraauthor=L.+D.+Casauthor=A.+di+Lenardaauthor=P.+Poole-Wilson&title=Beta-blockers+in+heart+failure%3A+are+pharmacological+differences+clinically+important%3F&doi=10.1023%2FB%3AHREV.0000046367.99002.a4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-Blockers in Heart Failure: Are Pharmacological Differences Clinically Important?</span></div><div class="casAuthors">Metra, Marco; Cas, Livio Dei; Di Lenarda, Andrea; Poole-Wilson, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Heart Failure Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-130</span>CODEN:
                <span class="NLM_cas:coden">HFREFC</span>;
        ISSN:<span class="NLM_cas:issn">1382-4147</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Beta-blockers are not an homogeneous group of agents.  Only three beta-blockers, carvedilol, bisoprolol and metoprolol succinate, have had favorable effects on prognosis in controlled clin. trials in the patients with chronic heart failure.  However, pharmacol. differences exist between them.  Metoprolol and bisoprolol are selective for beta1-adrenergic receptors while carvedilol blocks also beta2-, and alpha1- adrenergic receptors, and has assocd. antioxidant, anti-endothelin and antiproliferative properties.  In COMET carvedilol was assocd. with a significant redn. in mortality compared to metoprolol tartrate further showing that different beta-blockers may have different effects on the outcome.  These differences may be related to the ancillary properties of carvedilol or to its broader antiadrenergic profile.  However, also more effective and prolonged blockade of beta1 adrenergic receptors may occur with carvedilol compared to metoprolol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIbtD4AnPzyLVg90H21EOLACvtfcHk0lhJhU8YZGOFpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFegu7Y%253D&md5=7c43820be08572ce3e692644e020fb64</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1023%2FB%3AHREV.0000046367.99002.a4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AHREV.0000046367.99002.a4%26sid%3Dliteratum%253Aachs%26aulast%3DMetra%26aufirst%3DM.%26aulast%3DCas%26aufirst%3DL.%2BD.%26aulast%3Ddi%2BLenarda%26aufirst%3DA.%26aulast%3DPoole-Wilson%26aufirst%3DP.%26atitle%3DBeta-blockers%2520in%2520heart%2520failure%253A%2520are%2520pharmacological%2520differences%2520clinically%2520important%253F%26jtitle%3DHeart%2520Fail.%2520Rev.%26date%3D2004%26volume%3D9%26spage%3D123%26epage%3D130%26doi%3D10.1023%2FB%3AHREV.0000046367.99002.a4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wisler, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWire, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenoy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">16657</span>– <span class="NLM_lpage">16662</span>, <span class="refDoi"> DOI: 10.1073/pnas.0707936104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1073%2Fpnas.0707936104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=17925438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Wmu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=16657-16662&author=J.+W.+Wislerauthor=S.+M.+DeWireauthor=E.+J.+Whalenauthor=J.+D.+Violinauthor=M.+T.+Drakeauthor=S.+Ahnauthor=S.+K.+Shenoyauthor=R.+J.+Lefkowitz&title=A+unique+mechanism+of+beta-blocker+action%3A+Carvedilol+stimulates+beta-arrestin+signaling&doi=10.1073%2Fpnas.0707936104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A unique mechanism of β-blocker action: carvedilol stimulates β-arrestin signaling</span></div><div class="casAuthors">Wisler, James W.; Dewire, Scott M.; Whalen, Erin J.; Violin, Jonatan D.; Drake, Matthew T.; Ahn, Seungkirl; Shenoy, Sudha K.; Lefkowitz, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">16657-16662</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">For many years, β-adrenergic receptor antagonists (β-blockers or βAR antagonists) have provided significant morbidity and mortality benefits in patients who have sustained acute myocardial infarction.  More recently, β-adrenergic receptor antagonists have been found to provide survival benefits in patients suffering from heart failure, although the efficacy of different β-blockers varies widely in this condition.  One drug, carvedilol, a nonsubtype-selective βAR antagonist, has proven particularly effective in the treatment of heart failure, although the mechanism(s) responsible for this are controversial.  Here, we report that among 16 clin. relevant βAR antagonists, carvedilol displays a unique profile of in vitro signaling characteristics.  We obsd. that in β2 adrenergic receptor (β2AR)-expressing HEK-293 cells, carvedilol has inverse efficacy for stimulating Gs-dependent adenylyl cyclase but, nonetheless, stimulates (i) phosphorylation of the receptor's cytoplasmic tail on previously documented G protein-coupled receptor kinase sites; (ii) recruitment of β-arrestin to the β2AR; (iii) receptor internalization; and (iv) activation of extracellular regulated kinase 1/2 (ERK 1/2), which is maintained in the G protein-uncoupled mutant β2ART68F,Y132G,Y219A (β2ARTYY) and abolished by β-arrestin2 siRNA.  Taken together, these data indicate that carvedilol is able to stabilize a receptor conformation which, although uncoupled from Gs, is nonetheless able to stimulate β-arrestin-mediated signaling.  We hypothesize that such signaling may contribute to the special efficacy of carvedilol in the treatment of heart failure and may serve as a prototype for a new generation of therapeutic β2AR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo93wOR8ANKWbVg90H21EOLACvtfcHk0lhJhU8YZGOFpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Wmu7%252FJ&md5=cd03ae4a87363d9bca28b14dce173589</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0707936104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0707936104%26sid%3Dliteratum%253Aachs%26aulast%3DWisler%26aufirst%3DJ.%2BW.%26aulast%3DDeWire%26aufirst%3DS.%2BM.%26aulast%3DWhalen%26aufirst%3DE.%2BJ.%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DDrake%26aufirst%3DM.%2BT.%26aulast%3DAhn%26aufirst%3DS.%26aulast%3DShenoy%26aufirst%3DS.%2BK.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DA%2520unique%2520mechanism%2520of%2520beta-blocker%2520action%253A%2520Carvedilol%2520stimulates%2520beta-arrestin%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D16657%26epage%3D16662%26doi%3D10.1073%2Fpnas.0707936104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aryal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corder, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lober, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of opioid analgesics with reduced side effects</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>537</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1038/nature19112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnature19112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=27533032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKmsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=185-190&author=A.+Manglikauthor=H.+Linauthor=D.+K.+Aryalauthor=J.+D.+McCorvyauthor=D.+Denglerauthor=G.+Corderauthor=A.+Levitauthor=R.+C.+Klingauthor=V.+Bernatauthor=H.+Hubnerauthor=X.+P.+Huangauthor=M.+F.+Sassanoauthor=P.+M.+Giguereauthor=S.+Loberauthor=D.+Daauthor=G.+Scherrerauthor=B.+K.+Kobilkaauthor=P.+Gmeinerauthor=B.+L.+Rothauthor=B.+K.+Shoichet&title=Structure-based+discovery+of+opioid+analgesics+with+reduced+side+effects&doi=10.1038%2Fnature19112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based discovery of opioid analgesics with reduced side effects</span></div><div class="casAuthors">Manglik, Aashish; Lin, Henry; Aryal, Dipendra K.; McCorvy, John D.; Dengler, Daniela; Corder, Gregory; Levit, Anat; Kling, Ralf C.; Bernat, Viachaslau; Hubner, Harald; Huang, Xi-Ping; Sassano, Maria F.; Giguere, Patrick M.; Lober, Stefan; Da Duan; Scherrer, Gregory; Kobilka, Brian K.; Gmeiner, Peter; Roth, Bryan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7619</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is an alkaloid from the opium poppy used to treat pain.  The potentially lethal side effects of morphine and related opioids-which include fatal respiratory depression-are thought to be mediated by μ-opioid-receptor (μOR) signalling through the β-arrestin pathway or by actions at other receptors.  Conversely, G-protein μOR signalling is thought to confer analgesia.  Here we computationally dock over 3 million mols. against the μOR structure and identify new scaffolds unrelated to known opioids.  Structure-based optimization yields PZM21-a potent Gi activator with exceptional selectivity for μOR and minimal β-arrestin-2 recruitment.  Unlike morphine, PZM21 is more efficacious for the affective component of analgesia vs. the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses.  PZM21 thus serves as both a probe to disentangle μOR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiCff2w3U8iLVg90H21EOLACvtfcHk0lhJhU8YZGOFpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKmsbvI&md5=b8bb2d8575dadf4a6dc74d94c26d2c1a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature19112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19112%26sid%3Dliteratum%253Aachs%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DAryal%26aufirst%3DD.%2BK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DDengler%26aufirst%3DD.%26aulast%3DCorder%26aufirst%3DG.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DBernat%26aufirst%3DV.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DGiguere%26aufirst%3DP.%2BM.%26aulast%3DLober%26aufirst%3DS.%26aulast%3DDa%26aufirst%3DD.%26aulast%3DScherrer%26aufirst%3DG.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DStructure-based%2520discovery%2520of%2520opioid%2520analgesics%2520with%2520reduced%2520side%2520effects%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D185%26epage%3D190%26doi%3D10.1038%2Fnature19112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilts, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connery, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrington, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawler, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oxford, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Malley, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D<sub>2</sub>L receptor-transfected MN9D cells and pituitary lactotrophs</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.1124/jpet.301.3.1179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.301.3.1179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=12023553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1179-1189&author=J.+D.+Kiltsauthor=H.+S.+Conneryauthor=E.+G.+Arringtonauthor=M.+M.+Lewisauthor=C.+P.+Lawlerauthor=G.+S.+Oxfordauthor=K.+L.+O%27Malleyauthor=R.+D.+Toddauthor=B.+L.+Blakeauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Functional+selectivity+of+dopamine+receptor+agonists.+II.+Actions+of+dihydrexidine+in+D2L+receptor-transfected+MN9D+cells+and+pituitary+lactotrophs&doi=10.1124%2Fjpet.301.3.1179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs</span></div><div class="casAuthors">Kilts, Jason D.; Connery, Hilary S.; Arrington, Elaine G.; Lewis, Mechelle M.; Lawler, Cindy P.; Oxford, Gerry S.; O'Malley, Karen L.; Todd, Richard D.; Blake, Bonita L.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1189</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">D2-like dopamine receptors mediate functional changes via activation of inhibitory G proteins, including those that affect adenylate cyclase activity, and potassium and calcium channels.  Although it is assumed that the binding of a drug to a single isoform of a D2-like receptor will cause similar changes in all receptor-mediated functions, it has been demonstrated in brain that the dopamine agonists dihydrexidine (DHX) and N-n-propyl-DHX are "functionally selective".  The current study explores the underlying mechanism using transfected MN9D cells and D2-producing anterior pituitary lactotrophs.  Both dopamine and DHX inhibited adenylate cyclase activity in a concn.-dependent manner in both systems, effects blocked by D2, but not D1, antagonists.  In the MN9D cells, quinpirole and R-(-)-N-propylnorapomorphine (NPA) also inhibited the K+-stimulated release of [3H]dopamine in a concn.-responsive, antagonist-reversible manner.  Conversely, neither DHX, nor its analogs, inhibited K+-stimulated [3H]dopamine release, although they antagonized the effects of quinpirole.  S-(+)-NPA actually had the reverse functional selectivity profile from DHX (i.e., it was a full agonist at D2L receptors coupled to inhibition of dopamine release, but a weak partial agonist at D2L receptor-mediated inhibition of adenylate cyclase).  In lactotrophs, DHX had little intrinsic activity at D2 receptors coupled to G protein-coupled inwardly rectifying potassium channels, and actually antagonized the effects of dopamine at these D2 receptors.  Together, these findings provide compelling evidence for agonist-induced functional selectivity with the D2L receptor.  Although the underlying mol. mechanism is controversial (e.g., "conformational induction" vs. "drug-active state selection"), such data are irreconcilable with the widely held view that drugs have "intrinsic efficacy".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxKyo-BPUi-LVg90H21EOLACvtfcHk0lgNg6zvNfOS8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrc%253D&md5=6686ca6fae277969b216781088d74a87</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1179%26sid%3Dliteratum%253Aachs%26aulast%3DKilts%26aufirst%3DJ.%2BD.%26aulast%3DConnery%26aufirst%3DH.%2BS.%26aulast%3DArrington%26aufirst%3DE.%2BG.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DOxford%26aufirst%3DG.%2BS.%26aulast%3DO%2527Malley%26aufirst%3DK.%2BL.%26aulast%3DTodd%26aufirst%3DR.%2BD.%26aulast%3DBlake%26aufirst%3DB.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520II.%2520Actions%2520of%2520dihydrexidine%2520in%2520D2L%2520receptor-transfected%2520MN9D%2520cells%2520and%2520pituitary%2520lactotrophs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1179%26epage%3D1189%26doi%3D10.1124%2Fjpet.301.3.1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">GPCR functional selectivity has therapeutic impact</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">390</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2007.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.tips.2007.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=17629962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=390-396&author=R.+B.+Mailman&title=GPCR+functional+selectivity+has+therapeutic+impact&doi=10.1016%2Fj.tips.2007.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">GPCR functional selectivity has therapeutic impact</span></div><div class="casAuthors">Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">390-396</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Many in vitro data show that some ligands can cause the differential activation of signaling pathways mediated by a single receptor (termedfunctional selectivity').  It remains unclear, however, whether functionally selective properties are meaningful in vivo.  Data obtained with exptl. compds. that are functionally selective at the dopamine D2L receptor in vitro suggest that these properties might predict atypical behavioral actions.  Moreover, the antipsychotic drug aripiprazole is commonly thought to be a D2 partial agonist, but data clearly show that aripiprazole is functionally selective in vitro.  It is proposed that the effects of aripiprazole in animal models and humans can be reconciled only with its functionally selective D2 properties, not its partial D2 agonism.  Together, these data provide support for the hypothesis that compds. with functionally selective properties in vitro are likely to have novel actions in vivo, opening doors to new avenues of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGT3wJMrwLmrVg90H21EOLACvtfcHk0lgNg6zvNfOS8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltLg%253D&md5=e4647d1af70505c4711dd2d57d0b4cfd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DGPCR%2520functional%2520selectivity%2520has%2520therapeutic%2520impact%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D390%26epage%3D396%26doi%3D10.1016%2Fj.tips.2007.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailman, R. B.</span></span> <span> </span><span class="NLM_article-title">Aripiprazole has functionally selective actions at dopamine D<sub>2</sub> receptor-mediated signaling pathways</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1301071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fsj.npp.1301071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=16554739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=67-77&author=J.+D.+Urbanauthor=G.+A.+Vargasauthor=M.+von+Zastrowauthor=R.+B.+Mailman&title=Aripiprazole+has+functionally+selective+actions+at+dopamine+D2+receptor-mediated+signaling+pathways&doi=10.1038%2Fsj.npp.1301071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways</span></div><div class="casAuthors">Urban, Jonathan D.; Vargas, Gabriel A.; von Zastrow, Mark; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-77</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aripiprazole is a unique atypical antipsychotic drug with an excellent side-effect profile presumed, in part, to be due to lack of typical D2 dopamine receptor antagonist properties.  Whether aripiprazole is a typical D2 partial agonist, or a functionally selective D2 ligand, remains controversial (eg D2-mediated inhibition of adenylate cyclase is system dependent; aripiprazole antagonizes D2 receptor-mediated G-protein-coupled inwardly rectifying potassium channels and guanosine triphosphate nucleotide (GTP)γS coupling).  The current study examd. the D2L receptor binding properties of aripiprazole, as well as the effects of the drug on three downstream D2 receptor-mediated functional effectors: mitogen-activated protein kinase (MAPK) phosphorylation, potentiation of arachidonic acid (AA) release, and D2 receptor internalization.  Unlike quinpirole (a full D2 agonist) or (-)3PPP (S(-)-3-(3-hydroxyphenyl)-N-propylpiperidine hydrochloride, a D2 partial agonist), the apparent D2 affinity of aripiprazole was not decreased significantly by GTP.  Moreover, full or partial agonists are expected to have Hill slopes <1.0, yet that of aripiprazole was significantly >1.0.  Whereas aripiprazole partially activated both the MAPK and AA pathways, its potency vs MAPK phosphorylation was much lower relative to potencies in assays either of AA release or inhibition of cyclic adenosine 3',5'-cyclic monophosphate accumulation.  In addn., unlike typical agonists, neither aripiprazole nor (-)3PPP produced significant internalization of the D2L receptor.  These data are clear evidence that aripiprazole affects D2L-mediated signaling pathways in a differential manner.  The results are consistent with the hypothesis that aripiprazole is a functionally selective D2 ligand rather than a simple partial agonist.  Such data may be useful in understanding the novel clin. actions of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-qAW7cvG3i7Vg90H21EOLACvtfcHk0lgNg6zvNfOS8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqtbrJ&md5=20b9edb05787dadb09fb4c778205f0b2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301071%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DAripiprazole%2520has%2520functionally%2520selective%2520actions%2520at%2520dopamine%2520D2%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D67%26epage%3D77%26doi%3D10.1038%2Fsj.npp.1301071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin-biased ligands at seven-transmembrane receptors</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2007.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.tips.2007.06.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=416-422&author=J.+D.+Violinauthor=R.+J.+Lefkowitz&title=Beta-arrestin-biased+ligands+at+seven-transmembrane+receptors&doi=10.1016%2Fj.tips.2007.06.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DBeta-arrestin-biased%2520ligands%2520at%2520seven-transmembrane%2520receptors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D416%26epage%3D422%26doi%3D10.1016%2Fj.tips.2007.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gesty-Palmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span> <span> </span><span class="NLM_article-title">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">1ra1</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.3000071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1126%2Fscitranslmed.3000071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=20368153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&author=D.+Gesty-Palmerauthor=P.+Flanneryauthor=L.+Yuanauthor=L.+Corsinoauthor=R.+Spurneyauthor=R.+J.+Lefkowitzauthor=L.+M.+Luttrell&title=A+beta-arrestin-biased+agonist+of+the+parathyroid+hormone+receptor+%28PTH1R%29+promotes+bone+formation+independent+of+G+protein+activation&doi=10.1126%2Fscitranslmed.3000071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span></div><div class="casAuthors">Gesty-Palmer Diane; Flannery Pat; Yuan Ling; Corsino Leonor; Spurney Robert; Lefkowitz Robert J; Luttrell Louis M</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1ra1</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">About 40% of the therapeutic agents in use today exert their effects through seven-transmembrane receptors (7TMRs).  When activated by ligands, these receptors trigger two pathways that independently transduce signals to the cell: one through heterotrimeric GTP-binding proteins (G proteins) and one through beta-arrestins; so-called biased agonists can selectively activate these distinct pathways.  Here, we investigate selective activation of these pathways through the use of a biased agonist for the type 1 parathyroid hormone (PTH)-PTH-related protein receptor (PTH1R), (D-Trp(12),Tyr(34))-PTH(7-34) (PTH-betaarr), which activates beta-arrestin but not classic G protein signaling.  In mice, PTH-betaarr induces anabolic bone formation, as does the nonselective agonist PTH(1-34), which activates both mechanisms.  In beta-arrestin2-null mice, the increase in bone mineral density evoked by PTH(1-34) is attenuated and that stimulated by PTH-betaarr is ablated.  The beta-arrestin2-dependent pathway contributes primarily to trabecular bone formation and does not stimulate bone resorption.  These results show that a biased agonist selective for the beta-arrestin pathway can elicit a response in vivo distinct from that elicited by nonselective agonists.  Ligands with these properties may form the basis for improved 7TMR-directed pharmacologic agents with enhanced therapeutic specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmuM4aCIxthdXdcedVHT5tfW6udTcc2eYpFByBE--dKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D&md5=748e4367ded72b6b7e10fd759521ba62</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3000071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3000071%26sid%3Dliteratum%253Aachs%26aulast%3DGesty-Palmer%26aufirst%3DD.%26aulast%3DFlannery%26aufirst%3DP.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DCorsino%26aufirst%3DL.%26aulast%3DSpurney%26aufirst%3DR.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26atitle%3DA%2520beta-arrestin-biased%2520agonist%2520of%2520the%2520parathyroid%2520hormone%2520receptor%2520%2528PTH1R%2529%2520promotes%2520bone%2520formation%2520independent%2520of%2520G%2520protein%2520activation%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2009%26volume%3D1%26doi%3D10.1126%2Fscitranslmed.3000071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franceschini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borriello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceres, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ros, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coccone, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorini, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennini, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandager-Nielsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel-Kruger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkelsen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattorusso, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D<sub>3</sub> and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1021/jm800689g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800689g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=151-169&author=S.+Butiniauthor=S.+Gemmaauthor=G.+Campianiauthor=S.+Franceschiniauthor=F.+Trottaauthor=M.+Borrielloauthor=N.+Ceresauthor=S.+Rosauthor=S.+S.+Cocconeauthor=M.+Bernettiauthor=M.+De+Angelisauthor=M.+Brindisiauthor=V.+Nacciauthor=I.+Fioriniauthor=E.+Novellinoauthor=A.+Cagnottoauthor=T.+Menniniauthor=K.+Sandager-Nielsenauthor=J.+T.+Andreasenauthor=J.+Scheel-Krugerauthor=J.+D.+Mikkelsenauthor=C.+Fattorusso&title=Discovery+of+a+new+class+of+potential+multifunctional+atypical+antipsychotic+agents+targeting+dopamine+D3+and+serotonin+5-HT1A+and+5-HT2A+receptors%3A+design%2C+synthesis%2C+and+effects+on+behavior&doi=10.1021%2Fjm800689g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm800689g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800689g%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DCeres%26aufirst%3DN.%26aulast%3DRos%26aufirst%3DS.%26aulast%3DCoccone%26aufirst%3DS.%2BS.%26aulast%3DBernetti%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DNacci%26aufirst%3DV.%26aulast%3DFiorini%26aufirst%3DI.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DMennini%26aufirst%3DT.%26aulast%3DSandager-Nielsen%26aufirst%3DK.%26aulast%3DAndreasen%26aufirst%3DJ.%2BT.%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26aulast%3DFattorusso%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520new%2520class%2520of%2520potential%2520multifunctional%2520atypical%2520antipsychotic%2520agents%2520targeting%2520dopamine%2520D3%2520and%2520serotonin%25205-HT1A%2520and%25205-HT2A%2520receptors%253A%2520design%252C%2520synthesis%252C%2520and%2520effects%2520on%2520behavior%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D151%26epage%3D169%26doi%3D10.1021%2Fjm800689g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herenbrink, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span> <span> </span><span class="NLM_article-title">A structure-activity analysis of biased agonism at the dopamine D<sub>2</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9199</span>– <span class="NLM_lpage">9221</span>, <span class="refDoi"> DOI: 10.1021/jm401318w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401318w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9199-9221&author=J.+Shonbergauthor=C.+K.+Herenbrinkauthor=L.+Lopezauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=J.+R.+Lane&title=A+structure-activity+analysis+of+biased+agonism+at+the+dopamine+D2+receptor&doi=10.1021%2Fjm401318w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Structure-Activity Analysis of Biased Agonism at the Dopamine D2 Receptor</span></div><div class="casAuthors">Shonberg, Jeremy; Herenbrink, Carmen Klein; Lopez, Laura; Christopoulos, Arthur; Scammells, Peter J.; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9199-9221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased agonism offers an opportunity for the medicinal chemist to discover pathway-selective ligands for GPCRs.  A no. of studies have suggested that biased agonism at the dopamine D2 receptor (D2R) may be advantageous for the treatment of neuropsychiatric disorders, including schizophrenia.  As such, it is of great importance to gain insight into the SAR of biased agonism at this receptor.  The authors have generated SAR based on a novel D2R partial agonist, tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate.  This ligand shares structural similarity to cariprazine, a drug awaiting FDA approval for the treatment of schizophrenia, yet displays a distinct bias toward two different signaling end points.  The authors synthesized a no. of derivs. of tert-Bu (trans-4-(2-(3,4-dihydroisoquinolin-2-(1H)-yl)-ethyl)-cyclohexyl)-carbamate with subtle structural modifications, including incorporation of cariprazine fragments.  By combining pharmacol. profiling with anal. methodol. to identify and to quantify bias, the authors have demonstrated that efficacy and biased agonism can be finely tuned by minor structural modifications to the head group contg. the tertiary amine, a tail group that extends away from this moiety, and the orientation and length of a spacer region between these two moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocktbsOBHWB7Vg90H21EOLACvtfcHk0lhDHLA5NMxqcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrbJ&md5=124b940132336819740ec30d2962a3a3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401318w%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DHerenbrink%26aufirst%3DC.%2BK.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DA%2520structure-activity%2520analysis%2520of%2520biased%2520agonism%2520at%2520the%2520dopamine%2520D2%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9199%26epage%3D9221%26doi%3D10.1021%2Fjm401318w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally selective dopamine D<sub>2</sub>/D<sub>3</sub> receptor agonists comprising an enyne moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5130</span>– <span class="NLM_lpage">5141</span>, <span class="refDoi"> DOI: 10.1021/jm400520c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400520c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5130-5141&author=C.+Hillerauthor=R.+C.+Klingauthor=F.+W.+Heinemannauthor=K.+Meyerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D2%2FD3+receptor+agonists+comprising+an+enyne+moiety&doi=10.1021%2Fjm400520c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</span></div><div class="casAuthors">Hiller, Christine; Kling, Ralf C.; Heinemann, Frank W.; Meyer, Karsten; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5130-5141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonracemic ethynylcyclohexynylamines I and ent-I {R = 1,1'-biphenyl-4-yl, pyrazolo[1,5-a]pyridin-2-yl, pyrazolo[1,5-a]pyridin-3-yl, 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl, benzo[b]thiophene-2-yl, ferrocenyl} were prepd. as dopamine receptor agonists with atypical catechol isosteres; their selectivities for dopamine receptors and for activating receptors through G-protein subunits Go and Gi and the metabolic stability of rac-I (R = 4-PhC6H4) were detd.  The ethynylcyclohexynylamines bound to D2-like receptors with high affinities.  Ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) selectively activated D2slow-promoted Go activation over Gi coupling; the most significant functional bias obsd. was for ent-I {R = 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl} which selectively activated Go over Gi coupling at D2long receptors.  Functional selectivity for β-arrestin recruitment over Gi activation was obsd. for I (R = 1,1'-biphenyl-4-yl) and ent-I (R = benzothiophene-2-yl), while ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) preferred β-arrestin recruitment compared to Go coupling.  The structure of a nonracemic N-(ethynylcyclohexenyl)dinitrobenzamide was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXn2SrS-IBCrVg90H21EOLACvtfcHk0lhDHLA5NMxqcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D&md5=3855de949f505a83ed3aa561ca182e75</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400520c%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DHeinemann%26aufirst%3DF.%2BW.%26aulast%3DMeyer%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D2%252FD3%2520receptor%2520agonists%2520comprising%2520an%2520enyne%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5130%26epage%3D5141%26doi%3D10.1021%2Fjm400520c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein Herenbrink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D(2) receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4924</span>– <span class="NLM_lpage">4939</span>, <span class="refDoi"> DOI: 10.1021/jm500457x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500457x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4924-4939&author=M.+Szaboauthor=C.+Klein+Herenbrinkauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=B.+Capuano&title=Structure-activity+relationships+of+privileged+structures+lead+to+the+discovery+of+novel+biased+ligands+at+the+dopamine+D%282%29+receptor&doi=10.1021%2Fjm500457x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm500457x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500457x%26sid%3Dliteratum%253Aachs%26aulast%3DSzabo%26aufirst%3DM.%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DStructure-activity%2520relationships%2520of%2520privileged%2520structures%2520lead%2520to%2520the%2520discovery%2520of%2520novel%2520biased%2520ligands%2520at%2520the%2520dopamine%2520D%25282%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4924%26epage%3D4939%26doi%3D10.1021%2Fjm500457x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Functionally selective dopamine D(2), D(3) receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4861</span>– <span class="NLM_lpage">4875</span>, <span class="refDoi"> DOI: 10.1021/jm5004039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5004039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4861-4875&author=D.+M%C3%B6lerauthor=R.+C.+Klingauthor=M.+Skultetyauthor=K.+Leunerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D%282%29%2C+D%283%29+receptor+partial+agonists&doi=10.1021%2Fjm5004039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004039%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ler%26aufirst%3DD.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DLeuner%26aufirst%3DK.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D%25282%2529%252C%2520D%25283%2529%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4861%26epage%3D4875%26doi%3D10.1021%2Fjm5004039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzuneser, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skultety, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzheimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased dopaminergics with a pyrazolo[1,5-a]pyridine substructure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2908</span>– <span class="NLM_lpage">2929</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2908-2929&author=D.+M%C3%B6llerauthor=A.+Banerjeeauthor=T.+C.+Uzuneserauthor=M.+Skultetyauthor=T.+Huthauthor=B.+Plouffeauthor=H.+H%C3%BCbnerauthor=C.+Alzheimerauthor=K.+Friedlandauthor=C.+P.+Mullerauthor=M.+Bouvierauthor=P.+Gmeiner&title=Discovery+of+G+protein-biased+dopaminergics+with+a+pyrazolo%5B1%2C5-a%5Dpyridine+substructure&doi=10.1021%2Facs.jmedchem.6b01857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure</span></div><div class="casAuthors">Moller Dorothee; Banerjee Ashutosh; Skultety Marika; Hubner Harald; Gmeiner Peter; Uzuneser Taygun C; Muller Christian P; Huth Tobias; Alzheimer Christian; Plouffe Bianca; Bouvier Michel; Friedland Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2908-2929</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">1,4-Disubstituted aromatic piperazines are privileged structural motifs recognized by aminergic G protein-coupled receptors.  Connection of a lipophilic moiety to the arylpiperazine core by an appropriate linker represents a promising concept to increase binding affinity and to fine-tune functional properties.  In particular, incorporation of a pyrazolo[1,5-a]pyridine heterocyclic appendage led to a series of high-affinity dopamine receptor partial agonists.  Comprehensive pharmacological characterization involving BRET biosensors, binding studies, electrophysiology, and complementation-based assays revealed compounds favoring activation of G proteins (preferably Go) over β-arrestin recruitment at dopamine D2 receptors.  The feasibility to design G protein-biased partial agonists as putative novel therapeutics was demonstrated for the representative 2-methoxyphenylpiperazine 16c, which unequivocally displayed antipsychotic activity in vivo.  Moreover, combination of the pyrazolo[1,5-a]pyridine appendage with a 5-hydroxy-N-propyl-2-aminotetraline unit led to balanced or G protein-biased dopaminergic ligands depending on the stereochemistry of the headgroup, illustrating the complex structure-functional selectivity relationships at dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSsvEaQplNsM25P7XSLhESfW6udTcc2ebeCXDL3gx2Rbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czhs1Ojsw%253D%253D&md5=208855de29fed6b821fd6e4a5bfb412f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DUzuneser%26aufirst%3DT.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DHuth%26aufirst%3DT.%26aulast%3DPlouffe%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DAlzheimer%26aufirst%3DC.%26aulast%3DFriedland%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DC.%2BP.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520dopaminergics%2520with%2520a%2520pyrazolo%255B1%252C5-a%255Dpyridine%2520substructure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2908%26epage%3D2929%26doi%3D10.1021%2Facs.jmedchem.6b01857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Männel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Hydroxy-substituted heteroarylpiperazines: novel scaffolds for beta-arrestin-biased D<sub>2</sub>R agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4693</span>– <span class="NLM_lpage">4713</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00363</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4693-4713&author=B.+M%C3%A4nnelauthor=D.+Denglerauthor=J.+Shonbergauthor=H.+H%C3%BCbnerauthor=D.+M%C3%B6llerauthor=P.+Gmeiner&title=Hydroxy-substituted+heteroarylpiperazines%3A+novel+scaffolds+for+beta-arrestin-biased+D2R+agonists&doi=10.1021%2Facs.jmedchem.7b00363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00363%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnel%26aufirst%3DB.%26aulast%3DDengler%26aufirst%3DD.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHydroxy-substituted%2520heteroarylpiperazines%253A%2520novel%2520scaffolds%2520for%2520beta-arrestin-biased%2520D2R%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4693%26epage%3D4713%26doi%3D10.1021%2Facs.jmedchem.7b00363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Männel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiteh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeifman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randakova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, J.</span></span> <span> </span><span class="NLM_article-title">Structure-guided screening for functionally selective D<sub>2</sub> dopamine receptor ligands from a virtual chemical library</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2652</span>– <span class="NLM_lpage">2661</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00493</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00493" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A280%3ADC%252BC1cbitFOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2652-2661&author=B.+M%C3%A4nnelauthor=M.+Jaitehauthor=A.+Zeifmanauthor=A.+Randakovaauthor=D.+M%C3%B6llerauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=J.+Carlsson&title=Structure-guided+screening+for+functionally+selective+D2+dopamine+receptor+ligands+from+a+virtual+chemical+library&doi=10.1021%2Facschembio.7b00493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library</span></div><div class="casAuthors">Mannel Barbara; Randakova Alena; Moller Dorothee; Hubner Harald; Gmeiner Peter; Jaiteh Mariama; Zeifman Alexey; Carlsson Jens</div><div class="citationInfo"><span class="NLM_cas:title">ACS chemical biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2652-2661</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Functionally selective ligands stabilize conformations of G protein-coupled receptors (GPCRs) that induce a preference for signaling via a subset of the intracellular pathways activated by the endogenous agonists.  The possibility to fine-tune the functional activity of a receptor provides opportunities to develop drugs that selectively signal via pathways associated with a therapeutic effect and avoid those causing side effects.  Animal studies have indicated that ligands displaying functional selectivity at the D2 dopamine receptor (D2R) could be safer and more efficacious drugs against neuropsychiatric diseases.  In this work, computational design of functionally selective D2R ligands was explored using structure-based virtual screening.  Molecular docking of known functionally selective ligands to a D2R homology model indicated that such compounds were anchored by interactions with the orthosteric site and extended into a common secondary pocket.  A tailored virtual library with close to 13 000 compounds bearing 2,3-dichlorophenylpiperazine, a privileged orthosteric scaffold, connected to diverse chemical moieties via a linker was docked to the D2R model.  Eighteen top-ranked compounds that occupied both the orthosteric and allosteric site were synthesized, leading to the discovery of 16 partial agonists.  A majority of the ligands had comparable maximum effects in the G protein and β-arrestin recruitment assays, but a subset displayed preference for a single pathway.  In particular, compound 4 stimulated β-arrestin recruitment (EC50 = 320 nM, Emax = 16%) but had no detectable G protein signaling.  The use of structure-based screening and virtual libraries to discover GPCR ligands with tailored functional properties will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRW136So_JwDo2y4bB4mnvYfW6udTcc2eYdFDWqRsap77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbitFOhtg%253D%253D&md5=6fce6cbe07e10f7707b349c1de9c07d3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00493%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnel%26aufirst%3DB.%26aulast%3DJaiteh%26aufirst%3DM.%26aulast%3DZeifman%26aufirst%3DA.%26aulast%3DRandakova%26aufirst%3DA.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DCarlsson%26aufirst%3DJ.%26atitle%3DStructure-guided%2520screening%2520for%2520functionally%2520selective%2520D2%2520dopamine%2520receptor%2520ligands%2520from%2520a%2520virtual%2520chemical%2520library%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D2652%26epage%3D2661%26doi%3D10.1021%2Facschembio.7b00493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Männel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin biased dopamine D<sub>2</sub> receptor partial agonists: Synthesis and pharmacological evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5613</span>– <span class="NLM_lpage">5628</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1016%2Fj.bmc.2017.08.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5613-5628&author=B.+M%C3%A4nnelauthor=H.+H%C3%BCbnerauthor=D.+M%C3%B6llerauthor=P.+Gmeiner&title=Beta-arrestin+biased+dopamine+D2+receptor+partial+agonists%3A+Synthesis+and+pharmacological+evaluation&doi=10.1016%2Fj.bmc.2017.08.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnel%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DBeta-arrestin%2520biased%2520dopamine%2520D2%2520receptor%2520partial%2520agonists%253A%2520Synthesis%2520and%2520pharmacological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5613%26epage%3D5628%26doi%3D10.1016%2Fj.bmc.2017.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of beta-arrestin-biased dopamine D<sub>2</sub> ligands for probing signal transduction pathways essential for antipsychotic efficacy</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">18488</span>– <span class="NLM_lpage">18493</span>, <span class="refDoi"> DOI: 10.1073/pnas.1104807108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1073%2Fpnas.1104807108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=22025698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.+P.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+beta-arrestin-biased+dopamine+D2+ligands+for+probing+signal+transduction+pathways+essential+for+antipsychotic+efficacy&doi=10.1073%2Fpnas.1104807108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy</span></div><div class="casAuthors">Allen, John A.; Yost, Julianne M.; Setola, Vincent; Chen, Xin; Sassano, Maria F.; Chen, Meng; Peterson, Sean; Yadav, Prem N.; Huang, Xi-Ping; Feng, Bo; Jensen, Niels H.; Che, Xin; Bai, Xu; Frye, Stephen V.; Wetsel, William C.; Caron, Marc G.; Javitch, Jonathan A.; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18488-18493, S18488/1-S18488/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Elucidating the key signal transduction pathways essential for both antipsychotic efficacy and side-effect profiles is essential for developing safer and more effective therapies.  Recent work has highlighted noncanonical modes of dopamine D2 receptor (D2R) signaling via β-arrestins as being important for the therapeutic actions of both antipsychotic and antimanic agents.  We thus sought to create unique D2R agonists that display signaling bias via β-arrestinergic signaling.  Through a robust diversity-oriented modification of the scaffold represented by aripiprazole (1), we discovered UNC9975 (2), UNC0006 (3); and UNC9994 (4) as unprecedented β-arrestin-biased D2R ligands.  These compds. also represent unprecedented β-arrestin-biased ligands for a Gi-coupled G protein-coupled receptor (GPCR).  Significantly, UNC9975, UNC0006, and UNC9994 are simultaneously antagonists of Gi-regulated cAMP prodn. and partial agonists for D2R/β-arrestin-2 interactions.  Importantly, VNC9975 displayed potent antipsychotic-like activity without inducing motoric side effects in inbred C57BL/6 mice in vivo.  Genetic deletion of β-arrestin-2 simultaneously attenuated the antipsychotic actions of UNC9975 and transformed it into a typical antipsychotic .drug with a high propensity to induce catalepsy.  Similarly, the antipsychotic-like activity displayed by UNC9994, an extremely β-arrestin-biased D2R agonist, in wild-type mice was completely abolished in β-arrestin-2 knockout mice.  Taken together, our results suggest that β-arrestin signaling and recruitment can be simultaneously a significant contributor to antipsychotic efficacy and protective against motoric side effects.  These functionally selective, β-arrestin-biased D2R ligands represent valuable chem. probes for further investigations of D2R signaling in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr87mjP6jm447Vg90H21EOLACvtfcHk0lhj5VfqFyRGHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK&md5=d5b06e4ac4d2cc4cd04fd1de760ec628</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104807108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104807108%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520beta-arrestin-biased%2520dopamine%2520D2%2520ligands%2520for%2520probing%2520signal%2520transduction%2520pathways%2520essential%2520for%2520antipsychotic%2520efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493%26doi%3D10.1073%2Fpnas.1104807108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonifazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupica, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span> <span> </span><span class="NLM_article-title">Novel and potent dopamine D<sub>2</sub> receptor Go-protein biased agonists</span>. <i>ACS Pharmacol. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1021/acsptsci.8b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsptsci.8b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvF2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2019&pages=52-65&author=A.+Bonifaziauthor=H.+Yanoauthor=A.+M.+Guerreroauthor=V.+Kumarauthor=A.+F.+Hoffmanauthor=C.+R.+Lupicaauthor=L.+Shiauthor=A.+H.+Newman&title=Novel+and+potent+dopamine+D2+receptor+Go-protein+biased+agonists&doi=10.1021%2Facsptsci.8b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Potent Dopamine D2 Receptor Go-Protein Biased Agonists</span></div><div class="casAuthors">Bonifazi, Alessandro; Yano, Hideaki; Guerrero, Adrian M.; Kumar, Vivek; Hoffman, Alexander F.; Lupica, Carl R.; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">ACS Pharmacology & Translational Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-65</span>CODEN:
                <span class="NLM_cas:coden">APTSFN</span>;
        ISSN:<span class="NLM_cas:issn">2575-9108</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of functionally biased and physiol. beneficial ligands directed toward G-protein coupled receptors (GPCRs) has provided the impetus to design dopamine D2 receptor (D2R) targeted mols. that may be therapeutically advantageous for the treatment of certain neuropsychiatric or basal ganglia related disorders.  Here we describe the synthesis of a novel series of D2R agonists linking the D2R unbiased agonist sumanirole with privileged secondary mol. fragments.  The resulting ligands demonstrate improved D2R affinity and selectivity over sumanirole.  Extensive in vitro functional studies and bias factor anal. led to the identification of a novel class of highly potent Go-protein biased full D2R agonists with more than 10-fold and 1000-fold bias selectivity toward activation of specific G-protein subtypes and β-arrestin, resp.  Intracellular electrophysiol. recordings from midbrain dopamine neurons demonstrated that Go-protein selective agonists can elicit prolonged ligand-induced GIRK activity via D2Rs, which may be beneficial in the treatment of dyskinesias assocd. with dopamine system dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNIFl-FnvXCrVg90H21EOLACvtfcHk0lhj5VfqFyRGHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvF2nuw%253D%253D&md5=5b67e76002f6ceb85293c961f698722a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsptsci.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsptsci.8b00060%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DGuerrero%26aufirst%3DA.%2BM.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DHoffman%26aufirst%3DA.%2BF.%26aulast%3DLupica%26aufirst%3DC.%2BR.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520and%2520potent%2520dopamine%2520D2%2520receptor%2520Go-protein%2520biased%2520agonists%26jtitle%3DACS%2520Pharmacol.%2520Transl.%2520Sci.%26date%3D2019%26volume%3D2%26spage%3D52%26epage%3D65%26doi%3D10.1021%2Facsptsci.8b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span> <span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1124/pr.110.002642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.+M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors&doi=10.1124%2Fpr.110.002642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lgnabFTtDkEcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217%26doi%3D10.1124%2Fpr.110.002642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the D<sub>2</sub> dopamine receptor bound to the atypical antipsychotic drug risperidone</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature25758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnature25758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29466326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2018&pages=269-273&author=S.+Wangauthor=T.+Cheauthor=A.+Levitauthor=B.+K.+Shoichetauthor=D.+Wackerauthor=B.+L.+Roth&title=Structure+of+the+D2+dopamine+receptor+bound+to+the+atypical+antipsychotic+drug+risperidone&doi=10.1038%2Fnature25758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone</span></div><div class="casAuthors">Wang, Sheng; Che, Tao; Levit, Anat; Shoichet, Brian K.; Wacker, Daniel; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">7695</span>),
    <span class="NLM_cas:pages">269-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metab. and hormonal secretion.  Correspondingly, dysregulation of the dopaminergic system has been implicated in diseases such as schizophrenia, Parkinson's disease, depression, attention deficit hyperactivity disorder, and nausea and vomiting.  The actions of dopamine are mediated by a family of five G-protein-coupled receptors.  The D2 dopamine receptor (DRD2) is the primary target for both typical and atypical antipsychotic drugs, and for drugs used to treat Parkinson's disease.  Unfortunately, many drugs that target DRD2 cause serious and potentially life-threatening side effects due to promiscuous activities against related receptors.  Accordingly, a mol. understanding of the structure and function of DRD2 could provide a template for the design of safer and more effective medications.  Here we report the crystal structure of DRD2 in complex with the widely prescribed atypical antipsychotic drug risperidone.  The DRD2-risperidone structure reveals an unexpected mode of antipsychotic drug binding to dopamine receptors, and highlights structural determinants that are essential for the actions of risperidone and related drugs at DRD2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeo4Ov49kft7Vg90H21EOLACvtfcHk0lgnabFTtDkEcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKqt7c%253D&md5=2842adc1893293ea8dbf98ae3270a1b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnature25758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25758%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520of%2520the%2520D2%2520dopamine%2520receptor%2520bound%2520to%2520the%2520atypical%2520antipsychotic%2520drug%2520risperidone%26jtitle%3DNature%26date%3D2018%26volume%3D555%26spage%3D269%26epage%3D273%26doi%3D10.1038%2Fnature25758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Structure-functional selectivity relationship studies of beta-arrestin-biased dopamine D(2) receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7141</span>– <span class="NLM_lpage">7153</span>, <span class="refDoi"> DOI: 10.1021/jm300603y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300603y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWhsbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7141-7153&author=X.+Chenauthor=M.+F.+Sassanoauthor=L.+Zhengauthor=V.+Setolaauthor=M.+Chenauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=B.+L.+Rothauthor=J.+Jin&title=Structure-functional+selectivity+relationship+studies+of+beta-arrestin-biased+dopamine+D%282%29+receptor+agonists&doi=10.1021%2Fjm300603y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists</span></div><div class="casAuthors">Chen, Xin; Sassano, Maria F.; Zheng, Lianyou; Setola, Vincent; Chen, Meng; Bai, Xu; Frye, Stephen V.; Wetsel, William C.; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7141-7153</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Functionally selective G protein-coupled receptor (GPCR) ligands, which differentially modulate canonical and noncanonical signaling, are extremely useful for elucidating key signal transduction pathways essential for both the therapeutic actions and side effects of drugs.  However, few such ligands have been created, and very little purposeful attention has been devoted to studying what we term: "structure-functional selectivity relationships" (SFSR).  We recently disclosed the first β-arrestin-biased dopamine D2 receptor (D2R) agonists UNC9975 (44) and UNC9994 (36), which have robust in vivo antipsychotic drug-like activities.  Here we report the first comprehensive SFSR studies focused on exploring four regions of the aripiprazole scaffold, which resulted in the discovery of these β-arrestin-biased D2R agonists.  These studies provide a successful proof-of-concept for how functionally selective ligands can be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwoG1fasQ6GLVg90H21EOLACvtfcHk0lgnabFTtDkEcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWhsbfK&md5=00b0613e62ce7b5a4c98cb5212fea3b5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm300603y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300603y%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DStructure-functional%2520selectivity%2520relationship%2520studies%2520of%2520beta-arrestin-biased%2520dopamine%2520D%25282%2529%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7141%26epage%3D7153%26doi%3D10.1021%2Fjm300603y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of G protein-biased D<sub>2</sub> dopamine receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10601</span>– <span class="NLM_lpage">10618</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10601-10618&author=X.+Chenauthor=J.+D.+McCorvyauthor=M.+G.+Fischerauthor=K.+V.+Butlerauthor=Y.+Shenauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+G+protein-biased+D2+dopamine+receptor+partial+agonists&doi=10.1021%2Facs.jmedchem.6b01208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists</span></div><div class="casAuthors">Chen, Xin; McCorvy, John D.; Fischer, Matthew G.; Butler, Kyle V.; Shen, Yudao; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10601-10618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Biased ligands (also known as functionally selective ligands) of G protein-coupled receptors are valuable tools for dissecting the roles of G protein-dependent and independent signaling pathways in health and disease.  Biased ligands have also been increasingly pursued by the biomedical community as promising therapeutics with improved efficacy and reduced side effects compared with unbiased ligands.  The authors previously discovered first-in-class β-arrestin-biased agonists of dopamine D2 receptor (D2R) by extensively exploring multiple regions of aripiprazole, a balanced D2R agonist.  In the authors' continuing efforts to identify biased agonists of D2R, the authors unexpectedly discovered a G protein-biased agonist of D2R, compd. 1 (5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-methylbenzo[d]thiazole), which is the first G protein-biased D2R agonist from the aripiprazole scaffold.  The authors designed and synthesized novel analogs to explore two regions of 1 and conducted structure-functional selectivity relationship (SFSR) studies.  Here the authors report the discovery of 1, findings from the authors' SFSR studies, and characterization of novel G protein-biased D2R agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeKlhGCqSPxLVg90H21EOLACvtfcHk0lgI9Cb707Jnkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqs7vK&md5=81b1435b1ae82438aa3f270f7ee4f853</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DFischer%26aufirst%3DM.%2BG.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520G%2520protein-biased%2520D2%2520dopamine%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10601%26epage%3D10618%26doi%3D10.1021%2Facs.jmedchem.6b01208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structure-inspired design of beta-arrestin-biased ligands for aminergic GPCRs</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnchembio.2527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29227473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=126-134&author=J.+D.+McCorvyauthor=K.+V.+Butlerauthor=B.+Kellyauthor=K.+Rechsteinerauthor=J.+Karpiakauthor=R.+M.+Betzauthor=B.+L.+Kormosauthor=B.+K.+Shoichetauthor=R.+O.+Drorauthor=J.+Jinauthor=B.+L.+Roth&title=Structure-inspired+design+of+beta-arrestin-biased+ligands+for+aminergic+GPCRs&doi=10.1038%2Fnchembio.2527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs</span></div><div class="casAuthors">McCorvy, John D.; Butler, Kyle V.; Kelly, Brendan; Rechsteiner, Katie; Karpiak, Joel; Betz, Robin M.; Kormos, Bethany L.; Shoichet, Brian K.; Dror, Ron O.; Jin, Jian; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-134</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Development of biased ligands targeting G protein-coupled receptors (GPCRs) is a promising approach for current drug discovery.  Although structure-based drug design of biased agonists remains challenging even with an abundance of GPCR crystal structures, the authors present an approach for translating GPCR structural data into β-arrestin-biased ligands for aminergic GPCRs.  The authors identified specific amino acid-ligand contacts at transmembrane helix 5 (TM5) and extracellular loop 2 (EL2) responsible for Gi/o and β-arrestin signaling, resp., and targeted those residues to develop biased ligands.  For these ligands, the authors found that bias is conserved at other aminergic GPCRs that retain similar residues at TM5 and EL2.  The authors' approach provides a template for generating arrestin-biased ligands by modifying predicted ligand interactions that block TM5 interactions and promote EL2 interactions.  This strategy may facilitate the structure-guided design of arrestin-biased ligands at other GPCRs, including polypharmacol. biased ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVs9TaoxiFubVg90H21EOLACvtfcHk0lgI9Cb707Jnkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGmur3I&md5=2725e8487638cc07ce5e6a655fcd29f2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2527%26sid%3Dliteratum%253Aachs%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKelly%26aufirst%3DB.%26aulast%3DRechsteiner%26aufirst%3DK.%26aulast%3DKarpiak%26aufirst%3DJ.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure-inspired%2520design%2520of%2520beta-arrestin-biased%2520ligands%2520for%2520aminergic%2520GPCRs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D126%26epage%3D134%26doi%3D10.1038%2Fnchembio.2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span> <span> </span><span class="NLM_article-title">The ants go marching two by two: oligomeric structure of G-protein-coupled receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1082</span>, <span class="refDoi"> DOI: 10.1124/mol.104.006320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fmol.104.006320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1077-1082&author=J.+A.+Javitch&title=The+ants+go+marching+two+by+two%3A+oligomeric+structure+of+G-protein-coupled+receptors&doi=10.1124%2Fmol.104.006320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.006320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.006320%26sid%3Dliteratum%253Aachs%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520ants%2520go%2520marching%2520two%2520by%2520two%253A%2520oligomeric%2520structure%2520of%2520G-protein-coupled%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1077%26epage%3D1082%26doi%3D10.1124%2Fmol.104.006320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mottola, D. M.</span></span> <span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D<sub>2</sub> receptors linked to adenylate cyclase</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1124/jpet.301.3.1166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.301.3.1166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=12023552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1166-1178&author=D.+M.+Mottola&title=Functional+selectivity+of+dopamine+receptor+agonists.+I.+Selective+activation+of+postsynaptic+dopamine+D2+receptors+linked+to+adenylate+cyclase&doi=10.1124%2Fjpet.301.3.1166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span></div><div class="casAuthors">Mottola, David M.; Kilts, Jason D.; Lewis, Mechelle M.; Connory, Hilary S.; Walker, Q. David; Jones, Sara R.; Booth, Raymond G.; Hyslop, Deborah K.; Piercey, Monford; Wightman, R. Mark; Lawler, Cindy P.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1166-1179</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dihydrexidine (DHX), the first high-affinity D1 dopamine receptor full agonist, is only 10-fold selective for D1 vs. D2 receptors, having D2 affinity similar to the prototypical agonist quinpirole.  The D2 functional properties of DHX and its more D2 selective analog N-n-propyl-dihydrexidine (PrDHX) were explored in rat brain and pituitary.  DHX and PrDHX had binding characteristics to D2 receptors in rat striatum typical of D2 agonists, binding to both high- and low-affinity sites and being sensitive to guanine-nucleotides.  Consistent with these binding data, both DHX and PrDHX inhibited forskolin-stimulated cAMP synthesis in striatum with a potency and intrinsic activity equiv. to that of quinpirole.  Unexpectedly, however, DHX and PrDHX had little functional effect at D2 receptors expressed on dopaminergic neurons that mediate inhibition of cell firing, dopamine release, or dopamine synthesis.  Quant. receptor competition autoradiog. demonstrated that DHX bound to D2 receptors in striatum (predominantly postsynaptic receptor sites) with equal affinity as D2 sites in the substantia nigra (autoreceptor sites).  The data from these expts., coupled with what is known about the location of specific dopamine receptor isoforms, lead to the hypothesis that DHX, after binding to D2L and D2S receptors, causes agonist-typical functional changes only at some of these receptors.  This phenomenon (herein termed "functional selectivity") suggests that drugs may be targeted not only at specific receptor isoforms but also at sep. functions mediated by a single isoform, yielding novel approaches to drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpif5JbU-Rs9bVg90H21EOLACvtfcHk0lgI9Cb707Jnkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D&md5=b1d65ec3f66b3652deb9f9a4c76b70a3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1166%26sid%3Dliteratum%253Aachs%26aulast%3DMottola%26aufirst%3DD.%2BM.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520I.%2520Selective%2520activation%2520of%2520postsynaptic%2520dopamine%2520D2%2520receptors%2520linked%2520to%2520adenylate%2520cyclase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1166%26epage%3D1178%26doi%3D10.1124%2Fjpet.301.3.1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D<sub>2</sub>L receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1124/mol.110.068106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fmol.110.068106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=575-585&author=N.+Tschammerauthor=S.+Bollingerauthor=T.+Kenakinauthor=P.+Gmeiner&title=Histidine+6.55+is+a+major+determinant+of+ligand-biased+signaling+in+dopamine+D2L+receptor&doi=10.1124%2Fmol.110.068106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.068106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.068106%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DBollinger%26aufirst%3DS.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHistidine%25206.55%2520is%2520a%2520major%2520determinant%2520of%2520ligand-biased%2520signaling%2520in%2520dopamine%2520D2L%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D575%26epage%3D585%26doi%3D10.1124%2Fmol.110.068106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Free, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meade, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulcey, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant-Genevier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a G protein-biased agonist that inhibits beta-arrestin recruitment to the D<sub>2</sub> dopamine receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1124/mol.113.090563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fmol.113.090563" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=96-105&author=R.+B.+Freeauthor=L.+S.+Chunauthor=A.+E.+Moritzauthor=B.+N.+Millerauthor=T.+B.+Doyleauthor=J.+L.+Conroyauthor=A.+Padronauthor=J.+A.+Meadeauthor=J.+Xiaoauthor=X.+Huauthor=A.+E.+Dulceyauthor=Y.+Hanauthor=L.+Duanauthor=S.+Titusauthor=M.+Bryant-Genevierauthor=E.+Barnaevaauthor=M.+Ferrerauthor=J.+A.+Javitchauthor=T.+Beumingauthor=L.+Shiauthor=N.+T.+Southallauthor=J.+J.+Maruganauthor=D.+R.+Sibley&title=Discovery+and+characterization+of+a+G+protein-biased+agonist+that+inhibits+beta-arrestin+recruitment+to+the+D2+dopamine+receptor&doi=10.1124%2Fmol.113.090563"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.090563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.090563%26sid%3Dliteratum%253Aachs%26aulast%3DFree%26aufirst%3DR.%2BB.%26aulast%3DChun%26aufirst%3DL.%2BS.%26aulast%3DMoritz%26aufirst%3DA.%2BE.%26aulast%3DMiller%26aufirst%3DB.%2BN.%26aulast%3DDoyle%26aufirst%3DT.%2BB.%26aulast%3DConroy%26aufirst%3DJ.%2BL.%26aulast%3DPadron%26aufirst%3DA.%26aulast%3DMeade%26aufirst%3DJ.%2BA.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DDulcey%26aufirst%3DA.%2BE.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DTitus%26aufirst%3DS.%26aulast%3DBryant-Genevier%26aufirst%3DM.%26aulast%3DBarnaeva%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSouthall%26aufirst%3DN.%2BT.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520G%2520protein-biased%2520agonist%2520that%2520inhibits%2520beta-arrestin%2520recruitment%2520to%2520the%2520D2%2520dopamine%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D96%26epage%3D105%26doi%3D10.1124%2Fmol.113.090563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshitake, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichinose, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshitake, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyertyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adham, N.</span></span> <span> </span><span class="NLM_article-title">Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">1593</span>– <span class="NLM_lpage">1607</span>, <span class="refDoi"> DOI: 10.1007/s00213-018-4874-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1007%2Fs00213-018-4874-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29637288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntlCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2018&pages=1593-1607&author=J.+Kehrauthor=T.+Yoshitakeauthor=F.+Ichinoseauthor=S.+Yoshitakeauthor=B.+Kissauthor=I.+Gyertyanauthor=N.+Adham&title=Effects+of+cariprazine+on+extracellular+levels+of+glutamate%2C+GABA%2C+dopamine%2C+noradrenaline+and+serotonin+in+the+medial+prefrontal+cortex+in+the+rat+phencyclidine+model+of+schizophrenia+studied+by+microdialysis+and+simultaneous+recordings+of+locomotor+activity&doi=10.1007%2Fs00213-018-4874-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity</span></div><div class="casAuthors">Kehr, Jan; Yoshitake, Takashi; Ichinose, Fumio; Yoshitake, Shimako; Kiss, Bela; Gyertyan, Istvan; Adham, Nika</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1593-1607</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Aberrant glutamatergic, dopaminergic, and GABAergic neurotransmission has been implicated in schizophrenia.  Cariprazine reverses the behavioral effects obsd. in the rat phencyclidine (PCP)-induced model of schizophrenia; however, little is known about its in vivo neurochem.  Objectives: The study aims to compare the effects of cariprazine and aripiprazole on PCP-induced changes in the extracellular levels of glutamate, dopamine, serotonin, noradrenaline, and GABA in the rat medial prefrontal cortex (mPFC), and on locomotor activation.  Methods: Microdialysis was performed in awake rats with probes placed into the mPFC.  Rats (n = 7/group) received vehicle (saline), cariprazine (0.05, 0.2, or 0.8 mg/kg), or aripiprazole (3 or 20 mg/kg) via gavage.  After 60 min, 5 mg/kg PCP was administered i.p. (i.p.).  Samples were taken before drug administration, during pretreatment, and after PCP injection.  Locomotor activity recording and microdialysis sampling occurred simultaneously.  Results: PCP treatment increased extracellular levels of all the neurotransmitters tested except GABA, for which there were no significant changes.  Cariprazine and aripiprazole dose-dependently inhibited the PCP-induced increases of tested neurotransmitters.  Overall effects were significant for higher cariprazine doses and both aripiprazole doses for glutamate and noradrenaline, for higher cariprazine doses and 20 mg/kg aripiprazole for dopamine, and for 0.8 mg/kg cariprazine and 20 mg/kg aripiprazole for serotonin and locomotor activity.  Conclusion: Both cariprazine and aripiprazole dose-dependently attenuated PCP-induced hyperlocomotion and acute increases in glutamate, dopamine, noradrenaline, and serotonin levels in the mPFC; cariprazine was approx. 5-fold more potent than aripiprazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyoFEZIupSQ7Vg90H21EOLACvtfcHk0lgm4qe2n_-lwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntlCisLs%253D&md5=3e26d680cccb822d23518dcd8a4ce360</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00213-018-4874-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-018-4874-z%26sid%3Dliteratum%253Aachs%26aulast%3DKehr%26aufirst%3DJ.%26aulast%3DYoshitake%26aufirst%3DT.%26aulast%3DIchinose%26aufirst%3DF.%26aulast%3DYoshitake%26aufirst%3DS.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DAdham%26aufirst%3DN.%26atitle%3DEffects%2520of%2520cariprazine%2520on%2520extracellular%2520levels%2520of%2520glutamate%252C%2520GABA%252C%2520dopamine%252C%2520noradrenaline%2520and%2520serotonin%2520in%2520the%2520medial%2520prefrontal%2520cortex%2520in%2520the%2520rat%2520phencyclidine%2520model%2520of%2520schizophrenia%2520studied%2520by%2520microdialysis%2520and%2520simultaneous%2520recordings%2520of%2520locomotor%2520activity%26jtitle%3DPsychopharmacology%26date%3D2018%26volume%3D235%26spage%3D1593%26epage%3D1607%26doi%3D10.1007%2Fs00213-018-4874-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diduch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C.</span></span> <span> </span><span class="NLM_article-title">Review of cariprazine in management of psychiatric illness</span>. <i>Ment. Health Clin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.9740/mhc.2017.09.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.9740%2Fmhc.2017.09.221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29955527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FjtVyqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=221-229&author=R.+H.+Campbellauthor=M.+Diduchauthor=K.+N.+Gardnerauthor=C.+Thomas&title=Review+of+cariprazine+in+management+of+psychiatric+illness&doi=10.9740%2Fmhc.2017.09.221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Review of cariprazine in management of psychiatric illness</span></div><div class="casAuthors">Campbell Rebecca H; Diduch Michael; Gardner Kristen N; Thomas Christopher</div><div class="citationInfo"><span class="NLM_cas:title">The mental health clinician</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">221-229</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Schizophrenia and bipolar disorder are severe and debilitating psychiatric disorders.  Despite the availability of numerous antipsychotic drugs, many patients still experience poor outcomes and treatment-limiting adverse side effects.  Cariprazine is a novel antipsychotic with unique pharmacodynamic and pharmacokinetic properties.  It is both a dopamine type 2 and dopamine type 3 partial agonist with 2 equipotent metabolites, desmethyl cariprazine and didesmethyl cariprazine, of which didesmethyl cariprazine has a half-life of 1 to 3 weeks.  The objective of this article is to review the literature regarding efficacy and tolerability of cariprazine in the management of psychiatric disorders to determine its current place in therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLMvzSzveQ3DEwO064Z95rfW6udTcc2ebCYHpPknyZ8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FjtVyqtQ%253D%253D&md5=4e77980d23dd7dfba03dfd2c1598df8c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.9740%2Fmhc.2017.09.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.9740%252Fmhc.2017.09.221%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DR.%2BH.%26aulast%3DDiduch%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DK.%2BN.%26aulast%3DThomas%26aufirst%3DC.%26atitle%3DReview%2520of%2520cariprazine%2520in%2520management%2520of%2520psychiatric%2520illness%26jtitle%3DMent.%2520Health%2520Clin.%26date%3D2017%26volume%3D7%26spage%3D221%26epage%3D229%26doi%3D10.9740%2Fmhc.2017.09.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguère, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciaky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnsmb.3014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=25895059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=362-369&author=W.+K.+Kroezeauthor=M.+F.+Sassanoauthor=X.-P.+Huangauthor=K.+Lansuauthor=J.+D.+McCorvyauthor=P.+M.+Gigu%C3%A8reauthor=N.+Sciakyauthor=B.+L.+Roth&title=PRESTO-Tango+as+an+open-source+resource+for+interrogation+of+the+druggable+human+GPCRome&doi=10.1038%2Fnsmb.3014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span></div><div class="casAuthors">Kroeze, Wesley K.; Sassano, Maria F.; Huang, Xi-Ping; Lansu, Katherine; McCorvy, John D.; Giguere, Patrick M.; Sciaky, Noah; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-369</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and are important targets of drug action.  Of the approx. 350 nonolfactory human GPCRs, more than 100 are still considered to be 'orphans' because their endogenous ligands remain unknown.  Here, we describe a unique open-source resource that allows interrogation of the druggable human GPCRome via a G protein-independent β-arrestin-recruitment assay.  We validate this unique platform at more than 120 nonorphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs and describe a method (parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation (PRESTO-Tango)) for the simultaneous and parallel interrogation of the entire human nonolfactory GPCRome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbl7caV9gUrVg90H21EOLACvtfcHk0lgPtRBRcWpJ2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D&md5=2a78b74a5f1425fa9e8b79b730c16be6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3014%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGigu%25C3%25A8re%26aufirst%3DP.%2BM.%26aulast%3DSciaky%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DPRESTO-Tango%2520as%2520an%2520open-source%2520resource%2520for%2520interrogation%2520of%2520the%2520druggable%2520human%2520GPCRome%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D362%26epage%3D369%26doi%3D10.1038%2Fnsmb.3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stemp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashmeade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadley, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thewlis, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vong, A. K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avenell, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyfield, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middlemiss, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reavill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routledge, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D<sub>3</sub> receptor antagonist with high oral bioavailability and CNS penetration in the rat</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1878</span>– <span class="NLM_lpage">1885</span>, <span class="refDoi"> DOI: 10.1021/jm000090i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000090i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVKksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1878-1885&author=G.+Stempauthor=T.+Ashmeadeauthor=C.+L.+Branchauthor=M.+S.+Hadleyauthor=A.+J.+Hunterauthor=C.+N.+Johnsonauthor=D.+J.+Nashauthor=K.+M.+Thewlisauthor=A.+K.+K.+Vongauthor=N.+E.+Austinauthor=P.+Jeffreyauthor=K.+Y.+Avenellauthor=I.+Boyfieldauthor=J.+J.+Haganauthor=D.+N.+Middlemissauthor=C.+Reavillauthor=G.+J.+Rileyauthor=C.+Routledgeauthor=M.+Wood&title=Design+and+synthesis+of+trans-N-%5B4-%5B2-%286-cyano-1%2C2%2C3%2C4-tetrahydroisoquinolin-2-yl%29ethyl%5Dcyclohexyl%5D-4-quinolinecarboxamide+%28SB-277011%29%3A+A+potent+and+selective+dopamine+D3+receptor+antagonist+with+high+oral+bioavailability+and+CNS+penetration+in+the+rat&doi=10.1021%2Fjm000090i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of trans-N-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat</span></div><div class="casAuthors">Stemp, Geoffrey; Ashmeade, Tracey; Branch, Clive L.; Hadley, Michael S.; Hunter, A. Jacqueline; Johnson, Christopher N.; Nash, David J.; Thewlis, Kevin M.; Vong, Antonio K. K.; Austin, Nigel E.; Jeffrey, Phillip; Avenell, Kim Y.; Boyfield, Izzy; Hagan, Jim J.; Middlemiss, Derek N.; Reavill, Charlie; Riley, Graham J.; Routledge, Carole; Wood, Martyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1878-1885</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A selective dopamine D3 receptor antagonist offers the potential for an effective antipsychotic therapy, free of the serious side effects of currently available drugs.  Using clearance and brain penetration studies as a screen, a series of 1,2,3,4-tetrahydroisoquinolines, exemplified by (I), was identified with high D3 affinity and selectivity against the D2 receptor.  Following examn. of mol. models, the flexible Bu linker present in I was replaced by a more conformationally constrained cyclohexylethyl linker, leading to compds. with improved oral bioavailability and selectivity over other receptors.  Subsequent optimization of this new series to improve the cytochrome P 450 inhibitory profile and CNS penetration gave trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011).  This compd. is a potent and selective dopamine D3 receptor antagonist with high oral bioavailability and brain penetration in the rat and represents an excellent new chem. tool for the investigation of the role of the dopamine D3 receptor in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXG1k3rEOlYLVg90H21EOLACvtfcHk0lgPtRBRcWpJ2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVKksLw%253D&md5=0b44d738bbd9d27d6a0fbc5e8333f0df</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm000090i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000090i%26sid%3Dliteratum%253Aachs%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DAshmeade%26aufirst%3DT.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHunter%26aufirst%3DA.%2BJ.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DNash%26aufirst%3DD.%2BJ.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DAvenell%26aufirst%3DK.%2BY.%26aulast%3DBoyfield%26aufirst%3DI.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DReavill%26aufirst%3DC.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DRoutledge%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520trans-N-%255B4-%255B2-%25286-cyano-1%252C2%252C3%252C4-tetrahydroisoquinolin-2-yl%2529ethyl%255Dcyclohexyl%255D-4-quinolinecarboxamide%2520%2528SB-277011%2529%253A%2520A%2520potent%2520and%2520selective%2520dopamine%2520D3%2520receptor%2520antagonist%2520with%2520high%2520oral%2520bioavailability%2520and%2520CNS%2520penetration%2520in%2520the%2520rat%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1878%26epage%3D1885%26doi%3D10.1021%2Fjm000090i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klein
Herenbrink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donthamsetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudrat, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shonberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span> <span> </span><span class="NLM_article-title">The role of kinetic context in apparent biased agonism at GPCRs</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">10842</span> <span class="refDoi"> DOI: 10.1038/ncomms10842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fncomms10842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=26905976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1emtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=C.+Klein%0AHerenbrinkauthor=D.+A.+Sykesauthor=P.+Donthamsettiauthor=M.+Canalsauthor=T.+Coudratauthor=J.+Shonbergauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=P.+M.+Sextonauthor=S.+J.+Charltonauthor=J.+A.+Javitchauthor=A.+Christopoulosauthor=J.+R.+Lane&title=The+role+of+kinetic+context+in+apparent+biased+agonism+at+GPCRs&doi=10.1038%2Fncomms10842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The role of kinetic context in apparent biased agonism at GPCRs</span></div><div class="casAuthors">Klein Herenbrink, Carmen; Sykes, David A.; Donthamsetti, Prashant; Canals, Meritxell; Coudrat, Thomas; Shonberg, Jeremy; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Charlton, Steven J.; Javitch, Jonathan A.; Christopoulos, Arthur; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10842</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Biased agonism describes the ability of ligands to stabilize different conformations of a GPCR linked to distinct functional outcomes and offers the prospect of designing pathway-specific drugs that avoid on-target side effects.  This mechanism is usually inferred from pharmacol. data with the assumption that the confounding influences of observational (i.e., assay dependent) and system (i.e., cell background dependent) bias are excluded by exptl. design and anal.  Here we reveal that 'kinetic context', as detd. by ligand-binding kinetics and the temporal pattern of receptor-signalling processes, can have a profound influence on the apparent bias of a series of agonists for the dopamine D2 receptor and can even lead to reversals in the direction of bias.  We propose that kinetic context must be acknowledged in the design and interpretation of studies of biased agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoboe6-_23rF7Vg90H21EOLACvtfcHk0ljGk98YuBA5pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1emtbk%253D&md5=3afdebd5ad1c8a8b1db93478e9b2c7d4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fncomms10842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10842%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%2BHerenbrink%26aufirst%3DC.%26aulast%3DSykes%26aufirst%3DD.%2BA.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DCoudrat%26aufirst%3DT.%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520role%2520of%2520kinetic%2520context%2520in%2520apparent%2520biased%2520agonism%2520at%2520GPCRs%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fncomms10842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salahpour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didriksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghisi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Antagonism of dopamine D<sub>2</sub> receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">13656</span>– <span class="NLM_lpage">13661</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803522105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1073%2Fpnas.0803522105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13656-13661&author=B.+Masriauthor=A.+Salahpourauthor=M.+Didriksenauthor=V.+Ghisiauthor=J.+M.+Beaulieuauthor=R.+R.+Gainetdinovauthor=M.+G.+Caron&title=Antagonism+of+dopamine+D2+receptor%2Fbeta-arrestin+2+interaction+is+a+common+property+of+clinically+effective+antipsychotics&doi=10.1073%2Fpnas.0803522105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803522105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803522105%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DB.%26aulast%3DSalahpour%26aufirst%3DA.%26aulast%3DDidriksen%26aufirst%3DM.%26aulast%3DGhisi%26aufirst%3DV.%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAntagonism%2520of%2520dopamine%2520D2%2520receptor%252Fbeta-arrestin%25202%2520interaction%2520is%2520a%2520common%2520property%2520of%2520clinically%2520effective%2520antipsychotics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D13656%26epage%3D13661%26doi%3D10.1073%2Fpnas.0803522105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuho, I.</span>; <span class="NLM_string-name">Martemyanov, K. A.</span>; <span class="NLM_string-name">Lambert, N. A.</span></span> <span> </span><span class="NLM_article-title">Monitoring G protein activation in cells with BRET</span>. In  <i>G Protein-Coupled Receptors in Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filizola, M.</span></span>, Ed.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">NY</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">1335</span>, pp  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">113</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1007%2F978-1-4939-2914-6_8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=107-113&author=I.+Masuho&author=K.+A.+Martemyanov&author=N.+A.+Lambertauthor=M.+Filizola&title=G+Protein-Coupled+Receptors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2914-6_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4939-2914-6_8%26sid%3Dliteratum%253Aachs%26aulast%3DMasuho%26aufirst%3DI.%26atitle%3DMonitoring%2520G%2520protein%2520activation%2520in%2520cells%2520with%2520BRET%26btitle%3DG%2520Protein-Coupled%2520Receptors%2520in%2520Drug%2520Discovery%26aulast%3DFilizola%26aufirst%3DM.%26pub%3DHumana%2520Press%26date%3D2015%26volume%3D1335%26spage%3D107%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chun, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekariya, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Free, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namkung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laporte, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aube, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankowski, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity investigation of a G protein-biased agonist reveals molecular determinants for biased signaling of the D<sub>2</sub> dopamine receptor</span>. <i>Front. Synaptic Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">2</span> <span class="refDoi"> DOI: 10.3389/fnsyn.2018.00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.3389%2Ffnsyn.2018.00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29515433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsl2qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=L.+S.+Chunauthor=R.+H.+Vekariyaauthor=R.+B.+Freeauthor=Y.+Liauthor=D.+T.+Linauthor=P.+Suauthor=F.+Liuauthor=Y.+Namkungauthor=S.+A.+Laporteauthor=A.+E.+Moritzauthor=J.+Aubeauthor=K.+J.+Frankowskiauthor=D.+R.+Sibley&title=Structure-activity+investigation+of+a+G+protein-biased+agonist+reveals+molecular+determinants+for+biased+signaling+of+the+D2+dopamine+receptor&doi=10.3389%2Ffnsyn.2018.00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity investigation of a G protein-biased agonist reveals molecular determinants for biased signaling of the D2 dopamine receptor</span></div><div class="casAuthors">Chun, Lani S.; Vekariya, Rakesh H.; Free, R. Benjamin; Li, Yun; Lin, Da-Ting; Su, Ping; Liu, Fang; Namkung, Yoon; Laporte, Stephane A.; Moritz, Amy E.; Aube, Jeffrey; Frankowski, Kevin J.; Sibley, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Synaptic Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2/1-2/18</span>CODEN:
                <span class="NLM_cas:coden">FSNRBS</span>;
        ISSN:<span class="NLM_cas:issn">1663-3563</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The dopamine D2 receptor (D2R) is known to elicit effects through activating two major signaling pathways mediated by either G proteins (Gi/o) or β-arrestins.  However, the specific role of each pathway in physiol. or therapeutic activities is not known with certainty.  One approach to the dissection of these pathways is through the use of drugs that can selectively modulate one pathway vs. the other through a mechanism known as functional selectivity or biased signaling.  Our lab. has previously described a G protein signaling-biased agonist, MLS1547, for the D2R using a variety of in vitro functional assays.  To further evaluate the biased signaling activity of this compd., we investigated its ability to promote D2R internalization, a process known to be mediated by β-arrestin.  Using multiple cellular systems and techniques, we found that MLS1547 promotes little D2R internalization, which is consistent with its inability to recruit β-arrestin.  Importantly, we validated these results in primary striatal neurons where the D2R is most highly expressed suggesting that MLS1547 will exhibit biased signaling activity in vivo.  In an effort to optimize and further explore structure-activity relationships (SAR) for this scaffold, we conducted an iterative chem. campaign to synthesize and characterize novel analogs of MLS1547.  The resulting anal. confirmed previously described SAR requirements for G protein-biased agonist activity and, importantly, elucidated new structural features that are crit. for agonist efficacy and signaling bias of the MLS1547 scaffold.  One of the most important determinants for G protein-biased signaling is the interaction of a hydrophobic moiety of the compd. with a defined pocket formed by residues within transmembrane five and extracellular loop two of the D2R.  These results shed new light on the mechanism of biased signaling of the D2R and may lead to improved functionally-selective mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeVtJsFm0PX7Vg90H21EOLACvtfcHk0ljGk98YuBA5pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsl2qtL0%253D&md5=a0863ff200b0081710af0fac19d992d5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3389%2Ffnsyn.2018.00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnsyn.2018.00002%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DL.%2BS.%26aulast%3DVekariya%26aufirst%3DR.%2BH.%26aulast%3DFree%26aufirst%3DR.%2BB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DD.%2BT.%26aulast%3DSu%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DNamkung%26aufirst%3DY.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26aulast%3DMoritz%26aufirst%3DA.%2BE.%26aulast%3DAube%26aufirst%3DJ.%26aulast%3DFrankowski%26aufirst%3DK.%2BJ.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26atitle%3DStructure-activity%2520investigation%2520of%2520a%2520G%2520protein-biased%2520agonist%2520reveals%2520molecular%2520determinants%2520for%2520biased%2520signaling%2520of%2520the%2520D2%2520dopamine%2520receptor%26jtitle%3DFront.%2520Synaptic%2520Neurosci.%26date%3D2018%26volume%3D10%26doi%3D10.3389%2Ffnsyn.2018.00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agegnehu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tribo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, R. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Structural determinants of 5-HT2B receptor activation and biased agonism</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1038/s41594-018-0116-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fs41594-018-0116-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=30127358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGjtLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=787-796&author=J.+D.+McCorvyauthor=D.+Wackerauthor=S.+Wangauthor=B.+Agegnehuauthor=J.+Liuauthor=K.+Lansuauthor=A.+R.+Triboauthor=R.+H.+J.+Olsenauthor=T.+Cheauthor=J.+Jinauthor=B.+L.+Roth&title=Structural+determinants+of+5-HT2B+receptor+activation+and+biased+agonism&doi=10.1038%2Fs41594-018-0116-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of 5-HT2B receptor activation and biased agonism</span></div><div class="casAuthors">McCorvy, John D.; Wacker, Daniel; Wang, Sheng; Agegnehu, Bemnat; Liu, Jing; Lansu, Katherine; Tribo, Alexandra R.; Olsen, Reid H. J.; Che, Tao; Jin, Jian; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Serotonin (5-hydroxytryptamine; 5-HT) receptors modulate a variety of physiol. processes ranging from perception, cognition and emotion to vascular and smooth muscle contraction, platelet aggregation, gastrointestinal function and reprodn.  Drugs that interact with 5-HT receptors effectively treat diseases as diverse as migraine headaches, depression and obesity.  Here we present four structures of a prototypical serotonin receptor-the human 5-HT2B receptor-in complex with chem. and pharmacol. diverse drugs, including methysergide, methylergonovine, lisuride and LY266097.  A detailed anal. of these structures complemented by comprehensive interrogation of signaling illuminated key structural determinants essential for activation.  Addnl. structure-guided mutagenesis expts. revealed binding pocket residues that were essential for agonist-mediated biased signaling and β-arrestin2 translocation.  Given the importance of 5-HT receptors for a large no. of therapeutic indications, insights derived from these studies should accelerate the design of safer and more effective medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwC5QTOdEZhLVg90H21EOLACvtfcHk0ljGk98YuBA5pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGjtLjM&md5=93be9401bc680249499fa3af5d40f395</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fs41594-018-0116-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-018-0116-7%26sid%3Dliteratum%253Aachs%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DAgegnehu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DTribo%26aufirst%3DA.%2BR.%26aulast%3DOlsen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructural%2520determinants%2520of%25205-HT2B%2520receptor%2520activation%2520and%2520biased%2520agonism%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D787%26epage%3D796%26doi%3D10.1038%2Fs41594-018-0116-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucaites, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threlkeld, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinzie, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, D. L.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo evidence for a lack of interaction with dopamine D<sub>2</sub> receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268)</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1126</span>– <span class="NLM_lpage">1136</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.160598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1124%2Fjpet.109.160598" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=1126-1136&author=M.+J.+Fellauthor=K.+W.+Perryauthor=J.+F.+Falconeauthor=B.+G.+Johnsonauthor=V.+N.+Barthauthor=K.+S.+Rashauthor=V.+L.+Lucaitesauthor=P.+G.+Threlkeldauthor=J.+A.+Monnauthor=D.+L.+McKinzieauthor=G.+J.+Marekauthor=K.+A.+Svenssonauthor=D.+L.+Nelson&title=In+vitro+and+in+vivo+evidence+for+a+lack+of+interaction+with+dopamine+D2+receptors+by+the+metabotropic+glutamate+2%2F3+receptor+agonists+1S%2C2S%2C5R%2C6S-2-aminobicyclo%5B3.1.0%5Dhexane-2%2C6-bicaroxylate+monohydrate+%28LY354740%29+and+%28-%29-2-oxa-4-aminobicyclo%5B3.1.0%5D+Hexane-4%2C6-dicarboxylic+acid+%28LY379268%29&doi=10.1124%2Fjpet.109.160598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160598%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evidence%2520for%2520a%2520lack%2520of%2520interaction%2520with%2520dopamine%2520D2%2520receptors%2520by%2520the%2520metabotropic%2520glutamate%25202%252F3%2520receptor%2520agonists%25201S%252C2S%252C5R%252C6S-2-aminobicyclo%255B3.1.0%255Dhexane-2%252C6-bicaroxylate%2520monohydrate%2520%2528LY354740%2529%2520and%2520%2528-%2529-2-oxa-4-aminobicyclo%255B3.1.0%255D%2520Hexane-4%252C6-dicarboxylic%2520acid%2520%2528LY379268%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D33%26spage%3D1126%26epage%3D1136%26doi%3D10.1124%2Fjpet.109.160598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciaky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1038%2Fnsmb.3014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=25895059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=362-369&author=W.+K.+Kroezeauthor=M.+F.+Sassanoauthor=X.+P.+Huangauthor=K.+Lansuauthor=J.+D.+McCorvyauthor=P.+M.+Giguereauthor=N.+Sciakyauthor=B.+L.+Roth&title=PRESTO-Tango+as+an+open-source+resource+for+interrogation+of+the+druggable+human+GPCRome&doi=10.1038%2Fnsmb.3014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span></div><div class="casAuthors">Kroeze, Wesley K.; Sassano, Maria F.; Huang, Xi-Ping; Lansu, Katherine; McCorvy, John D.; Giguere, Patrick M.; Sciaky, Noah; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-369</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and are important targets of drug action.  Of the approx. 350 nonolfactory human GPCRs, more than 100 are still considered to be 'orphans' because their endogenous ligands remain unknown.  Here, we describe a unique open-source resource that allows interrogation of the druggable human GPCRome via a G protein-independent β-arrestin-recruitment assay.  We validate this unique platform at more than 120 nonorphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs and describe a method (parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation (PRESTO-Tango)) for the simultaneous and parallel interrogation of the entire human nonolfactory GPCRome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbl7caV9gUrVg90H21EOLACvtfcHk0lgv--Q2l7qsrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D&md5=2a78b74a5f1425fa9e8b79b730c16be6</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3014%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGiguere%26aufirst%3DP.%2BM.%26aulast%3DSciaky%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DPRESTO-Tango%2520as%2520an%2520open-source%2520resource%2520for%2520interrogation%2520of%2520the%2520druggable%2520human%2520GPCRome%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D362%26epage%3D369%26doi%3D10.1038%2Fnsmb.3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muniz-Medina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S.</span></span> <span> </span><span class="NLM_article-title">A simple method for quantifying functional selectivity and agonist bias</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1021/cn200111m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=193-203&author=T.+Kenakinauthor=C.+Watsonauthor=V.+Muniz-Medinaauthor=A.+Christopoulosauthor=S.+Novick&title=A+simple+method+for+quantifying+functional+selectivity+and+agonist+bias&doi=10.1021%2Fcn200111m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Method for Quantifying Functional Selectivity and Agonist Bias</span></div><div class="casAuthors">Kenakin, Terry; Watson, Christian; Muniz-Medina, Vanessa; Christopoulos, Arthur; Novick, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of seven-transmembrane (7TM) receptors by agonists does not always lead to uniform activation of all signaling pathways mediated by a given receptor.  Relative to other ligands, many agonists are "biased" toward producing subsets of receptor behaviors.  A hallmark of such "functional selectivity" is cell type dependence; this poses a particular problem for the profiling of agonists in whole cell test systems removed from the therapeutic one(s).  Such response-specific cell-based variability makes it difficult to guide medicinal chem. efforts aimed at identifying and optimizing therapeutically meaningful agonist bias.  For this reason, we present a scale, based on the Black and Leff operational model, that contains the key elements required to describe 7TM agonism, namely, affinity (KA-1) for the receptor and efficacy (τ) in activating a particular signaling pathway.  Utilizing a "transduction coeff." term, log(τ/KA), this scale can statistically evaluate selective agonist effects in a manner that can theor. inform structure-activity studies and/or drug candidate selection matrixes.  The bias of four chemokines for CCR5-mediated inositol phosphate prodn. vs. internalization is quantified to illustrate the practical application of this method.  The independence of this method with respect to receptor d. and the calcn. of statistical ests. of confidence of differences are specifically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxSkELs1bHQLVg90H21EOLACvtfcHk0lgv--Q2l7qsrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtLvN&md5=270841d11f9720caaf3e59a6fe0aee74</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fcn200111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200111m%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DMuniz-Medina%26aufirst%3DV.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DNovick%26aufirst%3DS.%26atitle%3DA%2520simple%2520method%2520for%2520quantifying%2520functional%2520selectivity%2520and%2520agonist%2520bias%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D193%26epage%3D203%26doi%3D10.1021%2Fcn200111m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Ligand pose and orientational sampling in molecular docking</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e75992</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0075992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1371%2Fjournal.pone.0075992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=24098414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyrtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=R.+G.+Colemanauthor=M.+Carchiaauthor=T.+Sterlingauthor=J.+J.+Irwinauthor=B.+K.+Shoichet&title=Ligand+pose+and+orientational+sampling+in+molecular+docking&doi=10.1371%2Fjournal.pone.0075992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand pose and orientational sampling in molecular docking</span></div><div class="casAuthors">Coleman, Ryan G.; Carchia, Michael; Sterling, Teague; Irwin, John J.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e75992</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Mol. docking remains an important tool for structure-based screening to find new ligands and chem. probes.  As docking ambitions grow to include new scoring function terms and to address ever more targets, the reliability and extendability of the orientation sampling and the throughput of the method, become pressing.  Here we explore sampling techniques that eliminate stochastic behavior in DOCK3.6, allowing us to optimize the method for regularly variable sampling of orientations.  This also enabled a focused effort to optimize the code for efficiency, with a three-fold increase in the speed of the program.  This, in turn, facilitated extensive testing of the method on the 102 targets, 22,805 ligands and 1,411,214 decoys of the Directory of Useful Decoys - Enhanced (DUD-E) benchmarking set, at multiple levels of sampling.  Encouragingly, we observe that as sampling increases from 50 to 500 to 2000 to 5000 to 20000 mol. orientations in the binding site (and so from about 1 × 1010 to 4 × 1010 to 1 × 1011 to 2 × 1011 to 5 × 1011 mean atoms scored per target, since multiple conformations are sampled per orientation), the enrichment of ligands over decoys monotonically increases for most DUD-E targets.  Meanwhile, including internal electrostatics in the evaluation ligand conformational energies and restricting arom. hydroxyls to low energy rotamers, further improved enrichment values.  Several of the strategies used here to improve the efficiency of the code are broadly applicable in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfVPNbD-iOR7Vg90H21EOLACvtfcHk0liFtM6pfuwHMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyrtbvE&md5=14ee7e84b0bfab5e646c0a7fea8a20d2</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0075992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0075992%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%2BG.%26aulast%3DCarchia%26aufirst%3DM.%26aulast%3DSterling%26aufirst%3DT.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DLigand%2520pose%2520and%2520orientational%2520sampling%2520in%2520molecular%2520docking%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0075992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Conformation guides molecular efficacy in docking screens of activated beta-2 adrenergic G protein coupled receptor</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1018</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1021/cb400103f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400103f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1018-1026&author=D.+R.+Weissauthor=S.+Ahnauthor=M.+F.+Sassanoauthor=A.+Kleistauthor=X.+Zhuauthor=R.+Strachanauthor=B.+L.+Rothauthor=R.+J.+Lefkowitzauthor=B.+K.+Shoichet&title=Conformation+guides+molecular+efficacy+in+docking+screens+of+activated+beta-2+adrenergic+G+protein+coupled+receptor&doi=10.1021%2Fcb400103f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcb400103f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400103f%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DD.%2BR.%26aulast%3DAhn%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DKleist%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DStrachan%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DConformation%2520guides%2520molecular%2520efficacy%2520in%2520docking%2520screens%2520of%2520activated%2520beta-2%2520adrenergic%2520G%2520protein%2520coupled%2520receptor%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1018%26epage%3D1026%26doi%3D10.1021%2Fcb400103f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Word, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">1735</span>– <span class="NLM_lpage">1747</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1998.2401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1006%2Fjmbi.1998.2401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=9917408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADyaK1MXhtV2ht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=1735-1747&author=J.+M.+Wordauthor=S.+C.+Lovellauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=Asparagine+and+glutamine%3A+using+hydrogen+atom+contacts+in+the+choice+of+side-chain+amide+orientation&doi=10.1006%2Fjmbi.1998.2401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Asparagine and Glutamine: Using Hydrogen Atom Contacts in the Choice of Side-chain Amide Orientation</span></div><div class="casAuthors">Word, J. Michael; Lovell, Simon C.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1735-1747</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Small-probe contact dot surface anal., with all explicit hydrogen atoms added and their van der Waals contacts included, was used to choose between the two possible orientations for each of 1554 asparagine (Asn) and glutamine (Gln) side-chain amide groups in a dataset of 100 unrelated, high-quality protein crystal structures at 0.9 to 1.7 Å resoln.  For the movable-H groups, each connected, closed set of local H-bonds was optimized for both H-bonds and van der Waals overlaps.  In addn. to the Asn/Gln "flips", this process included rotation of OH, SH, NH3+, and methionine Me H atoms, flip and protonation state of histidine rings, interaction with bound ligands, and a simple model of water interactions.  However, except for switching N and O identity for amide flips (or N and C identity for His flips), no non-H atoms were shifted.  Even in these very high-quality structures, about 20 % of the Asn/Gln side-chains required a 180° flip to optimize H-bonding and/or to avoid NH2 clashes with neighboring atoms (incorporating a conservative score penalty which, for marginal cases, favors the assignment in the original coordinate file).  The programs Reduce, Probe, and Mage provide not only a suggested amide orientation, but also a numerical score comparison, a categorization of the marginal cases, and a direct visualization of all relevant interactions in both orientations.  Visual examn. allowed confirmation of the raw score assignment for about 40 % of those Asn/Gln flips placed within the "marginal" penalty range by the automated algorithm, while uncovering only a small no. of cases whose automated assignment was incorrect because of special circumstances not yet handled by the algorithm.  It seems that the H-bond and the at.-clash criteria independently look at the same structural realities: when both criteria gave a clear answer, they agreed every time.  But consideration of van der Waals clashes settled many addnl. cases for which H-bonding was either absent or approx. equiv. for the two main alternatives.  With this extra information, 86 % of all side-chain amide groups could be oriented quite unambiguously.  In the absence of further exptl. data, it would probably be inappropriate to assign many more than this.  Some of the remaining 14 % are ambiguous because of coordinate error or inadequacy of the theor. model, but the great majority of ambiguous cases probably occur as a dynamic mix of both flip states in the actual protein mol.  The software and the 100 coordinate files with all H atoms added and optimized and with amide flips cor. are publicly available.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC6MEkiSKy07Vg90H21EOLACvtfcHk0liFtM6pfuwHMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtV2ht7g%253D&md5=a3bd044a8652a5ac03e2eb7b9414c2e0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2401%26sid%3Dliteratum%253Aachs%26aulast%3DWord%26aufirst%3DJ.%2BM.%26aulast%3DLovell%26aufirst%3DS.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DAsparagine%2520and%2520glutamine%253A%2520using%2520hydrogen%2520atom%2520contacts%2520in%2520the%2520choice%2520of%2520side-chain%2520amide%2520orientation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D285%26spage%3D1735%26epage%3D1747%26doi%3D10.1006%2Fjmbi.1998.2401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Berryman, J. T.</span>; <span class="NLM_string-name">Betz, R. M.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham, T. E.,  III</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Giese, T. J.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A. W.</span>; <span class="NLM_string-name">Homeyer, N.</span>; <span class="NLM_string-name">Izadi, S.</span>; <span class="NLM_string-name">Janowski, P.</span>; <span class="NLM_string-name">Kaus, J.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Madej, B.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Monard, G.</span>; <span class="NLM_string-name">Needham, P.</span>; <span class="NLM_string-name">Nguyen, H.</span>; <span class="NLM_string-name">Nguyen, H. T.</span>; <span class="NLM_string-name">Omelyan, I.</span>; <span class="NLM_string-name">Onufriev, A.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Salomon-Ferrer, R.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Smith, W.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wolf, R.
M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">York, D. M.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> <i>AMBER 2015</i>; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco, CA</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+A.+Case&author=J.+T.+Berryman&author=R.+M.+Betz&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=T.+J.+Giese&author=H.+Gohlke&author=A.+W.+Goetz&author=N.+Homeyer&author=S.+Izadi&author=P.+Janowski&author=J.+Kaus&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=P.+Li&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=K.+M.+Merz&author=G.+Monard&author=P.+Needham&author=H.+Nguyen&author=H.+T.+Nguyen&author=I.+Omelyan&author=A.+Onufriev&author=D.+R.+Roe&author=A.+Roitberg&author=R.+Salomon-Ferrer&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.%0AM.+Wolf&author=X.+Wu&author=D.+M.+York&author=P.+A.+Kollman&title=AMBER+2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%25202015%26pub%3DUniversity%2520of%2520California%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Comparison of automatic three-dimensional model builders using 639 X-ray structures</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1008</span>, <span class="refDoi"> DOI: 10.1021/ci00020a039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci00020a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=1000-1008&author=J.+Sadowskiauthor=J.+Gasteigerauthor=G.+Klebe&title=Comparison+of+automatic+three-dimensional+model+builders+using+639+X-ray+structures&doi=10.1021%2Fci00020a039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures</span></div><div class="casAuthors">Sadowski, Jens; Gasteiger, Johann; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1000-8</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    </div><div class="casAbstract">Several criteria were defined to select a dataset of high-quality x-ray structures from the Cambridge file resulting in 639 mols.  Six currently available programs for automatic 3D structure generation were compared by converting the connectivity tables, including appropriate stereodescriptors from this dataset of 639 mol. structures into 3D geometries: CONCORD, ALCOGEN, Chem-X, MOLGEO, COBRA, and CORINA.  The geometries produced by the different programs were evaluated in terms of several quality criteria and discussed in detail.  These criteria measure how well the different programs reproduce the x-ray geometries of the 639 input structures.  Accordingly, the major strengths and weaknesses of the programs are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8vEtyDrrlq7Vg90H21EOLACvtfcHk0ljSYMpLi5fwlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D&md5=246e4d66f11178a18daad2563c48331c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fci00020a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci00020a039%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DComparison%2520of%2520automatic%2520three-dimensional%2520model%2520builders%2520using%2520639%2520X-ray%2520structures%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D1994%26volume%3D34%26spage%3D1000%26epage%3D1008%26doi%3D10.1021%2Fci00020a039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M. T.</span></span> <span> </span><span class="NLM_article-title">Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1021/ci100031x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100031x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=572-584&author=P.+C.+Hawkinsauthor=A.+G.+Skillmanauthor=G.+L.+Warrenauthor=B.+A.+Ellingsonauthor=M.+T.+Stahl&title=Conformer+generation+with+OMEGA%3A+algorithm+and+validation+using+high+quality+structures+from+the+Protein+Databank+and+Cambridge+Structural+Database&doi=10.1021%2Fci100031x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.; Ellingson, Benjamin A.; Stahl, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present the algorithm and validation for OMEGA, a systematic, knowledge-based conformer generator.  The algorithm consists of three phases: assembly of an initial 3D structure from a library of fragments; exhaustive enumeration of all rotatable torsions using values drawn from a knowledge-based list of angles, thereby generating a large set of conformations; and sampling of this set by geometric and energy criteria.  Validation of conformer generators like OMEGA has often been undertaken by comparing computed conformer sets to exptl. mol. conformations from crystallog., usually from the Protein Databank (PDB).  Such an approach is fraught with difficulty due to the systematic problems with small mol. structures in the PDB.  Methods are presented to identify a diverse set of small mol. structures from cocomplexes in the PDB that has maximal reliability.  A challenging set of 197 high quality, carefully selected ligand structures from well-solved models was obtained using these methods.  This set will provide a sound basis for comparison and validation of conformer generators in the future.  Validation results from this set are compared to the results using structures of a set of druglike mols. extd. from the Cambridge Structural Database (CSD).  OMEGA is found to perform very well in reproducing the crystallog. conformations from both these data sets using two complementary metrics of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1SOwPH1NzrVg90H21EOLACvtfcHk0ljSYMpLi5fwlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D&md5=fb87ecc9c51eddef63b41fffcd9babee</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fci100031x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100031x%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DEllingson%26aufirst%3DB.%2BA.%26aulast%3DStahl%26aufirst%3DM.%2BT.%26atitle%3DConformer%2520generation%2520with%2520OMEGA%253A%2520algorithm%2520and%2520validation%2520using%2520high%2520quality%2520structures%2520from%2520the%2520Protein%2520Databank%2520and%2520Cambridge%2520Structural%2520Database%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D572%26epage%3D584%26doi%3D10.1021%2Fci100031x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truhlar, D. G.</span></span> <span> </span><span class="NLM_article-title">Model for aqueous solvation based on class IV atomic charges and first solvation shell effects</span>. <i>J. Phys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">16385</span>– <span class="NLM_lpage">16398</span>, <span class="refDoi"> DOI: 10.1021/jp9610776</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp9610776" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADyaK28XlsFCqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1996&pages=16385-16398&author=C.+C.+Chambersauthor=G.+D.+Hawkinsauthor=C.+J.+Cramerauthor=D.+G.+Truhlar&title=Model+for+aqueous+solvation+based+on+class+IV+atomic+charges+and+first+solvation+shell+effects&doi=10.1021%2Fjp9610776"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Model for Aqueous Solvation Based on Class IV Atomic Charges and First Solvation Shell Effects</span></div><div class="casAuthors">Chambers, Candee C.; Cramer, Christopher J.; Truhlar, Donald G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16385-16398</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new set of geometry-based functional forms is presented for parameterizing effective Coulomb radii and at. surface tensions of org. solutes in water.  In particular, the radii and surface tensions depend in some cases on distances to nearby atoms.  Combining the surface tensions with electrostatic effects included in a Fock operator by the generalized Born model enables one to calc. free energies of solvation, and exptl. free energies of solvation are used to parametrize the theory for water.  At. charges are obtained by both the AM1-CM1A and PM3-CM1P class IV charge models, which yield similar results, and hence the same radii and surface tensions are used with both charge models.  The authors considered 215 neutral solutes contg. H, C, N, O, F, S, Cl, Br, and I and encompassing a very wide variety of org. functional groups, and a mean unsigned error in the free energy of hydration of 0.50 kcal/mol using CM1A charges and 0.48 kcal/mol using CM1P charges was obtained.  The predicted solvation energies for 12 cationic and 22 anionic solutes have mean unsigned deviations from expt. of 4.6 and 4.8 kcal/mol for models based on AM1 and PM3, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9qoDbYAXHbVg90H21EOLACvtfcHk0ljSYMpLi5fwlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFCqurw%253D&md5=2ff8cd5c0e9d4f37070c0cdf3829fe7e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjp9610776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp9610776%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DC.%2BC.%26aulast%3DHawkins%26aufirst%3DG.%2BD.%26aulast%3DCramer%26aufirst%3DC.%2BJ.%26aulast%3DTruhlar%26aufirst%3DD.%2BG.%26atitle%3DModel%2520for%2520aqueous%2520solvation%2520based%2520on%2520class%2520IV%2520atomic%2520charges%2520and%2520first%2520solvation%2520shell%2520effects%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1996%26volume%3D100%26spage%3D16385%26epage%3D16398%26doi%3D10.1021%2Fjp9610776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitch, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human dopamine D<sub>3</sub> receptor in complex with a D<sub>2</sub>/D<sub>3</sub> selective antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1126/science.1197410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+W.+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+dopamine+D3+receptor+in+complex+with+a+D2%2FD3+selective+antagonist&doi=10.1126%2Fscience.1197410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0lj1C2fiFA0Vng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520in%2520complex%2520with%2520a%2520D2%252FD3%2520selective%2520antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095%26doi%3D10.1126%2Fscience.1197410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">D<sub>4</sub> dopamine receptor high-resolution structures enable the discovery of selective agonists</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1126/science.aan5468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=10.1126%2Fscience.aan5468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=29051383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&pages=381-386&author=S.+Wangauthor=D.+Wackerauthor=A.+Levitauthor=T.+Cheauthor=R.+M.+Betzauthor=J.+D.+McCorvyauthor=A.+J.+Venkatakrishnanauthor=X.+P.+Huangauthor=R.+O.+Drorauthor=B.+K.+Shoichetauthor=B.+L.+Roth&title=D4+dopamine+receptor+high-resolution+structures+enable+the+discovery+of+selective+agonists&doi=10.1126%2Fscience.aan5468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">D4 dopamine receptor high-resolution structures enable the discovery of selective agonists</span></div><div class="casAuthors">Wang, Sheng; Wacker, Daniel; Levit, Anat; Che, Tao; Betz, Robin M.; McCorvy, John D.; Venkatakrishnan, A. J.; Huang, Xi-Ping; Dror, Ron O.; Shoichet, Brian K.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">6361</span>),
    <span class="NLM_cas:pages">381-386</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine receptors are implicated in the pathogenesis and treatment of nearly every neuropsychiatric disorder.  Although thousands of drugs interact with these receptors, our mol. understanding of dopaminergic drug selectivity and design remains clouded.  To illuminate dopamine receptor structure, function, and ligand recognition, we detd. crystal structures of the D4 dopamine receptor in its inactive state bound to the antipsychotic drug nemonapride, with resolns. up to 1.95 angstroms.  These structures suggest a mechanism for the control of constitutive signaling, and their unusually high resoln. enabled a structure-based campaign for new agonists of the D4 dopamine receptor.  The ability to efficiently exploit structure for specific probe discovery-rapidly moving from elucidating receptor structure to discovering previously unrecognized, selective agonists-testifies to the power of structure-based approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8NDKhkv_ILbVg90H21EOLACvtfcHk0lj1C2fiFA0Vng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns73I&md5=0bbb93e6bcb33577f9d9b7459273d896</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan5468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan5468%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DD4%2520dopamine%2520receptor%2520high-resolution%2520structures%2520enable%2520the%2520discovery%2520of%2520selective%2520agonists%26jtitle%3DScience%26date%3D2017%26volume%3D358%26spage%3D381%26epage%3D386%26doi%3D10.1126%2Fscience.aan5468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CM4','PDB','6CM4'); return false;">PDB: 6CM4</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00508">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56650"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00508">10.1021/acs.jmedchem.9b00508</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra of compound <b>38</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00508/suppl_file/jm9b00508_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00508/suppl_file/jm9b00508_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00508/suppl_file/jm9b00508_si_001.pdf">jm9b00508_si_001.pdf (424.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00508/suppl_file/jm9b00508_si_002.csv">jm9b00508_si_002.csv (3.06 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00508&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00508%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-9" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00508" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999b207f363d9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
